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ABSTRACT OF DISSERTATION

UNDERSTANDING CARBOHYDRATE RECOGNITION MECHANISMS IN
NON-CATALYTIC PROTEINS THROUGH MOLECULAR SIMULATION
Non-catalytic protein-carbohydrate interactions are an essential element of
various biological events. This dissertation presents the work on understanding
carbohydrate recognition mechanisms and their physical significance in two groups of
non-catalytic proteins, also called lectins, which play key roles in major applications such
as cellulosic biofuel production and drug delivery pathways. A computational approach
using molecular modeling, molecular dynamic simulations and free energy calculations
was used to study molecular-level protein-carbohydrate and protein-protein interactions.
Various microorganisms like bacteria and fungi secret multi-modular enzymes to
deconstruct cellulosic biomass into fermentable sugars. The carbohydrate binding
modules (CBM) are non-catalytic domains of such enzymes that assist the catalytic
domains to recognize the target substrate and keep it in proximity. Understanding the
protein-carbohydrate recognition mechanisms by which CBMs selectively bind substrate
is critical to development of enhanced biomass conversion technology. We focus on
CBMs that target both oligomeric and non-crystalline cellulose while exhibiting various
similarities and differences in binding specificity and structural properties; such CBMs
are classified as Type B CBMs. We show that all six cellulose-specific Type B CBMs
studied in this dissertation can recognize the cello-oligomeric ligands in bi-directional
fashion, meaning there was no preference towards reducing or non-reducing end of
ligand for the cleft/groove like binding sites. Out of the two sandwich and twisted forms
of binding site architectures, twisted platform turned out to facilitate tighter binding also
exhibiting longer binding sites. The exterior loops of such binding sites were specifically
identified by modeling the CBMs with non-crystalline cellulose showing that high- and
low-affinity binding site may arise based on orientation of CBM while interacting with
non-crystalline substrate. These findings provide various insights that can be used for
further understanding of tandem CBMs and for various CBM based biotechnological
applications.

The later part of this dissertation reports the identification of a physiological
ligand for a mammalian glycoprotein YKL-40 that has been only known as a biomarker
in various inflammatory diseases and cancers. It has been shown to bind to oligomers of
chitin, but there is no known function of YKL-40, as chitin production in the human body
has never been reported. Possible alternative ligands include proteoglycans,
polysaccharides, and fibers such as collagen, all of which make up the mesh comprising
the extracellular matrix. It is likely that YKL-40 is interacting with these alternative
polysaccharides or proteins within the body, extending its function to cell biological roles
such as mediating cellular receptors and cell adhesion and migration. We considered the
feasibility of polysaccharides, including cello-oligosaccharides, hyaluronan, heparan
sulfate, heparin, and chondroitin sulfate, and collagen-like peptides as physiological
ligands for YKL-40. Our simulation results suggest that chitohexaose and hyaluronan
preferentially bind to YKL-40 over collagen, and hyaluronan is likely the preferred
physiological ligand, as the negatively charged hyaluronan shows enhanced affinity for
YKL-40 over neutral chitohexaose. Collagen binds in two locations at the YKL-40
surface, potentially related to a role in fibrillar formation. Finally, heparin nonspecifically binds at the YKL-40 surface, as predicted from structural studies. Overall,
YKL-40 likely binds many natural ligands in vivo, but its concurrence with physical
maladies may be related to the associated increases in hyaluronan.
KEYWORDS: protein-carbohydrate interaction, cellulose, glycosaminoglycan, collagen,
molecular dynamics, free energy perturbation.
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Chapter 1 – Introduction
1.1

Carbohydrate-binding proteins
Proteins are the most abundant macromolecules in mammals, and are the most

diverse biomolecules in the living organisms [1, 2]. Proteins play many different roles in
the chemical and biological events of a cell from its birth to death, functioning as
enzymes, structural proteins, transporters, energy storage proteins, motor proteins,
antibodies in immune response, and regulatory proteins, etc.. They are mostly known to
work synergistically with either other proteins or biomolecules like carbohydrates [3].
Carbohydrates are the most abundant macromolecules in plant cells, where cell walls
consist of long polysaccharides [4, 5]. However, various sizes of carbohydrates,
oligosaccharides and short polysaccharides, are also found along the cell plasma
membrane and in the extra-cellular matrix of all living organisms, both independently as
well as in the form of protein-conjugates like glycoproteins. Naturally, the interaction
between proteins and carbohydrates in biological processes has a significant role,
reportedly in metabolic activities, cell recognition and signaling, catalysis, and
inflammation [6-11]. Such interactions also affect industrial processes, and enzymatic
degradation of cellulosic biomass to produce bioethanol is one of the most important
process among them, as we will discuss further.
Carbohydrate-binding proteins can be primarily categorized into two broad
classes: carbohydrate-active enzymes and catalytically inactive proteins. The latter class
of this protein population is commonly referred to as lectins, which can recognize and
bind carbohydrates with high specificity and high to moderate affinity, but without any
catalytic activity [3, 12-14].
1

Figure 1.1

l classification of protein-carbohydrate interaction and groups of

lectins based on their area of existence/function.
These non-catalytic carbohydrate-binding proteins, lectins, can be further divided
into groups such as carbohydrate-binding antibodies, selectins (lectins in the cell
membranes), intra-cellular lectins, extra-cellular lectins, and carbohydrate binding
modules (CBMs) [3, 15, 16]. Every group of lectins exhibits further variation in structural
and functional properties making it very challenging to generalize the overall noncatalytic protein-carbohydrate partnership. In this dissertation, I focus on case studies of
two of these non-catalytic carbohydrate-binding proteins, investigating (1) the molecularlevel recognition mechanisms of Type B carbohydrate binding modules that can
differentially bind to oligomeric and non-crystalline cellulose, and (2) the binding
mechanisms of the mammalian glycoprotein YKL-40, which is an extra-cellular lectin
primarily known as a biomarker whose functionality remains largely unknown.

2

1.2
1.2.1

Motivation
Sustainable cellulosic bioethanol
Over the last few decades, it has been acknowledged that ethanol produced from

lignocellulosic biomass has great potential to become an excellent
for the transportation sector [17-20]. Even though there are other upcoming green
technologies like electric and fuel-cell vehicles, lignocellulosic biomass-derived ethanol
is much needed, as unlike other technologies, it has great potential to achieve target
reductions in greenhouse gas emissions [21-23]. In the journey toward developing
biofuels, researchers have studied various aspects of this field, pointing out advances as
well as challenges in building a sustainable cellulosic bioenergy enterprise [24-27]. The
biochemical conversion of cellulose to fermentable sugars is considered to be one of the
most promising approaches, particularly when compared to other thermochemical routes
[28, 29]. Lignocellulosic biomass comprises a majority of plant cell walls and can be
biochemically converted to ethanol in five general steps: i) biomass handling ii)
pretreatment, iii) enzymatic hydrolysis, iv) fermentation, and v) ethanol recovery. The
enzymatic hydrolysis step is both a rate determining as well as expensive step [30, 31].
The highly crystalline nature of cellulose makes it recalcitrant to facile deconstruction
and challenging for enzymes to access the strong glycosidic linkages connecting the
soluble glucose monomers [29].
Nature uses multibiomass recalcitrance. Multi-modula
at least one catalytic domain (CD) appended by linker peptides to one or more
carbohydrate binding modules (CBM) [32, 33] (Figure 1.2).

3

Figure 1.2 Stick representation of cello-oligomer showing

-1-4 glycosidic linkages

between glucose monomers with reducing and non-reducing ends (top panel). Multimodular glycoside hydrolase exhibiting a catalytic domain connected by linker peptides
to carbohydrate binding modules (bottom panel).
The CD is responsible for catalytic activity, cleaving the glycosidic linkages of
cellulose. The non-catalytic CBMs assist the CD in targeting the substrate and serves as
the primary biological means of protein-carbohydrate recognition [16]. To attain the goal
of efficient biomass conversion, a significant amount of prior research has focused on
catalytic domains, as they are directly involved in the cleavage of glycosidic linkages and
can offer obvious gains in enzymatic performance. On the other hand, researchers have
just begun to explore and realize the carbohydrate recognition capabilities of CBMs in
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optimization of efficient biomass conversion. The specificity of CBMs may also be
harnessed for multitudes of other biotechnological applications, including, for example,
bioprocessing, targeting, cell immobilization, protein engineering, diagnostics, and fiber
modification [34, 35].

how

these carbohydrate binding modules specifically recognize their carbohydrate substrates
as a means to develop enhanced CBM-based biotechnology.
1.2.2

Lectin-mediated targeted drug delivery
their substantial involvement in various biological processes, lectins have

been extensively studied in medicinal chemistry as drug targets or as carriers to target and
deliver drugs to their site of action [36, 37]. Vice versa, carbohydrates in their various
forms (mono/oligo/poly-saccharide) have been used as drug carriers or labels and have
also been the target of drug molecules, especially the glycosaminoglycans [38].
Accordingly, the intertwined relationship between lectins and carbohydrates is an
invaluable asset in the field of targeted drug delivery [39].
Different cells are known to express different glycan arrays, and natural
combination of monosaccharides with various sets of substitutions and isomorphs can
result in a vast range of different chemical structures, ea
sugar code [36, 40]. In other words, malignant cells, like tumor cells, express different
glycans or glycoproteins compared to their benign counterparts, making malignant cells
potential targets of lectins [41]. Such appears to be the case with mammalian
glycoprotein YKL-40, which is overproduced by the human body in conjunction with
cancers and chronic inflammatory ailments, making it a well known biomarker of many
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diseases [42]. However, experimental efforts to understand the biological role and
mechanism of YKL-40 have been hindered by the difficulty associated with isolating the
various contributions from the cellular environment. To date, it is unclear what YKL-40
interacts with in the human body, but it has been reported to bind in vitro to chitooligosaccharides and collagen [43-45]. Better understanding of the different mechanisms
by which such lectins can target specific carbohydrates can add a new dimension to
engineering lectin-mediated drug delivery pathways and enhance our understanding of
inflammatory disease and cancer progression. Here, we focus on identifying the potential
physiological binding partners of this infamous biomarker lectin by screening the most
likely carbohydrate ligand candidates found within the extra-cellular matrix and
investigating the associated molecular-level binding mechanisms.
1.3
1.3.1

Research background
Carbohydrate binding modules
The catalytic domains of the carbohydrate-active enzymes, e.g., cellulases or

cellulosome enzyme complexes, can have a single or multiple smaller CBM domains that
aid in function; the domains are connected by linker peptides and typically hold
complementary specificity towards carbohydrate substrates [33, 46-48] (Figure 1.2). Prior
to 1999 [49], CBMs were known as cellulose binding domains (CBDs) because almost all
of those initially characterized were specific to cellulose. As more enzymes with noncatalytic domains binding carbohydrates other than cellulose were observed through
advances in biochemical and structural characterization (NMR and Xnomenclature shifted to a more general terminology of Carbohydrate Binding Modules
(CBMs) [49]. There are three proposed functions of CBMs in biomass deconstruction: i)
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maintaining proximity to substrates, ii) targeting specific regions, and iii) disrupting
surface crystallinity [16, 50]. Experimental results confirm that maintaining proximity to
substrate contributes to increasing enzyme concentration at the surface, resulting in
enhanced enzymatic deconstruction of polysaccharides [51-58]. Their function in
targeting distinct regions, specificity towards orientation of substrate [59-62], and
apparent variable functional capacity on chemically invariant substrates [63-66] are
appealing targets for enhanced biotechnology development and, accordingly, from the
perspective of understanding fundamental protein-carbohydrate binding mechanisms. The
disruption of substrate surface crystallinity by CBMs has been reported by relatively few
biochemical studies [67-71], and similar results have not observed for other CBMs [50,
51, 56, 72]. Thus, this latter proposed CBM function has not been widely accepted as a
general function by the community.
Finally, cellulosic substrates are comprised of glucose monomers linked together
through -1,4 glycosidic bonds and span a range of degree of polymerizations. -1-4glycan-specific CBMs appear to bind either crystalline or non-crystalline/amorphous and
oligomeric cellulose [16]. Competition isotherms suggest CBMs do not compete for
binding sites on these variable crystalline surfaces despite similar substrate specificities
[66, 73].
led to the classification scheme of different CBMs [16].
1.3.1.1 Terminology of CBMs
Classification of CBMs is based on similarity
are defined according to
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, while

[16]. CBMs largely appear to bind
either crystalline or non-crystalline/amorphous and oligomeric substrates. As of August
2017, there are 81 CBM families
Carbohydrate Active Enzymes (CAZy) database (http://www.cazy.org/CarbohydrateBinding-Modules.html) [74] . The current protocol for abbreviation of a CBM from a
given family is CBM#, where # is its family number. Also, the name of the native
microorganism <Genus species> producing the CBM may be added as prefix, i.e.,
GsCBM#.

-sandwich fold is the most common, shared by
more than 30 families. The CBMs are also grouped into three types (A, B, and C) based
on functional similarity and binding site topology (Figure1.2). Type A CBMs consist of
those with affinity towards crystalline substrate and have planar binding sites. Type B
CBMs are specific to free-single-glycan chain polysaccharides, have groove or cleft-like
binding site, and bind internally on single free glycan chains. And Type C CBMs bind
the termini of glycans with a simplified lectin-like binding site that can accommodate
only mono-/di-/tri-saccharides at the terminal end of a glycan chain [16, 75] (Figure 1.3).
Families generally belong to one of the types, for example CBMs from families 4, 17,
and 28 are all Type B CBMs, but there are exceptions, e.g., in family 2 and 3, that
illustrate the functional diversity of these carbohydrate-binding proteins and difficulty in
developing a cohesive categorization scheme [76, 77]. Before going into the details of
specific CBM families,

ally important to define the chemical nature of their

substrate.
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Figure 1.3 Classification of CBMs in three types (A, B, and C) based on binding site
topology and morphology of target substrate. Type A CBMs have a planar binding site
and target crystalline substrate. Type B CBMs have cleft or groove shaped binding sites
and target single free glycan chains. Type C CBMs have a binding site that bind to glycan
chain termini, i.e. reducing or non-reducing ends.
1.3.1.2 Substrates of CBMs - different target morphologies
Nature has developed plant cell walls as a complex network containing different
high molecular weight polysaccharides to reinforce strength and provide protection
against microbial and animal attack [29, 78]. These polysaccharides primarily include
cellulose, hemicellulose, and pectin, in varying percentages depending on the plant. The
secondary cell wall also contains lignin, which strengthens and waterproofs the cell wall.
Cellulose, the most abundant biopolymer on Earth, is the unbranched polymer of
-1-4-linked glucans and is the primary component of plant cell walls [4, 79].
Several polymer chains are stacked upon each other and are held together through a
network of hydrogen bonds in either parallel or anti-parallel chains constituting
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microfibrils of crystalline cellulose; such variations in chain directions and hydrogen
bonding patterns between chains/sheets define various polymorphs of cellulose [80]. Two
polymorphs, cellulose I and I

are naturally produced by plants and both exhibit only

intralayer hydrogen bonding with parallel-oriented chains [81, 82]. Cellulose II and III
are synthetic cellulose polymorphs that have been obtained through chemical
pretreatment of cellulose I, and exhibit antiparallel chains with both intra- and inter-layer
hydrogen bonding [83, 84]. The average number of monomeric glucose units in the
polymeric chains is called as the degree of polymerization (DP) of that cellulosic
substrate. The DP and polymorphism of substrate varies with source as well as pretreatment conditions of the biomass. For example, microcrystalline cellulose (e.g.,
Avicel) has a DP between 150 and 300, cotton and other plant fibers can have a DP in the
range of 800-10,000, and secondary cell wall cellulose has a much higher DP, up to
15,000 [5, 85]. Apart from crystalline cellulose, other cellulosic forms, such as paracrystalline (pseudo-ordered), amorphous/non-crystalline, and soluble cellulose, have also
been observed, although not essentially in its native structure [80]. This variation in
crystallinity and polysaccharide construction is thought to significantly contribute to
microbial

secretion of many different enzymes
ell wall components [29, 86,

87].
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Figure 1.4 Illustration of different possible morphologies of cellulose after biomass
pretreatment. (A) Surface representation of perfectly crystalline microfibril of cellulose
I . (B and C) Non-crystalline cellulose with disruptions in the microfibril; non-crystalline
regions at the end and in the middle, respectively. (D) Highly amorphous bunch of
polysaccharides of cellulose (E) Independent insoluble polysaccharide chain of cellulose
(F) Soluble cello-oligosaccharides from cellohexaose to monomeric glucose.
Crystalline cellulose is well characterized, including the network of hydrogenbonding interactions, as the structure of both the n
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and various other polymorphs have been identified through nuclear magnetic resonance
(NMR) spectroscopy [88], atomic force microscopy (AFM) [89] and X-ray diffraction
(XRD) [81, 82]. On the other hand, 3-dimentional structure determination of noncrystalline cellulose is not straightforward, leaving us with relatively little understanding
as to the non-crystalline forms of cellulose that lie between truly crystalline and highly
amorphous phases [90, 91]. Characterization of the amorphous cellulose regenerated
from dissolution of microcrystalline cellulose in SO2-diethylamine-dimethylsulfoxide
with XRD, Fourier-transform infrared microscopy (FTIR) and differential scanning
microscopy (DSC) could only confirm that it is a cellulose with a decreased degree of
polymerization and crystallinity index [92]. Thus, the pretreated cellulosic biomass is
thought to consist of a substantial amount of non-crystalline cellulose, including kinks or
twists in microfibrils and/or voids, such as surface micropores, large pits, and capillaries,
having either no specific structural properties or highly undistinguishable structural
characteristics [33]. Soluble oligomers are the smallest forms of cellulose, known as
cello-

o 6 (Figure1.3) [93]. The origin of

the plant biomass and pretreatment strategy are prime variables determining the target
cellulose morphologies subjected to enzymatic hydrolysis. Certainly, cellulose
crystallinity exists within a continuum, where clear delineations between regions are
difficult to discern. However, with findings such as regional CBM specificity with noncrystalline cellulose substrates [64, 65], it is increasingly evident that CBMs hold the
potential to probe such regions and provide insights to the structural complexity of the
non-crystalline cellulose [94].
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1.3.1.3 Cellulose-specific Type B CBMs
All Type B CBMs characterized up to now exhibit the most common protein fold
among CBMs [16], termed the -sandwich fold, which consists of
which contain

-sheets each of

-strands. The characteristic groove-like nature of Type B

CBM binding sites is akin to the active sites of glycoside hydrolase catalytic domains,
where hydrogen bonding interactions along with aromatic stacking mechanisms are
responsible for ligand binding [95]. The length of these binding sites can accommodate
free-single-glycan chains, generally with at least 3 and a maximum of 6 monomers in a
row. The depth of these grooves varies from being able to enclose the whole width of a
pyranose ring ( > 6 Å) to merely a shallow cleft (1-2 Å) [16]. The relatively solventexposed binding site allows these Type B CBMs to expand their specificity to a large
range of substrate morphologies, excepting pure crystalline polysaccharides and very
small sugars (mono-/di-/tri-saccharides).
The Type B CBMs from families 4, 17, and 28 have been shown to bind both
soluble cello-oligomers and non-crystalline cellulose, but never crystalline cellulose [51,
52, 54, 73, 96-98]. Despite having the

-sandwich fold and groove-like binding

sites, CBMs from these three families have further individual characteristics that enable
them to differentially bind non-crystalline cellulose in an uncompetitive mode [64, 99,
100]. Structural and thermodynamic studies of Type B CBMs have been conducted to
gain insight into the CBM-carbohydrate recognition process, bringing to light additional
as mentioned ahead. For example, variations in thermodynamic binding
signatures for CBMs within these same families have been observed despite the strong
structural

similarities [64, 101, 102]. Mutagenic studies of key residues
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comprising the binding site report individual contributions to binding affinities [99, 100],
but comprehensive characterization of such contributions across several Type B CBMs is
needed to identify their roles in the carbohydrate recognition process. An NMR study
reported the counterintuitive finding that family 4 CBMs are able to bind oligomers in
multiple orientations [61], although structural-level carbohydrate binding mechanisms
were obscured; the crystal structures of ligand-bound CBMs from families 17 and 28
report only a single ligand orientation [62]. Additionally, the motivation for microbial
evolution of these carbohydrate binding modules from individual entities to tandem
systems is the long-term

(Details in Section 1.3.1.5).

Formation of these multivalent carbohydrate-binding proteins can significantly enhance
ligand-binding affinity relative to individual modules [51, 64, 102-104], although this is
not a given [98].
consideration, along with the fact that we have
an abundance of unexplained experimental phenomena, which could benefit from
theoretical investigations, our focus lies on understanding the carbohydrate recognition
mechanisms of family 4, 17, and 28 CBMs. We have conducted a comprehensive
examination of carbohydrate recognition in six different Type B CBMs (two from each
family 4, 17, and 28) having specificity for both cello-oligomers and non-crystalline
cellulose, along with two tandem CBMs (Figure 1.5). One tandem CBM is a blend of two
family 4 CBMs, whereas a second tandem CBM consists one from each family 17 and
28, as they would be naturally secreted by the associated microorganisms [105, 106].
Details of each CBM are described below based on the studies reporting their structural
biology and characterizations of soluble cello-oligomeric binding. Further information
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about the non-crystalline binding characterizations for these CBMs is then provided
collectively in the next section.

Figure 1.5 The study addresses carbohydrate recognition in six Type B CBMs, two from
each of the three families – 4, 17, and 28. Two tandem CBMs were included in this work.
The letters preceding the CBM# represent the name of bacteria that produces that CBM.
Cf – Cellulomonas fimi, Cc – Clostridium cellulovorans, Bsp – Bacillus sp. 1139, Cj –
Clostridium josui. Structures of CfCBM4-1 (light pink

), CcCBM17 (light

blue, PDB 1J84) and CjCBM28 (light green, PDB 3ACI) are shown for comparison.
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1.3.1.3.1 Family 4 CBMs
CfCBM4-1 and CfCBM4-2, selected to represent family 4, are two N-terminal
binding domains from Cellulomonas fimi -1,4-glucanase C (CenC/Cel9B) [105]. The
two CBMs naturally occur in tandem and are linked to the Cel9B catalytic domain
through a four-amino acid peptide linker. Through various methods to detect
carbohydrate-binding specificity, CfCBM4-1 appears to preferentially bind cellulosic
substrates, with cellopentaose and cellohexaose binding with similar affinities [98, 107].
Quantitative evaluation of binding affinity by Isothermal Titration Calorimetry (ITC)
suggested that CfCBM4-1 binds cello-oligomers in an enthalpically-driven fashion, based
on favorable change in enthalpy compensated by negative change in entropy [98].
Prevalent polar interactions, especially hydrogen bonding, appear to be central for
specificity towards the cello-oligosaccharides [99, 108, 109]. Structural studies with both
NMR spectroscopy and X-ray crystallography revealed that CfCBM4-1 binds cellooligomers in a binding groove formed on the

-sandwich fold. This binding

groove is comprised of oppositely facing hydrophobic residues sandwiching the relatively
hydrophobic pyranoside rings [62, 108] (Figure 1.5). On the sides, several polar and
hydrophilic residues are involved in binding, as identified through mutagenesis [99];
however, the role of orientation of cello-oligomers and their side chains in hydrogen
bonding was unclear. We identify the critical binding modes with which cello-oligomers
bind CfCBM4-1 in a directionless fashion, details of which are discussed in Chapter 3.
In addition to being a tandem CBM partner, CfCBM4-2 shares a very similar
tertiary structure and sugar binding properties with CfCBM4-1 [110]. Though very
similar, the CfCBM4-2 binding cleft is not identical to that of CfCBM4-1. Detailed
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comparison reveals that a few binding site residues that interact with the bound ligand in
CfCBM4-1 are substituted. The NMR structure captures CfCBM4-2 in its apo state, and
thus, the absence of ligand interactions could likely be the reason behind the larger width
of its binding groove relative to that of CfCBM4-1. Based on our molecular dynamics
study of CfCBM4-2 docked with cellopentaose in the binding
intriguing to observe that the width reduces to approximately that of CfCBM4-1 during
the

period and remains almost the same over the remainder of the

simulation (details in Chapter 3). We have further analyzed the variability in
thermodynamic signature between these two family 4 CBMs in Chapter 4. The two
CBM4s are naturally found in a side-by-side orientation, prevented from end-to-end
orientation as a result of the lack of a flexible peptide linker [110]. We anticipate that this
contributes, in part, to their apparent additive rather than cooperative binding when
studied as tandem system.
1.3.1.3.2 Family 17 CBMs
This family of CBMs is represented by CcCBM17, the C-terminal domain of
Clostridium cellulovorans Cel5A solved by Notenboom et al. [100]. As the only CBM17
structure to date, CcCBM17 has been the subject of numerous biochemical studies.
CcCBM17 appears to have optimal affinity towards cellohexaose, with a minimum
[97]. Although belonging to Type B, the binding site
of CcCBM17 is barely recognizable as groove, with a shallow depth of 1-2 Å compared
to the 4-6 Å of family 4 CBMs. The sandwich platform of CBM4s is also replaced by
twisted platform in CBM17s, such that two tryptophan residues are facing away from
protein core to stack directly with the ligand pyranoside rings in addition to the polar
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residue network running along

sides. Aromatic residues are of supreme

importance in these CBMs, as their mutation to alanine destroyed affinity of CcCBM17
for any tested ligand [100]. Up to 25-fold reductions in binding affinity with mutation of
each polar residue also illustrates the crucial contribution of hydrogen bonding [100]. A
computational alanine scan confirmed the importance, though not the role, of these polar
residues [111]. This study also calculated ligand binding free energy of cellotetraose and
cellohexaose bound to CcCBM17, but the accuracy of absolute binding free energies
calculated using molecular mechanics/generalized Born surface area (

) are

not reliable, and its application is typically restrained to relative ranking of binding
affinities in pharmaceutical applications [112]. Here we use a robust, explicit solvent and
enhanced sampling method, called as free energy perturbation with Hamiltonian replica
exchange MD, recently used to calculate reliable and more accurate absolute binding free
energies in relatively large protein-ligand system [113].
thermodynamic study for cellotetraose binding in CcCBM17 suggest that it is an
enthalpically-driven binding process, as they dominate over
changes in both enthalpic and entropic terms with increasing length of bound cello-driven. The large negative
change in heat capacity values, by comparison to those from family 4, are consistent with
burial of significant non-polar surface and solvent reorganization, which is strongly
correlated with change in entropy [100]. Such entropy-driven binding was also observed
in another family 17 member from Clostridium josui (CjCBM17) [102].
BspCBM17 is also included in this work given its occurrence in the
biochemically-characterized tandem CBM from Bacillus sp. 1139 Cel5A, though no
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structure is currently available. CcCBM17 has been used to draw parallels with
BspCBM17,
ligand binding residues are thought to be conserved [64]. Here, we used homology
modeling to construct BspCBM17 and investigate its binding functionality. Importantly,
it has also been used to study characteristics of cello-oligomer binding in the tandem
CBM, BspCBM17/CBM28. In spite of high fold similarity between family 17 and family
4, mode of carbohydrate recognition appears to be different across the two CBM families.
As we point out, the differences in topology of their binding sites and thermodynamics
are likely the driving force behind variation in binding (Chapter 4). Nature has evolved
these CBMs to recognize various architectural regions on the cellulosic substrate.
1.3.1.3.3 Family 28 CBMs
The first representative of family 28 CBM was identified from Bacillus sp. 1139
Cel5A, a C- terminal carbohydrate-binding module (BspCBM28) [96]. A second, related
CBM from Clostridium josui Cel5A (CjCBM28) is also considered in this study.
Structural studies for both the CBMs illustrate their differences from the other two Type
B CBM families. The binding site for family 28 CBMs is also wide and shallow, similar
to that of CcCBM17, with one face of the cello-oligomer stacking with tryptophans and
the other face exposed to solvent [101, 106]. There is one additional aromatic residue in
the binding site of CBM28s compared to that of CBM17s. According to ITC results,
BspCBM28 binds to cellotetraose, cellopentaose, and cellohexaose in increasing order of
binding affinity. Values for cellotetraose and cellopentaose suggest binding is driven
enthalpically, but binding of cellohexaose exhibited a thermodynamic signature
consistent with significant entropic contributions [96]. Contrasting with BspCBM28,
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CjCBM28 is reported to bind cello-oligosaccharides enthalpically, despite the fact that
the two structures are very similar; although, the study did not include binding with
cellohexaose, limiting a complete comparison [102]. The recognition process depends
upon key residues involved in binding of family 28 CBMs to cello-oligomers. However,
no mutagenesis study of these proteins has been reported to date. Here, using a
computational approach, we investigated the differences in oligosaccharide recognition
for both family 28 CBMs and address many of the remaining

posed by the

experimental studies.
Comparing CBMs from all three families, it is apparent that family 4 has deep
binding groove, whereas both family 17 and 28 have relatively shallow but similar
binding clefts. Why this difference evolved for structurally related CBMs of seemingly
the same function, at a superficial level, will be addressed. Additionally, even if relative
binding affinities for cello-oligosaccharides of family 28 and 17 imply similar
carbohydrate recognition mechanisms, the amino acids involved in binding are poorly
conserved in two families [64]. Ligand bound structural evidence for CBMs from both
family 17 and 28 show carbohydrates occupying the binding site in opposite directions
[101], and again despite the similarities, this kind of variation likely relates to functional
differences between the members and should be better understood from the molecular
level.
1.3.1.4 Non-crystalline cellulose recognition by Type B CBMs
The interesting fact that these cellulose-specific Type B CBMs bind cellooligomers and can selectively bind various forms of non-crystalline/amorphous cellulose
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is one of the primary reasons we initiated our study investigating these proteins and their
molecular-level substrate interactions. Experimentalists commonly use different forms of
purified cellulose like Avicel, regenerated amorphous cellulose (RAC), and phosphoric
acid swollen cellulose (PASC) to imitate specific cellulose microstructures. Avicel,
although being known as microcrystalline cellulose, contains partially decrystallized
regions, as binding of both CfCBM4-1 and CfCBM4-2 to Avicel was confirmed in one of
the first biochemical studies of Type B CBMs [114]. The latter two cellulose model
substrates have been specifically used as representatives of non-crystalline/amorphous
forms of cellulose. CfCBM4-1 was shown to bind 21-fold stronger to regenerated
cellulose than to Avicel, although still with a higher affinity for cello-oligomers [98]. In
contrast, the family 17 and 28 CBMs show a one order of magnitude affinity
improvement towards Avicel and regenerated amorphous cellulose relative to cellooligomers [99, 100]. Langmuir isotherms were not sufficient to describe this latter
binding affinity data for CcCBM17 and BspCBM28, and use of a two-binding-site model
suggested both CBMs recognized two binding sites on the amorphous substrate differing
in affinity, a high affinity site and a low affinity site [64]. Additionally, the CBMs did not
compete for these two binding sites [64, 73], which is indicative of the presence of
cellulose chains with structural features (e.g., conformation, proximity to other chains, or
variations in solvation) that are distinguishable by the specific CBMs only. A recent
study using fluorescent labels shows that two CBMs, one from each family 17 and family
28, bound two different non-crystalline regions of sweet potato roots [65]. In a further
study from Boraston et al., high and low affinity binding sites were again observed,
where binding to each was defined as an enthalpically-driven process [115]. Notably,
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there was less loss of configurational entropy in the low affinity sites, and we hypothesize
that they correspond to less crystalline or somewhat oligomeric nature of the ligand
[115]. Although all these studies confirm the important role these Type B CBMs play in
the targeting function
of CBMs based on type, architecture, and thermodynamics. In Chapter 4, we propose that
carbohydrate recognition mechanisms for cello-oligomers closely mimic those of the
identified low affinity binding sites on non-crystalline cellulose. Likewise, CBM
carbohydrate recognition of high affinity non-crystalline cellulose binding sites will
proceed through adapted mechanisms, allowing the CBMs to discriminate between
regions on the non-crystalline cellulose surface.
1.3.1.5 Carbohydrate recognition in tandem CBMs
Another confounding aspect of the Type B CBM carbohydrate recognition story
is the evolutionary presence of tandem CBMs found in glycoside hydrolases. Both family
4 CBMs are found in tandem arrangement, and one from each family 17 and 28 comprise
cooperatively acting tandem system (Figure 1.2). We anticipate that the specific
carbohydrate recognition mechanisms belonging to individual CBMs ultimately relate
back to the biological implications behind the evolutionary presence of tandem CBMs.
The contrasting examples of BspCBM17 and BspCBM28 connected together in tandem
in Bacillus sp. 1139 Cel5A that enhanced affinity of the system for non-crystalline
cellulose by 10–100 fold relative to their individual affinities [106], and tandem-linked
family 4 CBMs from Cellulomonas fimi CenC that merely additively improved affinity
relative to separate domains [98] have driven us to learn more about this. Other than these
affinity comparisons and a proposed two-step mechanism [116], much remains to be
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explored about structural or dynamical mechanisms involved in binding cooperativity and
effects of avidity on hydrolysis. The biological significance of cooperative affinity
enhancement in tandem CBMs is unclear, with such cooperativity used by hyperthermophilic organisms to overcome weak binding in high temperature environments
[104] also being exhibited by CBMs from mesophiles [64]. A potential alternative
function of tandem CBMs is that they may fine-tune the binding specificity, as binding
models suggest that low affinity binding sites will only be bound when all high affinity
sites are completely occupied [64]. Our computational approach provides an avenue to

1.3.2

Mammalian glycoprotein YKL-40

1.3.2.1 YKL-40: a biomarker
YKL-40, also known as chitinase 3-like 1 (CH3L1), is a mammalian glycoprotein
implicated as a biomarker associated with progression, severity, and prognosis of chronic
inflammatory diseases and a multitude of cancers [117-120]. The protein is
overexpressed in many pathological conditions that involve connective tissue remodeling
or increased deposition of connective tissue components. For example, increased levels
of YKL-40 are reported in the blood serum of patients with rheumatoid and osteoarthritis,
hepatic fibrosis, and asthma [121-125]. YKL-40 was first identified from the medium of
-63 [126]. The first three N-terminal amino acids of
this protein, Tyrosine (Y), Lysine (K) and Leucine (L), and the molecular mass of 40 kDa
are the basis of the name YKL-40. Many different types of cells including synovial,
endothelial, epithelial, smooth muscle, and tumor cells produce YKL-40 in vivo, likely in
response to environmental cues [42, 127-129]. Speculation as to biological function of
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YKL-40 varies from both inhibiting and antagonizing collagen fibril formation as a result
of injury or disease [45], as well as conferring drug resistance and increasing cell
migration leading to progression of cancer [119], and protection from chitin-containing
pathogens [43]. Though the association of YKL-40 with physical maladies is welldocumented, identification of the physiological ligand of this lectin, and thus biological
function, remains elusive.
1.3.2.2 Known structural and functional properties of YKL-40
Mammalian YKL-40 is

family 18 glycoside hydrolases
-conserved class of enzymes in the

CAZy database [43, 44, 74]
macrophage chitinase (HCHT) [130]. The crystal structure of human YKL-40, also
occasionally referred as human cartilage glycoprotein-

-39), was found to be

similar to the crystal structure of human chito-triosidase [130], mouse YM1 [131]
2 from common fruit fly [132] and other family 18

-

[133] (Figure 1.6.A). Structural

analyses of YKL-40 and these enzymes reveal that they consist of a (

)8 barrel (Figure

1.6.C), and in some cases, an extra / domain is inserted in one of the barrel loops [43,
44, 130]. Though very similar in binding site architecture to family 18

, YKL-40

lacks catalytic activity due to substitution of the glutamic acid and aspartic acid at the end
of the conserved DXXDXDXE motif typical of catalytically-active family 18

,

rendering YKL-40 a lectin – a non-catalytic sugar-binding protein. YKL-40 exhibits an
N-glycosylation site at Asn60, where a disaccharide of N-acetyl glucosamine is attached
(Figure 1.6.C) [43, 44]. Structural evidence suggests YKL-40 exhibits at least two
functional binding regions, the primary binding cleft has nine binding subsites lined with
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aromatic residues compatible with carbohydrate binding (Figure 1.6.B), where chitooligomers have been shown to bind with YKL-40 [43]. A second putative heparinbinding site, located within a surface loop, has also been suggested (Figure 1.6.B), though
in vitro binding affinity studies have been unable to conclusively demonstrate this [44].
-binding sites on the
external surface of folded YKL-40 [134]; however, the structural evidence of these
binding sites, again, has not been observed in any structural studies.
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Figure 1.6 (A) YKL-40 (gray cartoon) aligned with Serratia marcescens family 18
Chitinase A (cyan cartoon) illustrating structural similarity and chito-oligomers (stick of
respective color) binding similarity. (B) Surface representation of YKL-40 showing the
binding cleft with a bound hexamer of chitin. Binding sites +2 through -4 are numbered.
Sites -5, -6 and -7 have also been identified but are not shown. The putative heparinbinding site is shown in marine blue. (C) Side view of the structure of YKL-40 (gray
cartoon) illustrating the (

)8 barrel fold and N-linked glycosylation (green sticks).

Transparent surface rendering shows the overall bean-shaped nature of YKL-40.
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1.3.2.3 Potential physiological ligands
Binding affinity and structural studies reveal that chito-oligosaccharides are a
natural substrate [43, 44, 127]. In line with family 18

, YKL-

and long chito-oligomers, indicating preferential site selection based on affinity [43].
Chitohexaose binding has also been purported to induce conformational changes in YKL40 [43], though this has not been observed in all structural studies [44]. Lectin binding
niches are widely believed to be “pre-formed” with respect to the preferred ligand,
exhibiting little conformational change upon binding [13, 135]. Despite the apparent
affinity, chitin is not a natural biopolymer within mammalian or bacterial cells, and the
presence of chitin or chito-oligosaccharides in mammals is likely related to fungal
infection [136]. The noted up-regulation of YKL-40 in response to inflammation lends
credence to the argument that YKL-40 functions as part of the innate immune response in
recognition of self from non-self [12, 127]. Although, high expression levels of YKL- 40
in carcinoma tissues suggest function beyond the innate immune response may also exist
[137, 138]. The extracellular matrix is comprised of a mesh of proteoglycans (protein, including collagen
(Figure 1.7) [139]. An alternate theory to the pathogenic protection function is that a
closely related polysaccharide, instead of chitin, plays the role of the physiological ligand
in mediating cellular function [44].
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Figure 1.7 Molecular composition of extracellular matrix. The glycosaminoglycans are
most likely found as highly glycosylated components of proteoglycans. Structural
glycoproteins exhibit very little glycosylation.
The association of YKL-40 with ailments such as arthritis, fibrosis, and joint
disease is suggestive of molecular-level interactions with connective tissue, and thus
collagen [140-144]. Motivated by understanding the physiological role of YKL-40 in
connective tissue remodeling and inflammation, Bigg et al. investigated association of
YKL-40 with collagen types I, II, and III using affinity chromatography to confirm
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binding to each type [45]. The authors report YKL-40 specifically binds to all three
collagen types. Additionally, the authors used surface plasmon resonance (SPR) to
confirm binding to Type I collagen. Unfortunately, the reported affinity constants were
inconsistent across experiments as a result of aggregation. Nevertheless, the work clearly
indicates YKL-40 is capable of binding collagen. With more than 28 types of collagen
reported to exist in human body, it becomes critical to obtain molecular level insights to
such protein-protein interactions, as it likely has profound physiological significance in
understanding the functionality of YKL-40. However, this
of mechanism when considering physiological ligands, as YKL- 40 is capable of binding
both carbohydrates and proteins.
Proper consideration of the structure and chemical nature of the ligand relative to
the YKL-40 binding site(s) enables us to envision the chemical design of potent binding
partners for a target (in lectin-mediated drug delivery) or potential approaches to block
lectins of medical importance (in infection, tumor spread, or inflammation). With this
goal in the mind, we approach the tasks of identifying the physiological ligands of YKL40 from a subset of six polysaccharides and glycosaminoglycans plus four triple helical
collagen-like peptides and exploring the interactions characterizing the various aspects of
functionality of this well-known, but mysterious lectin.
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1.4

Outline of Dissertation
The overall theme of the dissertation is to identify and understand the interactions

mediating protein-carbohydrate recognition at the molecular level. We examine these
interactions in two different model protein-carbohydrate systems and address critical
pertaining to their structure-function relationships through dynamics and
affinity data. The insights we obtained here can be utilized in future studies in a wide
range of applications.
As we study carbohydrate recognition in the Type B CBMs, we focus the investigation
on two important objectives that highlight their story and role in nature:
I.

Cello-oligomer binding dynamics and bi-directional binding phenomenon in Type
B CBMs (Chapter 3).

II.

Role of binding site architecture and high/low affinity binding on non-crystalline
cellulose in Type B CBMs (Chapter 4).
identify the physiological ligand of the multi-functional mammalian

glycoprotein YKL-40, we divided the study into two parts:
I.

Carbohydrate ligands of YKL-40: Binding mechanisms, thermodynamic
preferences and surface binding ability (Chapter 5).

II.

Protein-protein interactions of YKL-40: Identification and characterization of
collagen binding sites (Chapter 6).
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Chapter 2 – Computational methods
Our computational investigation of complex protein-carbohydrate systems to

methods. Classical molecular dynamics (MD) simulations and free energy calculations
are two important methods that are have been used in this study. Additionally, we have
utilized tools prior to and after the primary, data-gathering calculations to build the
models, run the simulations, and analyze the data. In this chapter, the theoretical
background of these computational methods has been briefly explained to justify their
application in this dissertation. Detailed protocols of implementation for methods used in
a chapter have been described in respective methods section of each chapter.
2.1

Pre-dynamics tasks
Classical MD simulations of biomolecules have been used over the last few

decades to predict structural and dynamical properties, microscopic interactions, and
ultimately, calculate free energy profiles. To build and run an MD simulation for a
particular molecular system, one needs to have dependable initial atomic positions, like a
crystallographic structure or reliable homology model, well-tested, compatible force-

dissertation, we used available structural data for CBMs and YKL-40 from the Protein
Data Bank (PDB) in most cases; however, we needed to perform homology modeling in
the case of the BspCBM17 structure and occasionally molecular docking to obtain the
desired initial coordinates of the protein-carbohydrate and protein-protein complexes.
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2.1.1

Homology modeling
As the term suggests, homology modeling, or comparative modeling, is a method

to generate an atomic-resolution model of a target protein for which no structural data is

-ray crystallography
or NMR spectroscopy. Various applications of homology modeling in the drug-discovery
process have been reported, yielding critical insights about structural and mechanistic
properties of proteins that are experimentally difficult to purify or crystallize [145, 146],
-protein-coupled receptors [147]. Out of all the proteins studied in this dissertation,
we did not have the structural data for only one protein, BspCBM17. However, as
described in Chapter 1, this CBM is an important part of this study as a representative of
family 17 CBMs and as a component of the native tandem CBM construct of Cel5A from
Bacillus sp. 1139.
The general homology modeling protocol of a protein involves five general steps:
1. Search, identify, and select the template protein structure.
2.

.

3. Build a preliminary model based on the structural information from the template.
4. Check for errors. Atom-atom overlaps, missing segments, etc.
5. Evaluate the model. Fold, ramachandran plot, stereochemistry, etc.

can go back to first step, choose the next best template and repeat steps 2 to 5. The
detailed process of comparative protein modeling has been previously defined in the

32

literature [145]. We have used a fully automated protein structure homology-modeling
server SWISSwith a
simplified user interface and workflow [148-150]. It uses Qualitative Model Energy
Analysis (QMEAN), a composite scoring function based on four different geometrical
properties that provides both global (i.e., for the entire structure) and local (i.e., per
[151]. QMEAN4 < general overview of homology modeling of the BspCBM17 target structure from the
CcCBM17 template structure (PDB ID –
illustrated in Figure 2.1.
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Figure 2.1 Homology modeling of BspCBM17 using the SWISS-MODEL. The
QMEAN4 for this model was – 2.34 suggesti
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2.1.2

Molecular Docking
When two macromolecules, such as a protein and a carbohydrate, are known

through biochemical studies to form a complex, docking of one molecule to another can
be utilized to understand physical interactions, binding mechanisms, and binding affinity
between those two molecules; this presumes there is either sufficient structural evidence
of similar associations from which to model or biochemical evidence identifying the
protein binding site. There are multiple approaches to docking, and we implement three
different docking methods in this dissertation, each of which is appropriate to the
available experimental data and binding scenario. Our docking cases include two cases
where the binding site is clearly identified from structural evidence (bound docking) and
one case wherein a biochemical association suggests a binding site (unbound docking).
2.1.2.1 Docking of oligomeric ligands through pairwise alignment
situation where the cellooligomeric ligand was common and CBMs were different. The general assumption
behind this docking approach is that, with very high structural and chemical similarity of
binding sites in CBMs from same family the oligosaccharide ligands would occupy
approximately same position in the binding sites. For CBMs with only apo structures
available, we transferred the coordinates of the cello-oligomer from a holo structure of a
highly homologous CBM from the same family after a pairwise alignment. We used the
DALI pairwise comparison tool to obtain the aligned structures [152]. After the
alignment, we copied the cello-oligomer into the binding site of the target CBM, which
was followed by an extensive vacuum minimization protocol in the MD simulation setup
process. This docking methodology was used in the cases of CfCBM4-2, BspCBM17
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(apo structure obtained through homology modeling), and BspCBM28 where the cellooligomer was docked from the available holo structures of CfCBM4-1, CcCBM17, and
CjCBM28, respectively. A general overview of this docking is shown in Figure 2.2.

Figure 2.2 Docking of cello-oligomers through pairwise alignment. Illustrated here is an
example of docking cellopentaose with apo BspCBM28 (PDB 1UWW) structure using
the holo structure of CjCBM28 (PDB 3ACI).
2.1.2.2 Oligosaccharide docking based on structural similarity
All the carbohydrate ligands considered in search of the potential physiological
ligand of YKL-40 are composed of monomers with six-membered pyranose ring as the
structural backbone. In contrast with CBMs, here we have a common protein with
variable ligands. We utilized the structural similarity of the ligands to dock the
monomeric units of the desired oligosaccharide at the most favorable positions based on
the known coordinates of the bound chito-oligomer in the YKL-40 crystal structure. The
chair conformation of six-membered pyranose ring, being mostly symmetrical, allows
approximate positioning of the structurally similar monomer of the desired
oligosaccharide. The sidechains of the ligand were then built by using the internal
coordinate data (i.e., standard bond distances and angles for a given residue) provided in
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the topology of the respective monomeric units. An example of cellohexaose docking
based on chitohexaose coordinates is illustrated in Figure 2.3.

Figure 2.3 Transition from chitohexaose (green-red sticks) to cellohexaose (cyan-red
sticks) using structural similarity and sidechain rebuilding with internal coordinates from
topology database. This proc
2.1.2.3 Protein-protein docking with shape complementarity
To identify the surface-binding site on YKL-40 for relatively large ligands like
the triple helical collagen peptides, we used a different a
of rigid molecules. The binding affinity between two molecules depends upon nonbonded interactions such as van der Waals and electrostatic contributions, but it is also
necessary that their shapes are complementary to each other. Making the naïve
assumption that the interacting molecules have rigid surfaces, matching local shape
features, like local curvature maxima and minima, has been previously reported to
correctly predict biomolecular association [153-155]. We implemented the shape
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complementarity docking method by using the algorithm called PatchDock, which was

vision [156].

Figure 2.4 Surface representation of YKL-40 (gray) and collagen triple helix
(multicolored) illustrating the concave and convex patches.
The algorithm has three major stages [154], explained here in brief:
1. Molecular Shape Representation – In this step, the molecular surface of the
molecule is computed. Next, a segmentation algorithm is applied for detection of
geometric patches (concave, convex and flat surface pieces). The patches are filtered,
so that only p
2. Surface Patch Matching –

-Clustering

Concave patches are matched with convex and flat patches with any type of patches.

38

3. Filtering and Scoring – The candidate complexes from the previous step are
examined. All complexes with unacceptable penetrations of the atoms of the receptor
to the atoms of the ligand are discarded. Finally, the remaining candidates are ranked
according to a geometric shape complementarity score.
2.2

Molecular dynamics (MD) Simulations
MD simulations implemented in this study are a computational approach to

predicting atomic-level interactions in a system of molecules based on time-dependent
calculation of atomic positions using classical mechanics and empirically-derived forces
between all the atoms in the system (i.e., force fields) [157, 158]. When such calculations
are performed with very small time-steps (i.e., 1-2 femptoseconds) consecutively over a
period of time to obtain a trajectory, the statistical analysis of this large data set of atomic
catalytic protein-carbohydrate binding interactions. MD simulation of biomolecules has

significant impact on transformation of process of drug discovery [159, 160].
For N number of atoms in a system, the forces acting on each atom are governed
by the potential energy function, U(rN), which is function of the position of each atom, rN.

[161, 162]

[163, 164]

[165] being the most

commonly used versions.
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where,
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)

is the force acting upon atom i,

is the mass of the atom,

…

2.1

…

2.2

is the acceleration

of the atom, and is the position vector of the atom. i =(1,2,3,…,N)
The sum of bonded and non-bonded contributions represents the total
potential energy of the system as a function of atomic coordinates
b) from
b0), where Kb is the force constant; bending of angles ( ) from
0),

where K is the force constant; rotation of dihedral angles ( )
K is the force

constant; perturbation of improper angles (

0),

where K is the force constant; the Urey-Bradley vibrational term (UB, S); and the
backbone torsional correction factor (CMAP,

,

). The non-

2.5) include summation, over pairs of atoms, of Coulombic interactions between point
atomic charges (qi and qj) and the Lennard-Jones (LJ) 6-12 term, where
the depth of the potential well,

represents

is the distance at which the LJ potential reaches its

minimum value, and rij is the interatomic distance between two atoms, i and j. The
term represents the short-range repulsive interaction, and the
long-range attractive/dispersive interaction of the LJ potential.
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[166], is the

functional form of potential energy that can be used with the CHARMM36 all atom
forcethe

periodic boundary conditions, and temperature and pressure control methods can be
found in literature [167, 168]; also, details of our simulation protocols and parameter
selections have been provided in the methods section of each chapter with corresponding
references. In this dissertation, we have used CHARMM [166] and NAMD [169] as
simulation software packages in association with VMD [170] and PyMOL [171] as
molecular modeling and visualization tools. The latter two of which provide various
modules to perform and analyze the MD simulations according to scientific needs.
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2.3

Free energy calculations
While understanding the dynamic binding mechanisms of two biomolecules is

important, knowing the free energy change associated with a binding event is also
important, as it adds context to the characterization of ligand binding site dynamics and
enables comparison of thermodynamic favorability in the case of multiple potential
ligands. Free energy is a state function, and, although the difference in free energies of
two states of a system is independent of the path chosen, one must pay attention to
convergence and optimize use of computational resources. Here, we have used two
enhanced-sampling free energy computation approaches to determine binding affinities.
2.3.1

Free Energy Perturbation with Hamiltonian Replica Exchange Molecular
-REMD)
-REMD

-sampling,

i.e., replica exchange, to calculate relatively accurate absolute binding free energies of
small molecules to proteins. A computationally inexpensive FEP simulation protocol was
first developed by Deng and Roux, applicable to small ligands like benzene [172, 173].
With the availability of much faster and less expensive computational resources, Jiang et.
al. [174, 175] modified this protocol by using FEP in association with Hamiltonian
replica exchange MD to significantly improve the sampling and accelerate the
convergence of computations, expanding application to a wider range of ligand
molecules. The binding affinities of proteins for oligosaccharides calculated using this
method are directly comparable to experimental binding free energies of the same
systems measured using ITC.
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Figure 2.5 The thermodynamic pathway implemented in

-REMD to obtain ligand

binding free energy. “Solv” refers to the solvated system and “Vac” refers to the vacuum.
The overall alchemical pathway used in this method (Figure 2.5) to calculate the
b)

between protein and ligand includes two independent

steps: i) decoupling of the ligand interactions from the protein-ligand complex in solution
and ii) decoupling of the ligand interactions from the solvated ligand without the protein.
b.

In each

step of this pathway, the free energy change is calculated by gathering contributions from
-bonded
interactions and restraints.

=
where,

+

+

+

+

…

. 2.6

is the potential energy of the system with totally non-interacting ligand
Thermodynamic coupling parameters,

rep,

disp,

and

elec

and electrostatic interactions, respectively, are uniformly distributed over the number of
replicas dedicated to the type of interaction. Figure 2.6 illustrates the implementation of
replica distribution in which we used 128 replicas in total, with 72 repulsive, 32
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dispersive, and 24 electrostatic replicas. Each replica from the set of replicas within a
given type occupies multiple processors, in a parallel/parallel mode. The probability of
whether

-swap between the given two replicas will happen or not is calculated by a

conventional Metropolis Monte Carlo algorithm [174]. In our study, the fourth
contribution from restraints, usually having relatively little contribution (needed only in
the 1st step to maintain the distance between the center of mass of protein and that of

time. Instead, MD simulations with

rstr

distributed over 13 consecutive windows of 0.1

ns each, followed by numerical in

[173] were used to

determine the contribution to free energy from added restraints.

Figure 2.6 Scheme of replica distribution and exchange in

-REMD, as

implemented in this dissertation. Each box represents an individual MD simulation with
specified conditions of . The arrows represent the possible attempts of -swap with
neighboring replicas after each replica has completed the MD steps specified by replica

case. The scheme has been adapted with permission from Jiang et. al. [175]. Copyright
2010 American Chemical Society.
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For the three main contributions, we run these set of 128 replicas for 20 or more
consecutive (but independent) windows of 0.1 ns each. After collecting the output
potential energies from all the replicas and regrouping the values corresponding to values for each type of interactions at the end of each window, multistate Bennett
Acceptance Ratio (MBAR) method was used to determine the free energy changes for
individual contributions along with their statistical uncertainties [176]. The convergence

time progression of the total free energy change. The calculation was continued until we
observed converged output for 1 ns where 20 windows of 0.1-ns each were sufficient in
most cases in this study. The final free energy change was reported as the average of the
last 1 ns data. The error of the averaged free energy change was reported as 1 standard
deviation. More specifics of use of this method in this dissertation are provided in the
methods section of respective chapters. This free energy calculation method can now be
implemented through a dedicated module in the widely used simulation software
package, NAMD (version 2.12) [169], while we used a developer version in NAMD
provided by Wei Jiang, Argonne National Laboratory.
2.3.2

Umbrella Sampling
In principle, umbrella sampling is merely several MD simulations conducted over

the range of a pre-defined reaction coordinate (RC). A biasing potential term is added to
the conventional potential energy function, directing the simulation to cross energy
barriers and sample the conformational space typically inaccessible to unbiased classical
MD [177, 178]. Umbrella sampling can be used to determine the free energy surface of
the system, also referred to as potential of mean force (PMF), along that path of the

45

thermodynamic system from reference state to target state [179]. For calculation of the
PMF, usually a harmonic restraint is used as the biasing potential, a function of reaction
coordinate. This RC can be any observable like distance between protein and ligand
ultimately defining the desired path between two states. Enhanced sampling is performed
consecutively for windows covering the range of a selected RC that dictates the desired
path.

( ( )) =
where,

1
2

( ( )

)

…

( ) is the biasing potential,

is the restraining force constant,

. 2.7
is the

instantaneous RC, and

( )= ( )+
where,

( )

… Eq. 2.8

( ) is new biased total potential energy function and ( ) is old unbiased

potential energy function
The range of RC is divided into specific values (or windows), and MD
simulations are run for each window, collecting the instantaneous values of RC. Either
weighted histogram analysis method (WHAM) [180, 181] or multistate Bennett
acceptance ratio (MBAR) [176] analysis can be used to estimate unbiased probability
distribution and ultimately build the PMF profiles [182]. With WHAM, errors need to be
computed separately, which is usually done by a standard bootstrapping method [181,
183], while MBAR has a direct way to calculate errors [176]. The free energy of binding
is then determined from the PMF by taking the difference between the free energy at RC
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= 1 and RC = 0. For convergence and accuracy, two factors are closely observed, i)
-sampling windows where initial sampling data is discarded
ii) PMF profile near the ends of RC where minima/maxima/plateau is important for
accurate difference in free energy.
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Chapter 3 – Cello-oligomer binding dynamics and bi-directional binding
phenomenon in Type B CBMs
As the title suggests, Chapter 3 reports the bi-directional ligand binding
phenomenon in all three families (4, 17 and 28) of Type B CBMs and cellopentaose
binding dynamics in two family 4 CBMs. Most of this chapter, i.e. experiments related to
family 4 CBMs, has been adapted with permission from Kognole and Payne [184],
Copyright © 2015, Oxford University Press. As the experiments related to family 17 and
28 CBMs are going to be part of another journal article, we only add one subsection in
this chapter to discuss the results relative to the topic of this chapter.
3.1

Abstract
Carbohydrate binding modules (CBMs) play significant roles in modulating the

function of cellulases, and understanding the protein-carbohydrate recognition
mechanisms by which CBMs selectively bind substrate is critical to development of
enhanced biomass conversion technology. CBMs exhibit a limited range of specificity
and appear to bind polysaccharides in a directional fashion dictated by the position of the
ring oxygen relative to the protein fold. The two family 4 CBMs of Cellulomonas fimi
Cel9B (CfCBM4) are reported to preferentially bind cellulosic substrates. However,
experimental evidence suggests these CBMs may not exhibit a thermodynamic
preference for a particular orientation. We use molecular dynamics (MD) and free energy
calculations to investigate protein-carbohydrate recognition mechanisms in CfCBM4-1
and CfCBM4-2 and to elucidate preferential ligand binding orientation. For CfCBM4-1,
we evaluate four cellopentaose orientations including that of the crystal structure and
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three others suggested by NMR. These four orientations differ based on position of the
ligand reducing end and pyranose ring orientations relative to the protein core. MD
simulations indicate the plausible orientations reduce to two conformations. Calculated
ligand binding
calculated free energies are in excellent agreement with isothermal titration calorimetry
measurements from literature. Through MD simulations we confirm the bi-directional
binding of cellopentaose to four other Type B CBMs, two CBMs from family 17 and 28
each. These MD simulations further reveal the approximate structural symmetry of the
oligosaccharides relative to the amino acids along the binding cleft plays a role in the
promiscuity of ligand binding. A survey of ligand-bound structures insinuates this
phenomenon may be characteristic of the broader class of

-

sandwich fold.
3.2

Introduction
The multi-modular Cellulomonas fimi endoglucanase Cel9B (formerly CenC)

exhibits tandem Type B, N-terminal CBMs, both of which belong to Family 4 [105]. The
domains, CfCBM4-1 (formerly CBDN1) and CfCBM4-2 (formerly CBDN2), appear
[98]. CfCBM4-1 is of historical
significance as the first known soluble substrate-binding CBM, the discovery of which
led to renewed interest in CBM function in general. Both CfCBM4-1 and CfCBM4-2
bind cellotetraose and cellopentaose with increasing affinity [98, 110], suggesting each
-sheets of
-sandwich (Figure 3.1); this was later confirmed when Boraston et al. solved the
cellopentaose bound CfCBM4-1 structure [62]. The affinity of CfCBM4-1 and CfCBM4-
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2 for cello-oligomers is roughly the same for a given length, and isothermal titration
calorimetry suggests binding of cello-oligomers to both CBM4s is enthalpically driven
[98, 110]. This latter observation is consistent with the large population of potential
hydrogen-bonding polar residues lining the binding cleft [99], compared to those from
planar binding sites of Type A CBMs [16]. Despite the apparent similarities in specificity

amino acid substitutions along the binding cleft. The binding cleft of CfCBM4-2 is also
noticeably wider than CfCBM4-1 [62, 110]. We anticipated that direct comparison of the
dynamics of cellopentaose-bound CfCBM4-1 and CfCBM4-2 will elucidate the
-1,4-linked glucan specificity in Family 4 CBMs.
Furthermore, these findings are likely to have broad applicability to other CBM families
-sandwich folds.
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Figure 3.1 CfCBM4-1 and CfCBM4-2 ligand conformations considered in this study.
CfCBM4-1 is shown in gray cartoon. CfCBM4-2 is shown in salmon cartoon, and
cellopentaose is shown in green and red stick. (a) CfCBM4-1-RE represents the ligand
orientation of the CfCBM4-

-

to-right fashion, and (b) CfCBM4-1- NRE illustrates the reverse, transverse axis
transformation with the ligand oriented so the reducing end runs from right-to-left. (c)
CfCBM4-1-

-to-right,

but the cellopentaose has been rotated 180° about the length of the C1-C4 axis, locating
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the hydroxymethyl groups out of register. (d) CfCBM4-1transverse axis rotation and the 180° C1-C4 rotation of the cellopentaose in the binding
cleft. (e) CfCBM4-2-RE represents the CfCBM4-1 structural ligand orientation (PDB
-to-right. (f) CfCBM4-2NRE represents the transverse axis transformation of cellopentaose so the reducing end
runs from right-to-left.
NMR analysis of nitroxide spin-labeled cello-oligomer derivatives also put forth
the intriguing, though somewhat controversial, hypothesis that CfCBM4-1 and CfCBM42 are capable of binding a cello-oligomer in a multi-directional fashion [61]. Johnson et
al. examined association of 2,2,6,6-tetramethylpiperidine-1-oxyl-4-yl (TEMPO) labeled
cellotriose and cellotetraose with the individual CfCBM4-1 and CfCBM4-2 domains [61].
At the time of this study, structural resolution of a ligand bound CBM4 was unavailable,
rd understanding ligand
binding in lieu of crystallographic evidence. Determination of 1H and 15N chemical shifts
confirmed labeling did not significantly affect affinity, and paramagnetic relaxation
studies further revealed the nitroxide label could lie at either end of the binding clefts.
However, relative occupancies were not determined as a means to suggest a “more
favorable” conformation. The multi-directional binding observation is interesting because
it is counter to intuition. Polysaccharides exhibit a large dipole along the length of the
polymer as a result of several factors including the parallel orientation of chains, the
asymmetric pyranose ring oxygen atom, and the chemical polarity of the individual
chains [185, 186]; for the cellopentaose ligand, the dipole moment is approximately 12 D.
On the surface, it seems such a dipole would preclude multi-directional binding, as
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proteins would likely evolve in such a way as to most effectively hydrogen bond with the
oligomer in a given direction. Boraston et al. reached a similar conclusion upon solution
of the cellopentaose-bound CfCBM4-1 structure in 2002 [62]. The structure captured the
cellopentaose with one hydrophilic edge of the sugar pointed in toward the binding
groove and the other edge exposed to solvent. Unambiguous electron density pointed to a
single thermodynamically favorable conformation occupying the 5 subsites of the binding
cleft. Nevertheless, the authors left open the possibility that serendipitous crystal packing
interactions may have resulted in binding the least favorable cellopentaose orientation. Of
course, the ability to multi-directionally bind of cello-oligomers would be significantly
advantageous in engineered cellulase or cellulosomal constructs, allowing the CBMs to
target amorphous cellulose from virtually any angle. Thus, determining whether this
capability does in fact exist in a

-

directional CBM4 substrate binding is accomplished promises to inform future
biotechnological development.
3.3
3.3.1

Methods
Modeling of cello-oligomer in multiple orientations
We use molecular dynamics (MD) simulations to explicitly examine cello-

oligomer binding mechanisms in Family 4 CBMs. MD simulations of eight total systems
representing the various ligand configurations of CfCBM4-1 and CfCBM4-2 were
e variations in binding cleft
occupation were examined in addition to the two unbound proteins. Figure 3.1 illustrates
the corresponding case/system abbreviation used throughout this study. The CfCBM4-1
ta Bank (PDB) structure [62],
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and the CfCBM4-2 systems were constructed from the 1CX1 PDB structure [110]. As
discussed above, the CfCBM4-1 structure features a bound cellopentaose ligand, which
was used here as the basis for investigation of ligand dynamics and directionality
preference. Four ligand orientations bound to CfCBM4-1 were considered representing:
(1) the structural orientation (CfCBM4-1-RE); (2) a reversed ligand orientation where the
non-reducing end of the cellopentaose occupies the original reducing end position of the
structural conformation and symmetry of the glucopyranose side chains is maintained
(CfCBM4-1-NRE); (3) a rotation of the structural cellopentaose conformation about C1C4 axis so the opposite hydrophilic edge faces inward to the protein, effectively locating
a C5 hydroxymethyl group where the C3 hydroxyl previously existed (CfCBM4-1and (4) a transverse axis reversal along with the C1-C4 rotation (CfCBM4-1the CfCBM4-2 NMR structure does not contain a ligand, the bound CfCBM4-2 systems
were prepared by aligning CfCBM4-2 to CfCBM4-1 protein backbones and docking the
cellopentaose to the CfCBM4-2 structure. Two ligand orientations in CfCBM4-2 were
CfCBM4-2-RE) and the
transverse axis transformation (CfCBM4-2-NRE). The unbound CfCBM4-1 and
CfCBM4-2 systems were also considered to understand the contributions of ligand
binding to protein dynamics. A detailed description of simulation construction is
provided ahead.
3.3.2

MD simulation: Setup and parameters
All protein components of CfCBM4-1 and CfCBM4-2 simulations were

constructed from crystal structures, manually docking the cellopentaose ligands as
necessary through secondary structure alignment with crystal structure of CfCBM4-1 that
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already exhibits bound cellopentaose. The CfCBM4-1 simulations were constructed from
CfCBM4-1 binds cellopentaose in the binding cleft.
The nomenclature used in this study reflects the orientation of the ligand captured in
[62]; we have defined this as the “reducing end” conformation of the
bound ligand (CfCBM4-1-RE), numbering the pyranose moieties from 1 to 5 accordingly
(Figure 3.2). The “non-reducing end” conformation (CfCBM4-1-NRE) was prepared
from this same structure. To reverse the ligand direction, the coordinates of the heavy
ring atoms were retained
to locate the pyranose ring oxygen at the opposite end of the cleft (Figure 3.1).
CHARMM was used to reconstruct the remaining hydrogens and primary alcohol groups
from internal coordinate tables [166]. The reducing end and non-reducing end
cellopentaose conformations bound to CfCBM4-2, CfCBM4-2-RE and CfCBM4-2-NRE,
respectively, were constructed by docking the CfCBM4-1-RE and CfCBM-4-1-NRE
ligands through structural alignment with the 1CX1 PDB structure [110]. To prepare the
CfCBM4-1-

CfCBM4-1-

ring heavy atoms were again renamed such that the ligand was rotated along the
longitudinal axis relative to CfCBM4-1-RE and CfCBM4-1-NRE, respectively.
CHARMM was used to reconstruct remaining hydrogen and primary alcohol groups.
Protonation states of the titratable residues were determined using H++ and manual
inspection of the protein environment (i.e., possible salt bridge formation) [187-190].
PyMOL and VMD were used for structural alignment and visualization [170, 171].
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Figure 3.2 Binding site nomenclature for CfCBM4-1. The CBM binds cellopentaose
alo

-sheets forming the protein

core. These subsites are numbered from 1 to 5. Here, we define an additional “binding
subsite,” 0, for discussion of MD simulations of CfCBM4-1-

CfCBM4-1-

Subsite 0 represents a completely solvent exposed pyranose ring of the cellopentaose
chain. The bottom panel illustrates the symmetry of a cello-oligomer oriented in the
opposite direction. The primary alcohol groups remain in approximately the same
location regardless of direction.
All constructed systems were vacuum minimized, solvated with water, neutralized
with sodium ions, and minimized again. The minimized systems were then heated to 300
stems were simulated
for 250 ns at 300 K in the NVT ensemble using NAMD [169]. All simulations used the
CHARMM36 force-field with CMAP correction for proteins [166, 191, 192], and the
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CHARMM36 carbohydrate force-field for the cellopentaose ligands [193-195]. The
modified TIP3P force-field was applied to water molecules [196, 197]. Analysis of the
250 ns MD simulations included: determination of the RMSD and RMSF of the protein
backbones, the RMSF of cellopentaose on a per binding subsite basis, the hydrogen
bonding and interaction energies of each glucose residue with protein, and average
solvation of the ligand on per binding subsite basis.
3.3.3

-REMD

through a computational determination of absolute binding free energy. An enhanced
sampling free energy methodology, Free Energy Perturbation with Hamiltonian Replica
-REMD), was used to calculate the affinity of
cellopentaose to CfCBM4-1 [174]. We considered two cases representing the structural
orientation and the transverse axis rotation, CfCBM4-1-RE and CfCBM4-1-NRE,
respectively. The remaining two CfCBM4-1 ligand orientations, rotations about the C1C4 axis, were excluded from free energy calculations as the ligands significantly shifted

and no longer represented the intended conformational state.
This free energy calculation protocol couples free energy perturbation with
Hamiltonian replica-exchange molecular dynamics to enhance Boltzmann sampling [173,
174]. The calculations were performed by decoupling the potential energy into four
separate contributions scaled according to coupling parameters, defined mathematically
by Jiang et al [174]. In short, the contributions to overall free energy included the shifted
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Weeks-

repu

respectively,

elec.

disp,

Additionally, contributions from
rstr.

We used the

thermodynamic cycle in Figure 3.3 to arrive at the free energy of binding a cellopentaose
to CfCBM4-1. The cycle consisted of two separate sets of calculations: (1) decoupling the
bound cellopentaose from the solvated CfCBM4-1 and (2) decoupling the solvated
cellopentaose from solution. The difference between the two values is the standard
bind

b.

The restraining potential was used only in the first leg of the

cycle, decoupling cellopentaose from CfCBM4-1.

Figure 3.3 Thermodynamic cycle used to determine ligand binding free energy from
- REMD. In this case, “CBM” is CfCBM4-1 and “ligand” is cellopentaose. The
subscripts “solv” and “vac” refer to the solvated and vacuum (or decoupled) systems,
respectively.
The free energy calculations were constructed from 4 ns snapshots from the
explicitly solvated CfCBM4-1-RE and CfCBM4-1-NRE MD simulations. The absolute
binding free energy was determined from 40 consecutive 0.1 ns calculations, where the
first 1 ns data was discar

. The simulations used a set of 128 replicas

(72 repulsive, 24 dispersive, and 32 el
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steps (every 0.1 ps). The CfCBM4-1/cellopentaose systems included a positional restraint
defined by the distance of the center of the mass of the ligand to the center of mass of the
protein. This restraint bias during the decoupling of cellopentaose from the solvated
[173].
The output energies collected during simulation were post-processed using the Multistate
Bennett Acceptance Ratio (MBAR) to calculate the free energies and statistical
uncertainty of the individual repulsive, dispersive, and electrostatic contributions [176].
Finally, summation of all the four contributions gives total free energy change for each
2).

1

The binding free energy of

cellopentaose to CfCBM4-1 is the difference between the free energy of decoupling of
solvated cellopentaose from solution and the free energy of decoupling of bound
cellopentaose from CfCBM4-

b

2

–

1;

Figure 3.3). As described above,

the standard deviation of these values over the 3 ns data collection period, which were
combined using error propagation rules, is reported as the final binding free energy error.
Convergence was determined by monitoring the time evolution of the free energy
calculations. Additional details are provided in Appendix 1.
3.4
3.4.1

Results and Discussion
Symmetry of the cellopentaose is critical to binding
Four possible cellopentaose conformations occupying the CfCBM4-1 binding

groove were investigated as potential multi-directional binding forms. Two of these
conformations, CfCBM4-1-

CfCBM4-1-

suitability of the binding groove to accommodate larger carbohydrate side chain groups,
such as the hydroxymethyl group, regardless of binding subsite. The nomenclature of
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different binding subsites for CfCBM4-1 is illustrated in Figure 3.2. These two systems,
constructed by rotating the ligand around its longitudinal axis (Figures 3.1c and 3.1d),
place the cellopentaose off register by one binding subsite compared to the structurally

the binding subsites to consist of semi-redundant hydrogen bonding residues in every
binding subsite.
MD simulations indicate the CfCBM4-1 binding groove will not accept the
cellopentaose with the hydroxymethyl group arbitrarily located along the groove. This
result is immediately evident from visualization of both the CfCBM4-1CfCBM4-1-

Movie 3.1 and 3.2). From the CfCBM4-1-

ctory,

we observe the cellopentaose shift longitudinally across the groove within 2 ns of the 250
ns simulation (Figure 3.4, Movie 3.2). The displacement of the cellopentaose exposes a
glucopyranose moiety to solvent, external to the binding groove, leaving only four
moieties bound in the groove. For the purposes of describing ligand dynamics going
forward, we have numbered this external “binding subsite” as “0” (Figure 3.2). An
CfCBM4-1-

(Movie 3.1). As

described in the Methods, each of these starting configurations was extensively
minimized in a stepwise fashion, significantly reducing the possibility that unfavorable
molecular contacts influenced the ability of the cellopentaose to occupy the alternative
binding site. Additionally, each of these simulations was independently repeated varying
the random number seed, and the same shift of the cellopentaose across the binding
groove was observed. In the remaining two cellopentaose conformations, CfCBM4-1-RE
and CfCBM4-1-NRE, this displacement was not observed.
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Figure 3.4 Snapshots from the CfCBM4-1protein is shown in gray surface, and the ligand is shown in green and red stick. The
snapshots illustrate the ligand, initially out of register from the structurally bound
position, naturally sliding to the more energetically favorable position, defined by the
position of the hydroxymethyl side chain facing into the binding cleft. Schematic for this
sliding is illustrated on the panels to right in comparison with CfCBM4-1-NRE.
Johnson et al. suggested that the approximate structural symmetry of
oligosaccharides accounts for the ability of the protein to bind the cello-oligomer
regardless of directionality [61]. That is to say, upon reversing the cellopentaose within
the binding site, the hydroxymethyl group occupies roughly the same position as the
hydroxyl group, which may allow for similar hydrogen bonding. Rotating the
cellopentaose, as in the CfCBM4-1-

CfCBM4-1-

this structural symmetry. Positioning the ligand so that the hydrogen-bonding side chains
are no longer occupying symmetrically similar locations, the cellopentaose is no longer
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able to make the hydrogen bonds necessary to bind within the active site, as we will show
through explicit characterization of hydrogen bonding. Naturally, the ligand was
displaced by one glucopyranose moiety as it readjusted its side chains similar to
CfCBM4-1-NRE or CfCBM4-1position, the CfCBM4-1-

CfCBM4-1-

to CfCBM4-1-NRE and CfCBM4-1-RE, respectively.
In the upcoming sections, we discuss the results of the CfCBM4-1CfCBM4-1protein-bound bound moieties and a singular “external” moiety in subsite 0. Furthermore,
as the CfCBM4-1-

CfCBM-4-1-

ent to

CfCBM4-1-RE and CfCBM4-1-NRE, respectively, we did not perform free energy
calculations on the former two cases.
3.4.2

Thermodynamic preference of cello-oligomer orientation
CfCBM4-

1 has a thermodynamic preference for a given bound cello-oligomer conformation given
-REMD to
calculate the free energy of binding a cellopentaose ligand to the CfCBM4-1 binding
groove in two different orientations, CfCBM4-1-RE and CfCBM4-1-NRE, having
narrowed down putative binding conformations using MD. The free energy of binding
cellopentaose to CfCBM4-1 in either the CfCBM4-1-RE or CfCBM4-1-NRE
al. As shown in Table 3.1, the binding free energies
mol-1
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5.86

1.51 kcal mol-1 for CfCBM4-1-

RE and CfCBM4-1-NRE, respectively. The repulsive, dispersive, electrostatics, and
restraining potential contributions are provided individually. The free energies of each
2,

1

were obtained by summing these

contributions. Error calculation is explained ahead.
Table 3.1 Binding free energies of cellopentaose to CfCBM4-1 in two ligand orientations
representing bi-

2,

is

also tabulated as its three contributions – repulsion, dispersion, and electrostatics.

b

(kcal mol-1)
Cellopentaose

repu

disp

(kcal mol-1)

(kcal mol-1)

elec

(kcal mol-1)

-

rstr

(kcal mol-1)
-

CfCBM4-1-RE

CfCBM4-1-NRE
CfCBM4-1
Experimentala.
a.

0.06

-

-

-

-

Tomme, Creagh [98]
The corresponding error values represent standard deviations over the final 30 of

40 intervals, i.e., the final 3 ns of 4 ns total. The free energy over the course of the 4 ns
calculation, in 100 ps intervals, is given in Figure 3.5. The error of the binding free

deviations of the free energy of decoupling cellopentaose from CfCBM4-1 and the
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2.

1

Error calculations based on statistical

correlation of the data for each 100 ps interval are reported in the Supplementary Data
(Figure 3.5). We have chosen to report the standard deviation here, as this represents the
larger of the two values. Progress toward convergence was assessed by monitoring the
time evolution of the free energy calculation (Figure 3.5). The effect of replica-exchange

CfCBM4-1-RE was also considered (Details are provided in Appendix 1).

Figure 3.5

-ns calculations using

-REMD. The difference between the average value for either CfCBM4-1-RE or
CfCBM4-1-NRE and the cellopentaose solvation free energy represents the binding free
energy.
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The calculated binding free energies were in excellent agreement with a
previously measured value obtained by isothermal titration calorimetry (ITC) at 35°C
[98]. The reported value of cellopentaose binding to CfCBM4-1 in pure water at 35°C is
– 5.24

0.91 kcal mol-1. As ITC does not provide structural-level resolution of ligand

binding, the experimental binding free energy likely represents the ensemble of both
putative binding conformations. Considering the accuracy of both ITC and free energy
calculations [198, 199], the difference between the two is relatively insignificant.
Calculated free energies of binding cellopentaose to CfCBM4-1 support the hypothesis
that CfCBM4-1 possesses the ability to bi-directionally bind cello-oligomers. Our
th the original Johnson et
al. study using TEMPO-labeled cello-oligomers coupled with NMR to observe ligand
binding [61]. The crystallographic structure, later captured by Boraston, et al., temptingly
suggests that CfCBM4-1 binds cellopentaose in a single, thermodynamically favorable
orientation relative to the binding cleft [62]. Boraston et al. describe how the distancedependent nature of the NMR spin-labeling analysis prohibits calculation of relative
occupancy of each of the ligand binding conformations, dismissing the possibility that bidirectional binding represents anything more than a low-occupancy state. While free
energy calculations also suffer from the inability to capture the statistical likelihood of a
given orientation
CfCBM4-1-RE or the CfCBM4-1-NRE conformation suggests occupancy of each state is
or
experimental conditions of crystallography.
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3.4.3

CfCBM4-1 hydrogen bonding
The cellopentaose ligand formed approximately the same number of hydrogen

bonds in each binding subsite regardless of the direction of the ligand (Figure 3.6). VMD
was used to determine the average number of hydrogen bonds formed per pyranose ring
and side chain with the surrounding protein [170]. The criteria used to define a hydrogen
bond was a 3.0 Å donor-acceptor distance and a 20° angle cutoff. The number of
hydrogen bonds a ring formed was determined for each frame of the trajectory and
averaged over the 250-ns length. Hydrogen bonding primarily occurred with subsites 1
through 3, where

n81 were the primary residues

participating in hydrogen bonding.
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Figure 3.6 Hydrogen bonding partners (dashed lines) at each subsite between side chains
of cellopentaose (green and red sticks) and amino acids of CfCBM4-1-RE (yellow, red,
and blue sticks). The CfCBM4-1 backbone is shown in gray cartoon. To aid in viewing,
the aromatic residues of binding cleft are shown in thin, marine blue lines. Binding
subsites are numbered in balloons. Lower panel - Average number of hydrogen bonds (Hbonds) formed between the pyranose ring and the surrounding protein of CfCBM4-1
binding site. Error bars represent one standard deviation.
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Detailed analysis of hydrogen bonding over the course of MD simulations defined
the primary hydrogen bonding partners in the CfCBM4-1 binding subsites responsible for
acceptance of a bi-directionally bound cellopentaose (Figure 3.6). In subsite 1, Arg75 and
hydroxyl group
generally bonds with the primary hydroxyl group of the pyranose ring in subsite 2, while
occasionally hydrogen bonding with the secondary hydroxyl group of the subsite 3
pyranose. Asn50 and Asn81 hydrogen bond with the secondary hydroxyl groups of the
subsite 3 pyranose. The protein surrounding subsite 4 rarely participated in hydrogen
bonding with the pyranose ring, but when a hydrogen bond was formed, Ala18 was the
partner. This specificity for primary and secondary hydroxyl groups can only be fulfilled
by the orientation of cellopentaose in CfCBM4-1-RE and CfCBM4-1-NRE, resulting
from the symmetry of the ligands (Figure 3.2). When cellopentaose occupies the binding
site as initialized in CfCBM4-1-

CfCBM4-1-

partners were inaccessible, and thus, the ligand shift by one binding subsite
accommodates formation of hydrogen bonds with the protein. The binding subsites of
CfCBM4-1 do not appear to have redundant hydrogen bonding partners that would allow
binding of the CfCBM4-13.4.4

CfCBM4-1-

CfCBM4-1 dynamics
Molecular dynamics simulations further support the feasibility of bi-directional

ligand binding. Examination of the five CfCBM4-1 and three CfCBM4-2 molecular
dynamics simulations described above reveals remarkably similar dynamic behavior
among the CfCBM4-1-RE and CfCBM4-1-NRE conformations and the CfCBM4-2-RE
and CfCBM4-2-NRE conformations. Furthermore, the dynamics of the CfCBM4-1-
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and CfCBM4-1-

CfCBM4-1-RE and CfCBM4-

1-NRE dynamics, respectively, following translocation as described above. To evaluate
dynamic similarity, we applied a host of simulation trajectory analyses including:

deviation (RMSD) and root mean

-bonded interaction

energy measurements, and degree of ligand solvation.
Evaluation of the RMSD of the protein backbone over the course the 250-ns
simulation illustrates the relative stability of the CfCBM4-1-RE and CfCBM4-1-NRE
conformations (Figure 3.7a). The RMSD was calculated for each of the five CfCBM4
simulations, using the last coordinates of the 1reference coordinates. The RMSD of the protein backbones in the CfCBM4-1-RE and
CfCBM4-1-NRE simulations were extraordinarily well behaved, deviating little over the
course of the simulation. This particular result suggests the opposite ligand conformation
did not adversely affect the protein structure, and the binding site was capable of
accommodating the ligand without a significant structural rearrangement. When the
ligand was rotated around the longitudinal axis, as in the cases of CfCBM4-1CfCBM4-1li

CfCBM4-1-RE and CfCBM4-1-NRE positions. The RMSD

deviated significantly from that of the initial position as the protein rearranged the ligand,
and the last glucose binding subsite remained unoccupied. The CfCBM4-1CfCBM4-1-N
ligand free CfCBM4-1.
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Figure 3.7 CfCBM4-1 hydrogen bonding behavior and protein-ligand dynamics from
250-

CfCBM4-1

protein backbone over the 250 ns simulation. The RMSD reference structure is the last
frame of the 1binding-site basis. Error bars were determined from block averaging over 2.5 ns blocks of
data. (c) Average total interaction energy (sum of van der Waals and electrostatic
contributions) of each pyranose ring with the surrounding protein. Error bars represent
one standard deviation. (d) The average number of water molecules within 3.5 Å of each
binding subsite of CfCBM4-1. Error bars represent one standard deviation.
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Similarly, the RMSF of the protein backbones indicate the average protein
structure of each ligand bound CfCBM4-1 was generally unaffected by the
conformation (Figure 3.8a). In fact, the absence of ligand appeared to impact the protein
more than any of the ligand conformations. Figure 3.8a illustrates that the aromatic
residues along the binding cleft, Tyr43 and Tyr85, and key hydrogen bonding residues,
Asn50 and Asn81, fluctuated significantly in the absence of a ligand. These fluctuations
potentially contributed to the increase in RMSD of the apo structure, and gradually, the
backbone of the apo CBM became more flexible. This may be a mechanism by which the
CBM makes the binding site more accessible to ligands. In general, the N- and Cterminal domain RMSF values were significantly higher than the core of the protein
domain. While high terminal domain fluctuation is an expected behavior in nearly all
proteins, we mention this to add the caveat that CfCBM4-1 has been simulated without a
[62], but
Johnson et al. have reported that CfCBM4-1 coordinates calcium binding through
- and Cterminus, respectively. This lack of coordinating bonds tying together the termini leads to
higher relative fluctuation, as can be seen in the RMSD of the CfCBM4-1-apo at 70 ns
(Figure 3.7a). However, the calcium ion and coordinating residues are located on the
surface of CfCBM4-1, directly opposite the binding cleft, and the lack of a calcium ion
has no affect on binding affinity [200]. Thus, we chose to simulate the protein without the
calcium ion in accordance with the structure.
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Figure 3.8
CfCBM4-1 systems and (b) three CfCBM4-2 systems over 250 ns.
The flexibility of the CfCBM4-1-RE and CfCBM4-1-NRE ligands, as measured

ligand is a determination of the average position of the ring atoms over the course of the
entire simulation and is delineated on a per-binding subsite basis (Figure 3.7a). As
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previously described, the CfCBM4-1-

CfCBM4-1-

register very early in the MD simulation to positions approximating the side chain and
ring positioning of the CfCBM4-1-RE and CfCBM4-1-NRE ligands, respectively. The
“0” binding subsite represents a solvent exposed pyranose ring, external to the cleft.
Otherwise, the RMSF as a function of binding subsite (Figure 3.7a
positions along the cleft, where CfCBM4-1-RE has the same ring and side chain
orientation as CfCBM4-1-

CfCBM4-1-RE and

CfCBM4-1-NRE pyranose rings fluctuated within error of each other, suggesting the cleft
accommod
to 4 binding subsites, the CfCBM4-1-

CfCBM4-1-

than the fully bound ligands. The solvent exposed pyranose rings had a much larger range
of motion (Movies 3.1 and 3.2), uninhibited by the protein cleft, and this translated into
increased fluctuation along the entirety of the four bound pyranose rings.
The degree of solvation within the binding cleft was unaffected by the ligand
conformation (Figure 3.7d). For a given trajectory frame, the number of water molecules
within 3.5 Å of the pyranose ring of binding subsite was determined. This value was
averaged for each binding subsite over the entire 250-ns trajectory. The average value is a
numerical estimate of the degree to which any pyranose ring is exposed to the water
solvent. The degree of solvation of any given binding subsite was within one standard
deviation of that of any of the various ligand conformations. This is consistent with the
notion that CfCBM4-1 is capable of binding the cellopentaose ligand in both the
CfCBM4-1-RE and CfCBM4-1-NRE directions.
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The total interaction energy of the protein with the pyranose rings of
cellopentaose reveals aromatic stacking interactions were maintained with both faces of
the pyranose rings along the cleft. Electrostatic and van der Waals components of the
non-bonded interactions were calculated over the 250-ns MD simulations. The same nonbonded interaction cutoffs used in producing the simulations were applied in the data
analysis. For computational efficiency, the interaction energy analysis was conducted
using a cu

-spaced frames rather than the 25,000 frames

collected. The total interaction energy, the sum of the two components, was highest in
binding subsites 1 through 3, reflecting the availability of hydrogen bonding partners and
aromatic stacking interactions relative to subsites 4 and 5. As with other dynamic
analyses, the total interaction energy was generally unaffected by the direction of the
bound ligand (Figure 3.7c). The residues along the binding cleft maintained a similar
degre
stacking interactions with either face of the pyranose ring. From perturbations of 1H
chemical shifts upon cellotetraose binding, Johnson et al. reported that, despite the
multitude of aromatic residues lining the binding cleft, only Tyr19 and Tyr85 were
directly involved in aromatic stacking interactions [201]. From this determination of
interaction energies, we endorse addition of Tyr43 to the list of stacking aromatic
residues [62], as the interaction energy of Tyr43 with the ligand is of similar order as
Tyr85.
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3.4.5

CfCBM4-2 dynamics
Johnson et al. also made the case that CfCBM4-2 was capable of binding

TEMPO-labeled cello-oligomers with the label at either end of the cleft [61]. To date, a
ligand-bound structure of this homologous CBM4 structure has not been reported, though

CfCBM4-1-NRE cellopentaose to the CfCBM4-2 structure. MD simulations of the two
conformations were performed to elucidate the molecular interactions governing ligand
binding and the possibility of bi-directional binding.
CfCBM4-2 differs structurally from CfCBM4-1. The cleft of CfCBM4-2 appears
to be wider and several ligand binding residues are substituted (e.g., CfCBM4-1 residues

respectively, in CfCBM4-2; Figure 3.9a) [110]. However, MD simulation suggests the
apparent widened cleft of CfCBM4-2 may be an artifact of the structural study
conditions. When CfCBM4-2 was docked with cellopentaose in the binding groove, the
cleft width reduced, approximately matching that of CfCBM4-1 (Figure 3.10). The

in close contact with the ligand over the remainder of the simulation. The NMR structure
captured CfCBM4-2 in its ligand-free state [110], and thus, the absence of ligand
interactions is the likely reason behind the larger binding groove width relative to that of
CfCBM4-1. The RMSD of the CfCBM4-2 protein backbone reflects the protein
rearrangement that occurs when the binding cleft closes around the bound ligand,
3.9b). The ligand-free CfCBM4-2 exhibited
a great deal more flexibility in the loops surrounding the cleft (Figure 3.8b), suggesting
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flexibility in the cleft as a

mechanism. The N-terminus of the CfCBM4-2-RE

structure underwent a conformational change around 220 ns, as indicated by the change
in RMSD, but this does not affect ligand binding.

Figure 3.9 (a) Comparison of binding site of CfCBM4-1 (gray) and CfCBM4-2 (salmon)
illustrating substitutions of residues involved in cello-oligomer binding. CfCBM4-1
residues are labeled in black letters, and residues in the same position in CfCBM4-2 are
labeled in red. The binding subsites are numbered. (b) RMSD of the CfCBM4-2 protein
backbone over the 250-ns simulation. The RMSD reference structure is the last frame of
the 1-
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Figure 3.10 Comparison of CfCBM4-1 (gray surface) and CfCBM4-2 (salmon surface)
binding groove width. The average distance between center of mass of side chains of two
aromatic residues (blue sticks) forming sandwich platform in both CBMs was measured
over 250 ns (25,000 frames). For CfCBM4-1, this average distance was 9.37 Å and for
CfCBM4-2 this average distance was 8.58 Å. The < 1 Å difference between these
averages is insignificant in context of groove width. The CfCBM4-2 binding groove
width, measured from Tyr91 to Trp49, was 15.27Å in the apo structure, from which the
simulation was initialized.
As with CfCBM4-1, dynamic measurement associated with ligand binding and
hydrogen bond formation suggest CfCBM4-2 is capable of bi-directional binding. Again,
we have compared the average number of hydrogen bonds formed between the protein
and this pyranose rings of a given binding subsite, the RMSF of ligand along the cleft,
and the total interaction energy of the ligand with the protein on a per-binding-site basis
as function of ligand direction in the CfCBM4-2 cleft. All of these measures were
expected to be the same for the two conformations, indicating both li
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stable in the CfCBM4the number of hydrogen bonds formed between a given pyranose ring and the CfCBM4-2
binding site did not vary significantly upon reorientation of the ligand (Figure 3.11a). In
general, each binding subsite formed one intermittent hydrogen bond with the protein
over the course of the simulation. This is similar to the behavior of CfCBM4-1 (Figure
3.6), implying the substituted residues play

roles in ligand binding. The RMSF

of the ligand was approximately the same in each binding subsite irrespective of where
the reducing end resided (Figure 3.11b). The CfCBM4-2-NRE pyranose in binding
subsite 5 was unable to maintain stable interactions with any surrounding protein
residues, accounting for the slight deviation from the CfCBM4-2-RE ligand behavior.
However, the total interaction energy of the pyranose ring in a given CfCBM4-2 binding
subsite was the same regardless of ligand direction (Figure 3.11c). These dynamic
measures support the hypothesis that the CfCBM4-2 can bind cello-oligomers in at least
two different conformations. As we will describe, we further posit the ability to bidirectionally bind carbohydrate oligomers may be common to th
fold.
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-sandwich protein

Figure 3.11 CfCBM4-2 ligand dynamic measurements. (a) Average number of hydrogen
bonds formed between each of the five pyranose rings and side chains in each binding
subsite with the surrounding protein (b) RMSF of ligand on a per binding subsite basis
for CfCBM4-2 systems. Error bars were calculated using block averaging over 2.5 ns (c)
Average total interaction energy of each pyranose with the surrounding protein. Error
bars represent one standard deviation. (d) The average number of water molecules within
3.5 Å of each binding subsite of CfCBM4-2. Error bars represent one standard deviation.
3.4.6

Evidence of bi-directional binding beyond C. fimi CBM4s
Bi-directional cello-oligomer binding is likely a phenomenon common to CBM4s
-sandwich CBMs. While structural resolution of cello-

oligomers in two different orientations of the same CBM4 binding cleft does not
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currently exist, our computational results combined with the NMR studies from Johnson
et al. strongly suggest both CfCBM4-1 and CfCBM4-2 demonstrate bi-directional
binding capabilities,

As further

evidence of bi-directional binding in CBM4s, a computational docking study of a
Clostridium thermocellum CBM4, part of the cellulosomal cellobiohydrolase A construct,
found this particular CBM4 was likely to bind a cellohexaose in a direction opposite that
of the cellobiose bound in the reported crystal structure (PDB ID 3K4Z) [202].
CfCBM4-1 ado

-jelly roll fold, which belongs to the larger

-sandwich structures [16]. As CBMs are classified in the CAZy database
(Carbohydrate Active Enzyme Database
-sandwich protein fold [74]. Further,
-sandwich fold is common among other CBM families and is noted for its broad
specificity [16]. At the writing of this manuscript, 29 of the 69 CBM families
-sandwich fold, with a remarkable relative
-directional binding has been
previously observed in these structurally-related CBMs, but that it had perhaps not been
recognized as such. In such a comparison, one must be cognizant that -sandwiches can
sheets [16].

-

-sandwich CBM families, 10 families had deposited structures

with a glycan bound at the same binding site as that of CfCBM4-1-RE (i.e., on the face of
the beta-sheets). A total of 34 glycan-bound CBM structures, representing 10 of the 29 sandwich CBM families, were available for examination (Table 3.2). Using the Dali Web
Server (http://ekhidna.biocenter.helsinki.fi/dali_lite/start)[152] to structurally align the 34
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structures with CfCBM4ligands within the CBM binding clefts.
Table 3.2

CBM Family

-sandwich fold compared with CfCBM4-1-RE (PDB ID

PDB ID

4
4

2Y64

4

Protein Name

Ligand Direction

endo- -1,4-glucanase C (CenC) (Cel9B)

Same

xylanase (Xynl;Xyn1;RmXyn10A)(Xyn10A)

Same

xylanase (Xynl;Xyn1;RmXyn10A)(Xyn10A)

Same

4

2Y6K

xylanase (Xynl;Xyn1;RmXyn10A)(Xyn10A)

Same

4

2Y6L

xylanase (Xynl;Xyn1;RmXyn10A)(Xyn10A)

Same

4

3K4Z

cellobiohydrolase (CbhA;Cthe_0413) (Cbh9A)

Same

laminarinase (Lam;TmLam;TM0024) (Lam16)

Same

4
6

1UY0

endo- -1,4-glucanase B (CELB) (Cel5A; Cel5B)

OPPOSITE

6

1UYX

endo- -1,4-glucanase B (CELB) (Cel5A; Cel5B)

OPPOSITE

6

1UYY

endo- -1,4-glucanase B (CELB) (Cel5A; Cel5B)

OPPOSITE

6

1UZ0

endo- -1,4-glucanase B (CELB) (Cel5A; Cel5B)

OPPOSITE

6

2CDO

endo- -agarase I / B (AgaB; Sde_1175) (Aga16B)

Same

6

2CDP

endo- -agarase I / B (AgaB; Sde_1175) (Aga16B)

Same

9

1I82

xylanase A (XynA;Tm0061) (Xyl10A)

OPPOSITE

xylanase F / 10C (Xyl10C;CJA_3066) (Xyn10C)

OPPOSITE

15
15

1US2

xylanase F / 10C (Xyl10C;CJA_3066) (Xyn10C)

OPPOSITE

16

2ZEX

-mannanase A (ManA; CelA)(Man5A)

Same

16

2ZEY

-mannanase A (ManA; CelA)(Man5A)

Same
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16

3OEA

-mannanase A (ManA; CelA)(Man5A)

Same

16

3OEB

-mannanase A (ManA; CelA)(Man5A)

Same

17

1J84

27

1PMH

-mannanase (ManA;CsMan26)

Same

27

1OF4

-mannanase (ManB;TM1227) (Man5)

Same

27

1OH4

-mannanase (ManB;TM1227) (Man5)

Same

endo- -1,4-glucanase 5A (CelA) (Cel5A)

OPPOSITE

28

endo-

-1,4-glucanase 5A (EngF) (Cel5A)

Same

28

3ACH

endo- -1,4-glucanase 5A (CelA) (Cel5A)

OPPOSITE

28

3ACI

endo- -1,4-glucanase 5A (CelA) (Cel5A)

OPPOSITE

29

non-catalytic protein 1 (Ncp1)

Same

29

non-catalytic protein 1 (Ncp1)

Same

29

1OH3

non-catalytic protein 1 (Ncp1)

Same

29

1W8T

non-catalytic protein 1 (Ncp1)

Same

29

1W8U

non-catalytic protein 1 (Ncp1)

Same

39

3AQX

39

3AQZ

OPPOSITE

-1,3-glucan

OPPOSITE

-1,3-glucan

Visualization of the glycan-

-sandwich fold CBM structures reveals

apparent promiscuity in binding. The examined CBMs bind not only C6 sugars but also
C5 sugars; the sugars were often bonded through a variety of glycosidic linkages as well.
Further, multi-directional binding along the binding cleft appeared often across the
-sandwich CBM structures. Of the 34 structures examined, 22 displayed a
CfCBM4-1-RE); 12
ligands appeared in the opposite conformation corresponding to the modeled CfCBM4-1NRE conformation. As an example of the latter, we illustrate a family 15 CBM derived
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from Pseudomonas cellulosa
CfCBM4-

[203] aligned with
3.12. Family 6 CBMs exhibit bi-directional

ligand binding within the same family.

-sandwich CBMs makes

use of standard aromatic stacking interactions common among carbohydrate binding
proteins [204, 205], but we anticipate bievolutionary diversity of the protein fold [206], resulting in conveniently-spaced
hydrogen bonding partners along the cleft. While 34 structures is too small a sample to

indicates bi-directional b
new possibilities in the development of cellulosic biotechnology.

Figure 3.12 Family 15 CBM derived from Pseudomonas cellulosa xylanase Xyn10C,
PcCBM15 (purple cartoon), bound to xylopentaose (yellow and red sticks) aligned with
CfCBM4-1-RE (gray cartoon) bound to cellopentaose (green and red sticks).
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3.4.7

Bi-directional binding extends to family 17 and 28 CBMs
We have found that family 4 CBMs showed no thermodynamic preference

towards a given longitudinal orientation of cello-oligomers (i.e., the oligomers can bind
structural comparison of all 29 available (as of June 2015) ligand-bound CBM structures
exhibiting a -sandwich fold revealed ligand binding in opposite directions in many other
-sandwich CBM families [184]. We hypothesize bi-directional binding may be feature
Type B CBMs developed as an evolutionary advantage, given that bi-directional binding
could increase the probability of binding events up to 2-fold. Within the scope of this
dissertation, we investigate this bi-directional binding phenomenon in family 17 and 28
CBMs. According to Table 3.2, we already know that crystal structures of family 17
CBMs show same orientation of ligands while crystal structures of family 28 CBMs
exhibit the ligand in opposite orientation (Figure 3.13). Although there are architectural
differences in binding sites of family 4 (Sandwich platform) and, family17 and 28 CBMs
(Twisted platform; discussed in next chapter), the approximate symmetry of cellooligomeric ligands and redundancy of available hydrogen bonding partners in the cleft
are the determining factors in bi-directionality, which is transferable over the
architectures. To consider bi-directional binding within the twisted platform CBMs, we
investigated the binding dynamics of four CBMs from families 17 and 28 (CcCBM17,
BspCBM17, BspCBM28, and CjCBM28) with the cellopentaose ligand bound in both
possible orientations in the binding grooves. The homology modeling was used to build
BspCBM17 as its crystal structure is unavailable. Apo crystal structure was available to
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build BspCBM28. Details of these methods and docking of cellopentaose in opposite
direction for all CBMs has been discussed in the methods section of next chapter.

Figure 3.13 Structural alignment of CcCBM17-RE (left; PDB 1J84) and CjCBM28-NRE
(right; PDB 3ACI) with CfCBM4-1-

CcCBM17-RE and

CjCBM28-NRE are shown in purple cartoon with cello-oligomer in yellow sticks. The
common structure of CfCBM4-1-RE is shown in gray cartoon with cello-oligomer in
green sticks.
In all eight simulation cases, the bound cellopentaose ligand maintained
continuous interaction with the CBM binding surface over the entire 250-ns simulations,
indicating that the binding sites of these family 17 and 28 CBMs can generally
accommodate cello-oligomers bi-directionally. The RMSF of ligand in the binding site
ability of the interactions (Fig. 6), and while all four
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CBMs can accommodate the ligand bi-directionally, not all of them exhibit fully
stabilized protein-ligand interactions. CcCBM17-RE, BspCBM28-NRE and CjCBM28NRE bind the cello-oligomer with relatively little fluctuation about the average (~1 Å). In
the remaining five cases, though the cellopentaose ligands maintain contact with the
CBM binding grooves, we observed sliding of the cellopentaose ligand along the binding
site, which is reflected in the increased RMSF. We previously observed cellopentaose
sliding within the CBM4 binding sites, however, the oligomers moved only a single
subsite in either direction to rearrange the primary hydroxyl groups within the groove, as
a result of the purposeful perturbation of ligand orientation (Section 3.4.1). The sliding
observed in BspCBM17-RE, by two subsites or a cellobiose unit, maintains the primary
and secondary hydroxyl group positions within a given subsite, which is suggestive of a
functional mechanism rather than merely alleviation of steric hindrance. A cluster of
snapshots (every 2.5 ns) from each simulation has been provided in Figure 3.15
illustrating this phenomenon. In case of BspCBM17-NRE, between 85 ns to 100 ns, the
cellopentaose is slides by one subsite, but an accompanying flip around the longitudinal
axis maintains the original hydroxyl group orientation within the groove. Again, these
results suggest the family 17 and 28 CBMs feature extended binding sites capable of
binding cellohexaose or longer oligomers. These simulations provide sufficient evidence
to support the hypothesis that cellulose specific CBMs from all three families hold the
characteristics of a binding site that favors bi-directional binding to cellooligosaccharides irrespective of its overall architecture. On the other hand, this difference
in binding site architecture, being evolved within the same type of CBMs, does play a
role in recognition of substrate as discussed in the next chapter.
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Figure 3.14
average position over 250 ns trajectory calculated per binding subsite for all eight
systems. The Error bars were calculated as a standard deviation of block averages of
RMSFs with block size 2.5 ns each.
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Figure 3.15 Snapshots of cellopentaose (lines) at every 2.5 ns in the binding site of each
CBM (gray cartoon) over the 250-ns simulations. The position of cellopentaose at 0 ns is
shown in thick cyan stick representation. The aromatic residues along the binding site are
shown in dark blue stick representation.
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This section of MD simulations indicates that the modeling of proteincarbohydrate complexes that involve homology modeled protein structures or has ligands
docked based on structural alignment could use longer simulation times, most likely in
microseconds, to get well-stabilized non-bonded protein-ligand interactions. We also

the simulation setup, as without it we observed dissociation of ligands from these open
cleft binding sites at initial stages.
3.5

Conclusions
MD simulations and free energy calculations have enabled us to investigate the

molecular-level contributions to cellopentaose binding in protein-carbohydrate systems
Our results support the original Johnson
et al. hypothesis that C. fimi CBM4s are capable of binding cello-oligomers with the
reducing end of the pyranose at either end of the binding cleft. Free energy calculations
are remarkably comparable to experimental ITC measurement and go beyond experiment
in enabling delineation between conformational populations. MD simulations reveal
abundant hydrogen bonding partners, in near 1:1 parity, exist along the binding cleft, so
that regardless of direction, the pyranose ring primary and secondary alcohol are capable
of maintaining a hydrogen bond with relevant partners from the interior of the cleft. MD
simulations of CfCBM4-2 extend th
similarity) familial representatives. Observation of the dynamic markers indicative of a
stably-bound ligand again suggest that CfCBM4-2 is capable of binding cellopentaose in
a bi-directional fashion. This observation appears to be not limited to CBM4s, but rather,
many carbohydrate-

-sandwich fold, which currently include
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29 additional CBM families, may bind pyranose rings irrespective of direction. Out of
those 29 CBM families, we further confirm the bi-directional binding phenomenon for
family 17 and 28 CBMs that have been categorized as Type B CBMs along with family 4
CBMs but differ in shape of binding site.
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Chapter 4 – Role of binding site architecture and recognition of non-crystalline
cellulose in Type B Carbohydrate Binding Modules
Chapter 4 reports the characteristics of two different binding site platforms in
Type B CBMs and non-crystalline cellulose binding in family 17 and 28 CBMs.
Copyright © Abhishek A. Kognole 2017.
4.1

Introduction
CBMs are structurally diverse proteins, binding with many different types of

carbohydrate polymorphs and morphologies. To capture this diversity, CBMs have been
divided into both fami
respectively [16, 75]. Currently, this nomenclature defines function as the ability to target
particular substrate crystallinities, as CBMs appear to bind either crystalline or noncrystalline/amorphous and oligomeric substrates. Type A CBMs are specific for
crystalline substrates and exhibit a complementary planar binding site lined with aromatic
residues [207, 208]. Type B and C CBMs are only subtly different from each other, with
both types binding oligosaccharides and non-crystalline/amorphous substrates in clefts or
grooves. Type C CBMs have been also shown to bind crystalline cellulose [59].
However, Type B CBMs are capable of binding at any point along the length of the
substrate, and Type C CBMs are limited to the end of the oligomer. The underlying
protein features enabling this distinction are difficult to define.
The most common protein fold among Type B CBMs is the -sandwich fold, the

varying degrees of polymerization, from the smallest of oligosaccharides to amorphous
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substrates [16]. This suggests the -sandwich fold is a versatile architecture that allows
al properties of the
binding cleft/groove to determine carbohydrate binding specificity. Moreover, despite
similar substrate specificities and, in some cases, similar measured affinities, some Type
B CBMs appear to uncompetitively discriminate between binding sites on variable
crystallinity surfaces [73, 208]. Attempts to experimentally characterize noncrystalline/amorphous cellulose have revealed few details of specific structural
properties, only that it is cellulose with a decreasing degree of polymerization and
crystallinity index [92]. Non-crystalline/amorphous cellulose derived from pretreatment
of native crystalline cellulose could be composed of anything from variable-length
polysaccharide chains to only partially decrystallized substrate. Thus, the ability to
recognize both soluble oligomers and non-crystalline/amorphous cellulose is a key aspect
of Type B CBM functionality.
Cellulose-specific Type B CBMs, including those from families 4, 17, and 28,
each with the -sandwich fold (Figure 4.1), have been shown to bind both soluble cellooligomers and non-crystalline cellulose [51-54, 56, 96-98]. Additionally, adsorption
y
binding sites on representative non-crystalline cellulose substrates [64]. These studies
also reveal that family 17 and 28 Type B CBMs exhibit higher affinities towards noncrystalline cellulose than toward oligomeric substrates [64, 100]. Oligomeric substrates of
Cellulomonas fimi CBM4-1 and CBM4-2 (CfCBM4-1 and CfCBM4-2, respectively) also
appear to bind cello-oligomers bi-directionally, with the reducing end of the pyranose
ring at either end of the cleft; there is positive, but limited, evidence of this phenomenon
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being common among -sandwich CBMs [61, 184]. Collectively, the data imply that
these Type B CBMs are discriminating between the various available binding sites on the
non-crystalline carbohydrate surface, but there is not necessarily a directional preference
within the binding site.

Figure 4.1 CBMs (cartoon) from families 4, 17, and 28 with bound cello-oligomers
(medium gray sticks). Binding site aromatic residues are shown in a dark gray stick
representation. The structures, Cellulomonas fimi CBM4-1, Clostridium cellulovorans
CBM17, and Clostridium josui CBM28, were obtained from crystal structures with PDB
, respectively. After structural alignment of the -sandwich
proteins, the family 4 and 17 CBM cello-oligomer is bound in same direction, with the
reducing end toward the left of the figure, whereas the family 28 CBM
is oriented in the opposite direction.

93

-oligomer

To gain a molecular-level understanding of how these three families of Type B
CBMs discriminate between binding soluble oligomeric and non-crystalline/amorphous
substrates, we implemented a computational approach to describe the differences in
binding behavior and affinities within and among the CBM families. From molecular
dynamics (MD) simulations, we explore the role of binding site architecture. Free energy
perturbation with Hamiltonian replica exchange MD (FEP/ -REMD) and umbrella
sampling MD was used to examine bidirectional ligand binding ability and apparent
binding modes in non-crystalline substrate recognition. At each step of our study, we
compare the computational results with available experimental data to assess the validity
of our observations and to translate observations to practice.
4.2
4.2.1

Methods and materials
Modeling protein-carbohydrate complexes
Two representative CBMs from each of the three CBM families, 4,17, and 28,

were selected to gain an understanding of the variations in protein-carbohydrate binding
within and across the families. The selected representatives were Cellulomonas fimi
CBM4-1 and CBM4-2 (CfCBM4-1 and CfCBM4-2), Clostridium cellulovorans CBM17
(CcCBM17), Bacillus sp. 1139 CBM17 and CBM28 (BspCBM17 and BspCBM28), and
Clostridium josui CBM28 (CjCBM28). The representatives were selected on the basis
that they are characterized as cellulose-specific Type B CBMs and are shown to have
affinity for both oligomeric and non-crystalline cellulose. CBMs with available structural

The protein-carbohydrate systems were modeled in the following configurations
(Figure 4.2): (A) CBMs with the cello-oligosaccharide bound in the orientation observed
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in the crystallographic structure, (B) CBMs with the oligosaccharide bound in the
opposite direction of the structural orientation (i.e., with the reducing end of the sugar
longitudinally rotated to the opposite end of the groove), and (C) CBMs bound with a
partially decrystallized cellulose microfibril, approximating non-crystalline cellulose, in
both the structural and reverse orientations. Additionally, each of the CBM

molecular models (Table 4.1).
Table 4.1 List of all the MD simulations performed in this study with length of MD
simulations and free energy calculation method.
Simulation

Free Energy

Time

Calculation

CcCBM17

250 ns

-

-

BspCBM17

250 ns

-

BspCBM28

-

BspCBM28

250 ns

-

CjCBM28

-

CjCBM28

250 ns

-

CcCBM17

Cellopentaose

CcCBM17-RE

250 ns

FEP/ -REMD

BspCBM17

Cellopentaose

BspCBM17-RE

250 ns

FEP/ -REMD

BspCBM28

Cellopentaose

BspCBM28-NRE

250 ns

FEP/ -REMD

CjCBM28

Cellopentaose

CjCBM28-NRE

250 ns

FEP/ -REMD

CcCBM17

Cellopentaose

CcCBM17-NRE

250 ns

-

BspCBM17

Cellopentaose

BspCBM17-NRE

250 ns

-

BspCBM28

Cellopentaose

BspCBM28-RE

250 ns

-

CBM

Substrate

System

CcCBM17

-

BspCBM17
Apo

A

B
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CjCBM28

Cellopentaose

CcCBM17
CcCBM17
C
BspCBM17
BspCBM17

Cellulose
microfibril
Cellulose
microfibril
Cellulose
microfibril
Cellulose
microfibril

CjCBM28-RE

250 ns

CcCBM17-F

100 ns + 100 ns

CcCBM17-R

100 ns + 100 ns

BspCBM17-F

100 ns + 100 ns

BspCBM17-R

100 ns + 100 ns

Umbrella
Sampling
Umbrella
Sampling
Umbrella
Sampling
Umbrella
Sampling

Explicitly solvated models of each CBM were developed from Protein Data Bank
(PDB) structures or via homology modeling. CfCBM4-1 and CfCBM4-2 models, in the
apo and cellopentaose-bound states, were previously constructed [184]. CcCBM17 was
constructed from the 1J84 PDB structure, which features cellotetraose bound in the
groove [100]. Similarly, BspCBM28 was constructed from the 1UWW PDB structure,
having no bound ligand [106], and CjCBM28 was constructed from the 3ACI PDB
structure, featuring cellopentaose [101]. With no available crystal structure for
BspCBM17, we used homology modeling, with CcCBM17 as a template, to build the
protein model [148, 150]
similarity and 70% structural similarity. For comparative purposes, we modeled the
CBM-bound cello-oligomers as cellopentaose; an additional beta-D-glucose residue was
constructed near the end of the CcCBM17 groove, and the cellopentaose ligand was
docked with BspCBM17 and BspCBM28 by structural alignment with their homologous
family member using Dali pairwise alignment tool [152]. These four systems represent
the oligomer-bound CBMs exhibiting the structural orientation, CcCBM17-RE,
BspCBM17-RE, BspCBM28-NRE, and CjCBM28-NRE (Figure 4.2A).
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Figure 4.2 Cartoon illustration of the protein-carbohydrate complexes modeled in this
study. CBMs from family 17 and 28 were modeled with cellopentaose bound in the (A)
crystallographic structure orientation and (B) with the reducing end of the pyranose ring
at the opposite end of the groove from the structural orientation. (C) CBMs were also bidirectionally bound with partially decrystallized cellulose I microfibrils, approximating
non-crystalline cellulose substrates. RE = reducing end; NRE = non-reducing end.
To investigate the bi-directional binding phenomenon in family 17 and 28 CBMs
(Figure 4.2B), we rotated the ligand from the structural orientation longitudinally along
the

ligand,

as

described

for

CfCBM4-1

and

CfCBM4-1

[184].

Cellopentaose was docked in the opposite direction of that captured in the crystal
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structures by assuming the mean position of the pyranose ring heavy atoms must reside in
approximately the same position regardless of direction. The approximate symmetry of
the pyranose chair conformation enables this by merely exchanging the ring atom
coordinates. CHARMM internal coordinate data was then used to establish the
coordinates of the remaining sidechain atoms [193-195]. Extensive stepwise
minimization of the ligand and the protein system was conducted before and after
solvation to remove any deformation or bad contacts. These four systems, representing
the “opposite” orientation, have been named CcCBM17-NRE, BspCBM17-NRE,
BspCBM28-RE, and CjCBM28-RE for reference here.
We hypothesize high affinity CBM-binding occurs when the CBM associates with
amorphous or non-crystalline cellulose via partially decrystallized oligomeric chains
decorating the top layers of degraded cellulose microfibrils (i.e., whiskers). Here, the
partially decrystallized microfibril model used to represent amorphous/non-crystalline
cellulose was adapted from the three-layer cellulose I model used in previous cellulose
decrystallization studies [209, 210]. The five-pyranose long decrystallized segment was

using PyMOL (Figure 4.3). We docked two CBMs, a representative from both families
17 and 28 selected based on the availability of experimental affinity data for later
comparison, in both ligand orientations such that we explore both possible interactions
between these CBMs and non-crystalline cellulose. When aligned with each other or with
CfCBM4-1-RE (Figure 3.13), CcCBM17 and BspCBM28 appear to bind their cellooligomeric ligands in opposite orientations, relative to the directionality of the core sheets. Assuming the structural orientations represent thermodynamically-preferred
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recognition modes, we docked the CcCBM17 on the cellulose reducing end and
BspCBM28 on the cellulose non-reducing end and refer to them as CcCBM17-F and
BspCBM28-

A second set of systems were prepared with
-directional binding and

additional CBMas CcCBM17-R and BspCBM28-R (Figure 4.2C). System construction was followed by
extensive minimization and 1-ns of NPT
modeled protein-carbohydrate interaction and reduce solvation effects. During heating,
f the cellulose microfibril was
restrained by applying harmonic restraints to the pyranose ring atoms; the CBMs and all
other atoms of the systems were free of restraints. Protein alignment and ligand docking
by alignment was carried out using PyMOL [171] and Dali pairwise comparison version
3.1 [152].
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Figure 4.3 Initial position of BspCBM28 in the forward orientation (after 500 ps of NPT
cellulose-

a middle chain of the top layer

occupying the binding cleft of the CBM. The front view (left) and left-side view (right)
illustrate the CBM (gray cartoon), its aromatic residues in the shallow binding cleft (blue
sticks with transparent surface), and the cellulose microfibril (green sticks with red
oxygens). A similar setup approach was used for the other three cases.
4.2.2

MD simulation parameters and protocols
The CHARMM36 force-field with CMAP corrections was used to simulate all

proteins [191, 192], and carbohydrates were modeled with the CHARMM36
carbohydrate force-field [193-195]. Water molecules were represented by the modified
TIP3P force-field [196, 197]. Ions were modeled based on the force-field by Beglov and
Roux [211]

CcCBM17 –

1J84, BspCBM28 – 1UWW & CjCBM28 – 3ACI) and homology modeling
(Bsp
using H++ web server [189]. Visual inspection revealed additional residues to be
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protonated, including Asp200 in CcCBM17, Asp72 in BspCBM17, Asp184 in
BspCBM28, and Asp198 in CjCBM28. Sixteen different molecular dynamics (MD)
simulations were constructed using CHARMM [166]. The systems, containing CBMs,
crystallographic waters, calcium ions, and ligands (cellopentaose or microfibril), were
constructed in vacuum and minimized for 1000 steps of Steepest Descent (SD) and 1000
steps of adopted basis Newton-Raphson (ABNR) with a tolerance of 0.01 for the average
gradient. The vacuum-minimized systems were then solvated in explicit water, where the
apo CBMs and CBMs bound with cellopentaose were solvated in a 70 Å × 70 Å × 70 Å
cubic box (~35,000 atoms), and the CBMs bound with the cellulose microfibril were
solvated in a 110 Å × 80 Å × 110 Å orthorhombic box. To neutralize the system charge,
sodium or chloride ions were added by replacing random waters with the ions. The
solvated systems were then subjected to extensive stepwise minimization: 2000 steps of
SD with the protein and ligand fixed, 2000 steps of SD with only the protein heavy atoms
fixed, and 10000 steps of SD and 10000 steps of ABNR (tolerance 0.01) with no
restraints. The minimized systems were heated from 100 K to 300 K in 50 K increments
over 20 ps, and then

500 ps in the NPT ensemble at 300 K and 1 atm. The

Nosé-Hoover thermostat and barostat were used to control temperature and pressure in
CHARMM [212, 213].
For the data collection (production) MD, in the NVT ensemble, the apo and
oligomeric systems were simulated for 250 ns seconds, while the CBM-microfibril
systems were simulated twice (independently) for 100 ns each. These simulations were
carried out at 300 K using NAMD 2.10 [169]. The Langevin thermostat was used to
control temperature [214], and the SHAKE algorithm was used to fix the bond distances
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of all hydrogen atoms [215]. Non-bonded interactions were truncated with a cutoff
distance of 10 Å, a switching distance of 9 Å, and a non-bonded pair list distance of 12
Å. Long range electrostatics were described using the Particle Mesh Ewald (PME)
method with 6th order bspacing [216]. The velocity Verlet multiple time-stepping integration scheme was used to
evaluate non-bonded interactions every 1 time step, electrostatics every 3 time steps, and
6 time steps between atom reassignments. All simulations used a 2-fs time step.
4.2.3

Free energy calculations
We calculated the absolute free energies of binding cellopentaose to CBMs for all

three families using an enhanced sampling free energy method, FEP/ -REMD.

-

REMD is an enhanced sampling free energy methodology developed by Jiang, Hodoscek
[174], which we have previously implemented for protein-carbohydrate systems
obtaining good agreement with experimental data [113, 184, 217]. For two different
systems, the CBM-cellopentaose complex in solvent and solvated cellopentaose, the nonbonded interactions of cellopentaose with the rest of the system were systematically
turned off to obtain the change in free energy. This free energy calculation protocol was
implemented using dedicated module in NAMD [169]. The non-covalent interaction
between the CBM and cellopentaose was distributed into repulsive, dispersive,
electrostatic, and restraining components over 128 replicas. The total change in free
repu

disp

elec,

and

rstr

CBM groove into vacuum and the solvation free energy of cellopentaose gives the
absolute free energy of binding a solvated ligand to a solvated protein. Convergence of
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the free energy values was determined by Multistate Bennett Acceptance Ratio (MBAR)
analysis method [176]and can depend on whether the model was prepared from crystal
structure or homology model. Free energy calculations using models implementing
ligand docking or homology modeling included additional restraining forces to improve
convergence. For direct comparison, the FEP/ -REMD calculations conducted here
comply with the specifications outlined in our earlier study of family 4 CBMs [184];
accordingly, all methodological details are identical.
Umbrella sampling MD was used to determine the potential of mean force (PMF)
of decoupling the CBM from the model non-crystalline surface into the solvent, from
which we can estimate the free energy of binding. The distance between the projection of
the center of mass of the CBM and the projection of center of mass of the lower layer of
the cellulose microfibril on the Z-axis served as the reaction coordinate. This distance
was gradually increased by 15 Å in 0.5 Å increments, or 31windows, until the nonbonded interaction between the protein and substrate no longer existed. The biasing force
along the reaction coordinate was applied using collective variables during the 10 ns MD
of each window in NAMD [169]. To assist strictly perpendicular movement of the CBM
relative to the microfibril surface, the distance between the same pair of projections on
the X- and Y-axes was restrained as a constant. The harmonic restraint on the ring atoms
of the lower layer of the microfibril was maintained throughout sampling. A force
constant of 10 kcal/mol was used to maintain the collective variables to their specified
values. In CcCBM17-F, the pyranose ring immediately prior to the decrystallized chain
was harmonically restrained to the cellulose surface preventing further decrystallization
as the CBM was pulled away. Last 5 ns data was used in construction of potential mean
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coordinates were normalized to represent the change in distance (i.e. 0 Å to 15 Å). The
calculation of potential mean force profile and error analysis was performed using
MBAR analysis [176].
4.3
4.3.1

Results and discussion
Role of binding site architecture in substrate recognition
The three CBM families, 4, 17, and 28, share the same -sandwich protein fold

but exhibit key differences in binding site architectures/platforms. As they all belong to
the Type B classification, the binding site generally conforms to either a cleft or groove
capable of accommodating a single glycan chain. However, structural examine reveals
the family 4 CBMs exhibit much deeper binding clefts relative to the more open grooves
of family 17 and 28 CBMs, which we expect plays a critical role in substrate recognition
mechanisms. Both CfCBM4-1 and CfCBM4-2 display aromatic residues lining the cleft
and whose hydrophobic surfaces face each to sandwich the substrate pyranose rings
between them (Figure 4.4). The oligomeric substrate is enveloped in a 4 to 5 Å-deep cleft
with its pyranose ring perpendicular to the CBM surface [62]. Family 17 and 28 CBM
binding grooves also display aromatic residues, although they are positioned side-by-side
with their hydrophobic surfaces exposed to the solvent. Additionally, these aromatic
residues are not exactly aligned in parallel planes, as in Type A CBMs, but, rather,
-binding platform
[100, 101].
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Figure 4.4 Differences in the two binding site architectures of family 4, 17, and 28
CBMs, as illustrated through hydrophobic interactions (dark blue sticks and transparent
surface) and hydrogen bonding (red sticks) with the cellopentaose ligand (light green and
red sticks). The front view (top left) and side view (top right) of the CfCBM4-1 binding
site with bound cellopentaose clearly show the sandwich platform and deep cleft with
one-sided hydrogen bonding of the ligand. The front view (bottom left) and side (bottom
right) of the CjCBM28 binding site with bound cellopentaose show a twisted surface
platform and shallow groove with hydrogen bonding partners available on both sides of
ligand.
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The significance of individual hydrophobic aromatic residues and polar residues
in both family 17 and 28 CBMs has been examined in prior experimental studies [100,
102, 111]
similarity, thermodynamic binding signatures are not always consistent within members
of the same family [96, 101]. We have previously discussed the similarities and
differences within the two family 4 CBMs for ligand binding dynamics and
thermodynamic preference [184]. In this section, we focus on comparing and contrasting
oligomeric ligand binding modes and affinity across the two different binding platforms
as well as within
and across the three Type B CBM families.
Here, we select CfCBM4-1 and CfCBM4-2, having sandwich platforms, and
CcCBM17-RE and CjCBM28-NRE, having twisted platforms for comparison, as
experimental binding affinities and structures have been determined for each. Reported
affinities for cellopentaose of each of the four CBMs are kcal/mol [110], -

[98], -5.80

[100], and -

[102],

respectively. Additional cellopentaose affinities have been reported for several of these
CBMs, though experimental conditions vary making direct comparison challenging [96,
97, 218]. For the same four CBM·cellopentaose systems, we calculated binding affinity
using FEP/ -REMD under conditions identical to experiment, at 300 K and pH 7.0. We
found that CfCBM4-1 and CfCBM4-2 exhibited affinities for cellopentaose at -4.51
1.30 kcal/mol [184] and

. CcCBM17-RE and CjCBM28-NRE

exhibited affinities for cellopentaose at -

-

respectively, and were more favorable than affinities of CBM4s. Detailed distribution of
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free energy components, including charge, dispersion, van der Waals, and restraining
contributions (Table 4.2), and illustration of calculation convergence (Figure 4.5) has
been provided in Supplementary Material. These subtle thermodynamic preferences of
different platforms are definitely one of the factors that play a role in building the
recognition mechanisms targeted towards specific substrates. Further in this study, we
address our hypothesis that this tighter binding in twisted platform is evolutionary feature
of family 17 and 28 CBMs that allow them to preferably recognize non-crystalline
cellulose over cello-oligomers.
Table 4.2

binding to
b

°

represent one

standard deviation.

System

b

°

rep

disp

elec

rstr

CfCBM4-

-4.51 1.30

73.54
0.19

-78.87
0.05

-59.18
0.15

CfCBM4-

-5.41 1.38

81.19
0.33

-81.01
0.06

-67.59
0.17

b

2.03

Cc

-6.94

0.91

76.09
0.19

-77.27
0.05

-67.81
0.18

b

2.05

Cj

-6.26

0.74

75.74
0.19

-72.55
0.08

-69.34
0.17

-0.11

a

a

Data obtained from Kognole and Payne [184]

b

Harmonic restraints were applied to rings atoms of ligand.
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0.29

Figure 4.5 Convergence of the free energy calculations of cellopentaose binding to
CBMs over 20 consecutive windows of 0.1 ns using enhanced sampling method FEP/ REMD.
MD simulations provide additional insight into the binding free energy
calculations, revealing that CcCBM17-RE and CjCBM28-NRE form more stable noncovalent interactions with the cellopentaose ligand than either family 4 CBM. From the
250-ns MD trajectories, we calculated the

RMSF) of the

ligand on a per-binding-subsite basis (Figure 4.6); error was estimated by block
averaging over 2.5 ns blocks. This value describes how much a given pyranose ring
fluctuates from its average position over the course of a simulation. Collectively, as well
as in nearly every binding site, the pyranose rings within the CfCBM4-1 and CfCBM4-2
binding cleft fluctuate more than that of either CcCBM17-RE or CjCBM28-NRE,
indicating the latter two ligands form more protein-carbohydrate contacts and are, likely,
more tightly bound as we will show below. Moreover, the lower RMSF combined with
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higher binding affinity in the twisted platforms suggests that the unfavorable entropic
penalty is compensated by enthalpic contributions, especially hydrogen bonding, as
discussed ahead.

Figure 4.6

the cellopentaose ligand from its

average position in the clefts/grooves of representatives from family 4, 17, and 28 CBMs
obtained from 250-ns MD simulation on a per-binding-subsite basis. Error was calculated
from block averaging with block sizes of 2.5 ns. The binding site nomenclature with
subsites 1 to 5 is assigned from reducing end to non-reducing end of cellopentaose; refer
Figure 4.1.
There are three aromatic residues in the binding sites of the CBM4s and CBM28s,
while CBM17s display only two, so the contribution to ligand binding from hydrophobic
stacking interactions is not platform-dependent, varying by family. Rather, hydrogen
bonding interactions appear to be a key determinant in affinity differences between the
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two binding site architectures. The average number of hydrogen bonds formed between a
given pyranose ring with the side chains of the surrounding protein was determined using
VMD; detailed analysis of hydrogen bonding over the course of the MD simulations
identified the primary hydrogen bonding partners in all the CBM-oligomer interactions.
The average number of hydrogen bonds formed per binding site was calculated from the
250-ns MD trajectories, where a hydrogen bond was defined as two polar atoms having a
donor-acceptor distance of < 3.0 Å a

. Table 4.3 shows the hydrogen

bonding pairs from the calculations along with percent occupancy of each pair, where
occupancy refers to the percent of the simulation during which the hydrogen bond was
formed. While the CBMs with the same binding site architecture exhibit comparable
hydrogen bonding, the total number of hydrogen bonds formed with the twisted platform
was almost 100% higher than that of the sandwich platform. Total percent occupancy of
100% indicates that at any given time of simulation there is, on average, at least one live
hydrogen bond between the ligand and protein. Along the twisted platform, there are one
or more additional hydrogen bonding partners, accounting for an additional 1-2 kcal/mol
of binding free energy for the whole binding site [219, 220]. CcCBM17-RE and
CjCBM28-NRE form more hydrogen bonds with cellopentaose than either CfCBM4-1
and CfCBM4-2, fitting with our conjecture that the loss of conformational entropy in
ligand binding is compensated with enthalpic contributions to free energy. This
difference in hydrogen bonding can be justified by analysis of the positioning of partner
amino acid residues along the binding site. In the sandwich platform, where the ligand is
approximately perpendicular to protein surface, primary and secondary hydroxyl groups
of only one edge of cellopentaose chain contact the CBM and the other edge is exposed
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to solvent (Figure 4.4). In contrast, the cellopentaose bound in the twisted platform
hydrogen bonds with partners on both sides of the groove. In CBM4s, there are relatively
few hydrogen bonding partners available at binding subsite 5, but in the case of
CcCBM17-RE and CjCBM28-NRE, each binding subsite exhibits at least one residue
capable of hydrogen bonding.
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Table 4.3 Percent occupancy of each hydrogen bond formed between the pyranose ring
at each binding site and the surrounding protein residue over the 250 ns simulation. Data
are shown in decreasing order of occupancy. Pairs with occupancy lower than 1% are not
shown.

-D-glucose. A hydrogen bond was defined as two polar

atoms having a donor-acceptor distance of < 3.0 Å a

CfCBM4-1

Sandwich Platform

Donor

Acceptor

CfCBM4-2
Occupancy

Donor

Acceptor
-Side

Occupancy

-Side

-Side

26.86%

-Side

-Side

ASN81-Side

25.70%

-Side

-Side

ALA18-Main

25.14%

-Side

TYR43-Main

16.61%

-Side

LEU24-Main

7.83%

-Side

-Side

15.37%

-Side

SER23-Side

6.96%

-Side

HSE132-Side

-Side

43.83%
40.02%
26.11%

-Side

-Side

6.54%

-Side

SER23-Side

5.24%

-Main

-Side

5.11%

ASN56-Side

-Side

3.98%

-Side

-Side

2.23%

SER23-Side

-Side

3.27%

-Side

ASN50-Side

1.90%

SER23-Side

-Side

2.86%

ASN50-Side

-Side

1.57%

-Side

1.47%

-Side

-Side

ASN81-Main

1.43%

-

-

-

-Side

-Side

1.11%

-

-

-

-Side
Total

-Side

1.04%
130.61%
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Total

141.57%

CcCBM17-RE
Donor
-Side

Twisted Platform

-Side

CjCBM28-NRE

Acceptor

Occupancy

ASP54-Side

63.20%

-Side

-Side

65.98%

59.43%

-Side

-Side

54.69%

-Side

Donor

Acceptor

-Side

-Side

37.35%

-Side

-Side

ASP54-Side

27.80%

-Side

-Side

-Side

20.06%

-Side

ASN185-Side

-Side

15.67%

-Main

ASN137-Side

-Side

14.64%

-Side

ASP135-Side

3.14%

ASN52-Side

-Side

9.25%

-Side

ASP76-Side

2.68%

THR184-Side

-Side

2.64%

-Side

-Side

1.67%

-Side

-Side

2.15%

TRP129-Side

-Side

1.57%

-Side

1.12%

-Side

THR184-Main

1.54%

TRP78-Main

-Side

ASN137-Side

1.08%

-

Total

254.81%

-Side

Occupancy

ASP76-Side
-Main
-Side

Total

45.93%
26.08%
23.77%
7.54%

234.17%

Average change in solvent accessible surface area (SASA) upon ligand binding
(Figure 4.7) reveals that the sandwich platform buried more solvent exposed surface area
upon binding than the twisted platform, though the latter was more solvent exposed
initially. The average change in SASA was calculated over 2500 frames of MD
simulation, taking the difference between summation of average SASA of apo CBMs and
average SASA of solvated cellopentaose and average SASA of respective CBMcellopentaose complexes (Figure 4.7). The mean change in SASA is lower for twisted
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platform CBMs than sandwich platform CBMs, with less of a change in SASA observed
for CjCBM28-NRE than CcCBM17-RE. The extra aromatic residue (Phe128) in the
CjCBM28 binding groove, being the most obvious difference within the twisted
platforms of family 17 and 28 CBMs, appears to contribute to this difference, but it also
suggests that having an aromatic residue may not always contribute to higher change in
SASA when compared to sandwich platform CBMs that also have three aromatic
residues. Solvent-exposed residues along the twisted platforms do not appear to retain
ordered water molecules proximal to the aromatic side chains when there is no bound
ligand; upon ligand binding, additional water molecules were retained at the proteincarbohydrate interface, as hydroxyl groups of cello-oligosaccharides enable solvent
reorganization [101]. Thus, there is limitation to use of mean change in SASA, which is

through solvent reorganization. However, the larger change in SASA for sandwich
platform CBMs reflects a conformational change upon ligand binding. As observed in the
MD simulations, the deep cleft of the two family 4 CBMs narrows over time as it
sandwiches the cello-oligomer and excludes water from the hydrophobic core of the
protein. The twisted platform on the other hand does not appear to implement this
sandwiching mechanism and may, rather, prefer sliding along the polysaccharide chain
more freely that would involve less change in SASA.
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Figure 4.7 Average change in solvent acc
VMD over the 250 ns MD simulation trajectories of each CBM-cellopentaose system to
compare the difference between sandwich (lined pattern) and twisted (dotted pattern)
platforms. The error bars represent the standard deviation (SD) of the mean.
Overall, MD simulation results, especially hydrogen bonding patterns, suggest
that the difference in cleft architecture (i.e., twisted vs. sandwich) greatly contributes to
differences in affinity and, likely, protein-carbohydrate recognition mechanism. The
recognition mechanism of the oligomeric ligand by these two different architectures is
readily distinguishable based on the binding affinity and hydrogen-bonding pattern. It is
tempting to suggest variations in molecular-level behavior, such as these, are a result of

targeting regional substrate features [64, 100].
To further differentiate oligomeric recognition mechanisms between CcCBM17
and CjCBM28, we compared ligand binding dynamics at each binding subsite (Figure
4.8). Despite the apparent similarity in binding site architecture, the two CBMs feature
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cello-oligomers bound in opposite directions in their crystal structures (i.e., with the
reducing end oriented at a different end of the groove when structurally aligned) [100,
101]. To enable comparison, the binding subsites of the two CBMs were structurally
aligned, and a letter-based subsite nomenclature was invoked based on the two common
solvent-exposed Trp residues (Figure 4.8). The RMSF and hydrogen bonding evaluations
reported above follow the numbered binding subsite nomenclature from crystal structure
publications, as a cumulative comparison across the platforms. Alignment and renaming
binding subsites (A to F), as previously implemented by Tsukimoto, Takada [101],
reveals that four common binding subsites (B, C, D, and E) are occupied by
cellopentaose in CcCBM17-RE (B to F) and CjCBM28-NRE (A to E).
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Figure 4.8 Alignment of the twisted platform binding sites of CcCBM17-RE (top) and
CjCBM28-NRE (bottom) with respect to the common pair of Trp residues (dark sticks).
The new common naming of binding subsites (letters) is given in between the panel, and
the original nomenclature (numbers) is given above and below the cartoon
representations. (B) Average total interaction energy of the pyranose rings with the
surrounding amino acid residues, on a per-subsite-basis, of CcCBM17-RE and
CjCBM28-NRE calculated from the 250-ns trajectory. Error bars represent 1 SD.
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The average total interaction energy of protein with the cellopentaose ligand was
determined from the 250-ns trajectory on a per-binding-subsite basis. The interaction
energy distribution was very similar for CBM17 and CBM28, in the binding subsites B
and C that reside along the hydrophobic face of pair of Trp residues common to both
CBMs (Figure 4.8). Difference arises in the binding subsites as the extra aromatic residue
in family 28 CBMs (Phe128 in CjCBM28 and Tyr118 in BspCBM28) that can provide
hydrophobic stacking interaction at binding site E. Nevertheless, we observe little
difference at subsites D and E in total interaction energy calculation that accounts for
both van der Waals and electrostatic interactions. Based on overall analysis oligomeric
binding affinities, collective nature of hydrogen bonding and total interaction energy at
twisted platform, one can agree that these two families with same platforms exhibit very
similar binding mechanisms for oligomeric ligands except the difference in mean change
in SASA. CBM17s and CBM28s are reported to bind oligomers as long as cellohexaose
[100] [96], and it is apparent that, for CBM17s, the sixth subsite would be A, while for
CBM28s, the sixth sugar can be accommodated in either F or X. As CcCBM17 and
CjCBM28 are known to bind non-crystalline substrates as well, it is possible there exist
secondary binding subsites for chains even longer than cellohexaose. Accordingly, we
docked cellohexaose with CjCBM28 in two orientations, occupying subsites A to F and
X to E, and conducted 100-ns MD simulations; these simulations showed that both
subsite X and F functionally interact with the ligand, although X had a higher interaction
than subsite F (Figure 4.9). Extended binding sites may play a critical role in recognition
of non-crystalline substrates, as we will discuss ahead.
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Figure 4.9 Average total interaction energy per binding subsite with the surrounding
amino acid residues of CjCBM28 for a cellohexaose chain of the microfibril occupying
the cleft in two different ways, A to F (red) and X to E (blue). Values were calculated
over the entire 100-ns trajectory. The error bars represent one standard deviation.
4.3.2

Differentiation of high and low affinity binding sites non-crystalline cellulose
Structural characterizations of many carbohydrate active enzymes focus strictly

on the interactions occurring in the carbohydrate binding site or catalytic active sites,
while protein surface residues or secondary binding sites may be just as important to
functionality [221]. Type B CBMs are reported to bind both cello-oligomers and noncrystalline/amorphous cellulose, covering a broad range of polymeric structural diversity
and suggesting recognition processes may involve interactions beyond the primary
binding site. Interestingly, CBMs from families 17 and 28 appear to bind non-crystalline
cellulose with high and low binding affinities, as determined from isothermal titration
calorimetry (ITC) data, and the two families do not compete with each other for
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carbohydrate binding sites [64, 65]. We further explore both the concept of bi-directional
binding and the high/low binding affinity phenomena of family 17 and 28 CBMs on noncrystalline cellulose by modeling representative Type B CBMs bound with a model noncrystalline substrate in multiple orientations. At the nanoscale, we propose a partially
decrystallized cellulose I microfibril sufficiently represents the interaction of a CBM
with non-crystalline cellulose, which retains a significant degree of crystallinity.
Additionally, given our above insights into family 17 and 28 CBM members (i.e., that
there is relatively little difference in oligomeric binding dynamics between members of
the same family), we modeled only four representative CBM·microfibril systems: one

orientations, forward and reverse. Details of this have been provided in methods section
above.
Fully atomistic MD simulations were used to explore the primary modes of Type
B carbohydrate recognition with respect to non-crystalline cellulose. All atomic
interactions were unbiased except for the lower layer of the cellulose microfibril, which
was harmonically restrained to prevent excessive fraying and further decrystallization. In
all four cases, CcCBM17-F, CcCBM17-R, BspCBM28-F, and BspCBM28-R, the
CBM·non-crystalline cellulose complexes stabilized in a global minimum state in each of
the 100-ns MD simulations, illustrated by the rapid plateau in the protein backbone
RMSD over time (Figure 4.10). Throughout the simulation, most CBMs bind all five
pyranose moieties of the whisker along the twisted binding sites in the fully
decrystallized state; in the case of BspCBM-F, the fifth pyranose ring closest to the
cellulose surface partially re-annealed into the microfibril, which is not unexpected [222].
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Comparing RMSF of the CBM backbone when bound to either an oligomer or noncrystalline cellulose reveals that ligand binding stabilized the protein (lower RMSF);
unbound CBM RMSFs exhibited larger fluctuations near binding site residues in both
CBMs. Only BspCBM28-RE, bound with the rotated cellopentaose, showed large protein
backbone fluctuations (Figure 4.11), resulting from ligand movement along the binding
groove discussed in Chapter 3 (Figure 3.15).

Figure 4.10 RMSD of the CBM backbone bound to the model non-crystalline cellulose
microfibril over 100 ns of MD simulation (10000 frames captured at every 0.01 ns).
RMSD was determined with respect to the coordinates of each respective CBM at 0 ns.
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Figure 4.11 Root
(top) and BspCBM28 (bottom) in each ligand occupancy state.
Comparing these four simulations and the oligomer-bound simulations above, we
identified molecular-level factors contributing to substrate recognition in each family
with respect to variation in substrate and orientation. The interaction energy of each CBM
residue with the substrate was determined by averaging the calculation over trajectories,
for all CBM·substrate systems (Figure 4.12). For both family 17 and 28 CBMs, the
average interaction of a given CBM residue with the substrate is independent of direction
of cellopentaose ligand in the binding site, which is, again, consistent with bi-directional
ligand binding. The hydrophobic-stacking aromatic residues and hydrogen bonding
partners of the CBM·cellopentaose systems, as discussed above, produce substantial
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favorable interaction energies (< – 5 kcal/mol). These same residue·substrate interactions
exist when the CBM is bound with non-crystalline cellulose. However, additional protein
residues along the CBM surface also appear to be involved in binding non-crystalline
cellulose (Figure 4.12), as revealed from the rather significant new interactions formed in
regions where the CBM·cellopentaose systems produce no such interactions.
While it is clear that protein surface residues play an auxiliary role in noncrystalline cellulose binding, each CBM and orientation relative to the cellulose surface
ubstrate interactions to amplify non-crystalline
cellulose binding affinity over oligomeric affinity. In the case of CcCBM17-F, two
peptide loops adjacent to the binding groove, residues 30-35 and 95-106, interact with
cellulose as a result of their proxim
orientation. Most residues in these loops are polar residues, including Pro31, Lys32,

the microfibril through additional hydrogen bonding. In the case of CcCBM17-R, Asp81,
Asn86, and Asn137 produce new, large electrostatic interactions between the CBM and
substrate. Also, aromatic residues like Trp88 produced more favorable interaction
energies in the reverse orientation, while interacting loops in the forward orientation
played no role at all. Similarly, for BspCBM28-F, the family 28 CBM lost hydrogen bond

(subsite 4); however, new hydrogen bond interactions with residues in loop 65-68 were
formed. The BspCBM28-R orientation exhibited more consistent interaction patterns,
with no loss of affinity contributors and formation of additional favorable interactions
between cellulose and residues in loops 66-68 and 115-130. Ultimately, it seems each
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orientation of a given CBM relative to the cellulose surface produces a specific set of
substrate interactions that enhance non-crystalline cellulose binding relative to oligomeric
binding.

Figure 4.12 Total interaction energy between the substrate and each protein residue,
averaged over the length of the MD simulations. The CcCBM17 (top) and BspCBM28
(bottom) residue numbers are shown along the x-axis. The simulation case label is given
at left, four cases for each family 17 and 28 CBM. The magnitude of the interaction
energy between a given residue and the bound ligand, as indicated in the case name, is
shown in grayscale. Favorable interactions are more negative and, thus, darker. In
cellopentaose binding, ligand direction does not affect CBM·cellopentaose interactions,

124

as redundant protein residues along the binding groove maintain association with
cellopentaose. In non-crystalline cellulose binding, the CBM protein surface interacts
with the surrounding carbohydrate, in both forward and reverse orientations, to enhance

each direction.
To thermodynamically characterize the effects of orientation and substrate
crystallinity on family 17 and 28 binding, we calculated binding affinities from the
crystalline cellulose substrate. We used umbrella sampling MD to disassociate the CBM
from non-crystalline cellulose, pulling the CBMs away from the substrate
perpendicularly. Sampling simulations were started

-ns MD

simulation snapshots of each CBM·non-crystalline cellulose complex. For all four cases,
the corresponding PMFs indicate binding affinities are higher for non-crystalline
cellulose than for oligomeric ligands in respective CBMs (Figure 4.13); this result aligns
with our hypothesis that the higher affinity binding sites described in experimental
binding studies corresponds to CBM·non-crystalline cellulose binding and lower affinity
binding sites correspond to CBM binding in oligomeric or highly decrystallized regions.

dissociation process from a non-crystalline substrate (Figure 4.13). The free energy of
binding non-crystalline cellulose is determined from the difference between the free
energy at the beginning (0 Å) and end (15 Å) of the reaction coordinate. For both
CcCBM17 and BspCBM28, the orientation of the CBM relative to the surface affects
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binding affinity, favoring the forward orientation in CBM17 and the reverse orientation
with CBM28. Additionally, there is a significant difference in affinity between the two
high-affinity orientations of each CBM family; CcCBM17-F binds with the highest
affinity, 23.0

1.1 kcal/mol, and BspCBM28-

0.8 kcal/mol. Combined with the knowledge that these two CBM families do not
competitively bind non-crystalline cellulose [64], our results suggest that CBMs from
these two families are capable of recognizing cellulose binding sites based on binding
orientations relative to the substrate. The difference between the affinity of CBM17 and
CBM28 for nonsurface interactions that contribute to the affinity as well as fortuitous compatibility of
CBM17s than CBM28s with proposed non-

surface

topology around oligomeric binding site of CBM28 Decrystallized edge chain
morphology could be one of the other cases of non-crystalline cellulose that are preferred
by CBM28s over CBM17s.
The model non-crystalline substrate simulated in this study represents a subset of
cellulose morphologies that are very close to crystalline substrate, and the calculated free
energies correspond to association constants as high as 1012 mol-1, which are not
detectable by experimental methods such as ITC. The reported high affinity cellulose
binding sites for CcCBM17 and BspCBM28 on regenerated cellulose, from ITC, were 8.41

0.32 and -8.28

0.35 kcal/mol, respectively [64] and while these values are much

lower than those calculated from PMFs, it is plausible that the experimental affinities
correspond to a range of other cellulose morphologies more amorphous in nature than the
model non-crystalline substrate. Nevertheless, taken
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together with the

calculated and experimental values of cellopentaose binding to CcCBM17 and
BspCBM28, our results offer promising evidence that high and low affinity noncrystalline cellulose binding sites correspond to degree of substrate crystallinity. In other
words, these family 17 and 28 CBMs appear to bind cellulose with a higher degree of
crystallinity with greater affinity than small, oligomeric substrates.

Figure 4.13 Potential of mean force (PMF) in uncoupling (A) CcCBM17 and (B)
BspCBM28 from non-crystalline cellulose. Umbrella sampling MD was conducted over
30 0.5-Å-windows using the projection of the distance vector on the z-axis as the reaction
coordinate.
Finally, dissociation appears to occur in two separate events along the PMF
profile (Figure 4.13), with an initial exertion of work to decouple the CBM from the
substrate surface and a final extrication of the polymeric chain from the CBM binding
groove. The CBM bound with non-crystalline cellulose must initially overcome the
strong electrostatic interactions and hydrogen bonds formed between the CBM protein
surface and the cellulose surface. After the exterior of the CBM was free of the cellulose
surface, t

to dissociate the CBM was associated with
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overcoming both van der Waals interactions between with the aromatic residues and
pyranose rings and several hydrogen bonds formed with the substrate along the length of
the groove. Combined with our MD simulation results above, the increase in affinity
observed in binding CcCBM17 and BspCBM28 with non-crystalline cellulose with
appears to be directly related to the additional protein·carbohydrate interactions mediated
by residues exterior to the CBM binding groove.
4.4

Conclusions
With better resolution of thermodynamic affinities and detailed analysis of

protein-carbohydrate interactions like hydrogen bonding for two different binding
platforms within same type of CBMs, it is evident that binding site architecture has
profound effect on CBM functionality in recognizing carbohydrate substrates.
Comparison of twisted platform in two different CBM families, 17 and 28, showed
similarity in oligomeric ligand binding dynamics and certainly provided sufficient
rationale towards their exten
crystalline cellulose binding, expanding upon experimental observations identifying
enthalpic interactions as dominant in non-crystalline substrate recognition by CcCBM17
and BspCBM28 [115]. Specifically, we identified individual contributions to
thermodynamics parameters, revealing that the gain in enthalpy in binding noncrystalline cellulose over oligomers results from direct contact of the CBM exterior with
the cellulose substrate. We also provided insights into how family 17 and 28 CBMs could
uncompetitively bind non-crystalline cellulose, despite having very similar binding
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binding affinities to non-crystalline substrate binding sites remains, hinging on future
experimental efforts to structurally characterize non-crystalline cellulose of increasingly
amorphous nature. This study also provides the basis for our future investigations of
glycoside hydrolases linked with tandem CBMs, as the two family 4 CBMs (CfCBM4-1
and CfCBM4-2) and the two Bacillus sp. 1139 family 17 and 28 CBMs (BspCBM17 and
BspCBM28) are natural tandem constructs appended to

-1,4-endoglucanses. We

anticipate the results toward understanding Type B CBM oligomeric and non-crystalline
recognition mechanisms will advance our understanding of how protein-protein
interactions and inter-module networking determines additive or cooperative binding in
tandem systems and why organisms secret multi-modular enzymes with seemingly
redundant CBM domains.
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Chapter 5 – Carbohydrate ligands of YKL-40: Binding mechanisms,
thermodynamic preferences and surface binding ability
In Chapter 5, we report molecular-level investigation of YKL-40s binding sites
for carbohydrate ligands like chito-oligomer and determine the most likely physiological
binding partner. This chapter has been adapted with permission from Kognole and Payne
[223], Copyright © 2017, American Society for Biochemistry and Molecular Biology.
5.1

Abstract
YKL-40 is a non-catalytic mammalian glycoprotein and biomarker associated

with progression, severity, and prognosis of chronic inflammatory diseases and a
multitude of cancers. Despite this well-documented association, conclusive identification
, and accordingly, biological function, has proven
experimentally difficult. From experiments, YKL-40 has been shown to bind chitooligosaccharides; however, the natural production of chitin by the human body has not
yet

been

documented.

Possible

alternative

ligands

include

proteoglycans,

polysaccharides, and fibers such as collagen, all of which make up the mesh comprising
the extracellular matrix. It is likely that YKL-40 is interacting with these alternative
polysaccharides or proteins within the body, extending its function to cell biological roles
such as mediating cellular receptors and cell adhesion and migration. Here, we consider
the feasibility of polysaccharides, including cello-oligosaccharides, hyaluronan, heparan
sulfate, heparin, and chondroitin sulfate as potential physiological ligands for YKL-40.
Molecular dynamics (MD) simulations resolve the molecular-level recognition
mechanisms, as several of these potential ligands appear to bind YKL-40 in modes
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analogous to chito-oligosaccharides. Further, we calculate the free energy of binding of
the hypothesized ligands to YKL-40 to address thermodynamic preference relative to
chito-oligosaccharides. Our results suggest that chitohexaose and hyaluronan
preferentially bind to YKL-40, and hyaluronan is likely the preferred physiological
ligand, as the negatively charged hyaluronan shows enhanced affinity for YKL-40 over
neutral chitohexaose. Finally, heparin non-specifically binds at the surface of YKL-40, as
predicted from structural studies. Overall, YKL-40 likely binds many natural ligands in
vivo, but its concurrence with physical maladies may be related to associated increases in
hyaluronan.
5.2

Introduction
Significance of YKL-40 as a biomarker in various malignancies and structural

properties of this chitinase-3-like-1 protein have been described in the general
introduction (Section 1.3.2). In this chapter, we specifically focus on the polysaccharide
binding sites of YKL-40 and exploring oligosaccharides of different glycosaminoglycans
-40. Despite the structural similarity between chito-

beyond the original structural studies exists [43, 44]. In fact, we are aware of only one
other study focusing on the molecular-level mechanism of carbohydrate binding in YKL40 [224]. From a bioinformatics and structural comparison of YKL-40 to a similar chilectin, mammary gland protein-40, the authors propose an oligosaccharide binding
mechanism that involves tryptophan-mediated gating of the primary carbohydrate
binding site [224, 225]. Though in lieu of a dynamics-based investigation, little can be
concluded about the binding mechanism of YKL-40 ligands other than chito-
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oligosaccharides, and conformational changes relative to binding are inaccessible. From
-Sepharose chromatography, we also
know that YKL-40 reversibly binds heparin [44, 128, 226]; however, affinity data for this
interaction does not exist. Based on the interaction with heparin, it is reasonable to
hypothesize heparan sulfate glycosaminoglycans, existing as part of the extracellular
matrix construct, are a potential physiological ligand. Visual inspection of the protein
structure initially suggested heparan sulfate fragments might be easier to accommodate
within the carbohydrate binding site than heparin itself [44]. It follows that other
structurally similar carbohydrate fragments would bind with similar affinity in a
comparable mechanism.
Understanding the mechanism and affinity by which YKL-40 binds ligands is
crucial to our comprehension of its physiological function. This knowledge will serve as
a foundation for future campaigns toward rational development of a potent antagonists
enabling cell biological study and addressing YKL-40 as a therapeutic target. To
accomplish this goal, we must describe the molecular-level mechanisms governing the
interaction of YKL-40 with polysaccharides

. In this

study, we used classical molecular dynamics (MD) simulations to differentiate modes of
ligand recognition and specificity. Using free energy perturbation with replica exchange
-

determined affinities overcoming

the experimental difficulties encountered thus far. As polysaccharide physiological
ligands, we considered several options; provided below is a brief description of each
carbohydrate ligand considered, as well as justification for consideration.
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Figure 5.1 Monomeric units of the polysaccharides considered as potential physiological
ligands of YKL- 40: cellohexaose, chitohexaose, heparan sulfate, heparin, hyaluronan,
and chondroitin sulfate. The chito-

-1,4-

-1,4-1,4-

c

cNAc

-1,4-linked oligomers; the former
– -D-
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– N-acetyl- -DD-

– -D-glucuronic acid; IdoA – -

– N-sulfo- -D-

– N-acetyl- -D-

galactosamine.
Chito-oligomer
After cellulose, chitin is the second most abundant naturally occurring biopolymer
on earth [4], and is comprised of repeating N-acetyl- -D-1,4 glycosidic linkages (Figure 5.1). Based on the
experimental evidence of in vitro binding to YKL-40 [43], the chito-oligomers were
included as a control for comparison with other carbohydrates. Additionally, structural
data is available for YKL-40 bound to chito-hexaose, which was used to as base in our
computational modeling [43, 44].
Cello-oligomer
The central ring of the monomer, a six-membered pyranose, is common to a
number of carbohydrates including glucose, th
chemical similarity with chitin, as well as the general presence of glucose in mammalian
cells as a form of energy, a hexameric cello-oligomer was also examined as a potential
physiological ligand, despite its unlikely pr
Heparan sulfate and heparin
As described earlier, YKL-40 binds heparin, and thus, likely also binds heparan
sulfate. Heparan sulfate, a less sulfated form of heparin, is a polysaccharide found in
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abundance in the ECM and at the cell surface [227]. Heparan sulfate is constructed from
a repeating disaccharide of -D-glucuronic acid and N-acetyl- -D-glucosamine (Figure
5.1). Of all the glycosaminoglycans, heparan sulfate is the most structurally complex. At
least 24 different combinations of the disaccharide monomer exist, with differences
arising as a result of variation in both isomer and degree of side chain sulfation [228].
Additionally, the heparan sulfate polysaccharide can exhibit both sulfated (NS) and
-D-glucuronic
acid – (1,4) N-acetyl- -D-glucosamine is the most prevalent form of heparan sulfate
[228]. Focusing on the most relevant physiological ligands, we examined the fully
sulfated form heparin and the completely unsulfated form heparan sulfate.
Chondroitin sulfate
Chondroitin sulfate is also a glycosaminoglycan prevalent in mammals reportedly
known to have various functions as cell surface receptors, as extracellular signaling
molecules,

in

sulfation-mediated

neuronal

plasticity,

and

in

myogenic

differentiation/regeneration [229]. The primary structural units of chondroitin sulfate are
-D-glucuronic acid and N-acetyl- -D-galactosamine disaccharides
-1,3 and

-1,4 glycosidic linkages (Figure 5.1). As with

heparan sulfate, chondroitin sulfate exists in variably sulfated types along with its
stereoisomer dermatan sulfate [229, 230]; we have selected the 4,6-Ovariant of chondroitin sulfate polysaccharide as our candidate based on its dominant
existence over other forms in human aggrecan preparations isolated from knee cartilages
[231].
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Hyaluronan
Hyaluronan is a particularly interesting glycosaminoglycan relative to this study
because of two main reasons, first being the fact that chito-oligosaccharides are
precursors to hyaluronan synthesis in vivo [232-234], and secondly it is seen that
hyaluronan is also up-regulated in similar malignancies just like YKL-40 which we
discuss the details ahead in this chapter. The structural relationship of these two
molecules is such that binding mechanisms were expected to be similar at alternating
-D-glucuronic acid and Nacetyl- -D-glucosamine disaccharides conne

-

-1,4

glycosidic linkages (Figure 5.1). As with heparan sulfate, hyaluronan is also a
glycosaminoglycan comprising the extracellular matrix and plays critical role in
stabilization of cartilage matrix [235]. At extracellular pH, the carboxyl groups of
glucuronic acid are fully deprotonated giving the ligand an overall negative charge under
typical physiological conditions [236, 237].
5.3
5.3.1

Methods
Molecular Dynamics Simulation
MD simulations were constructed starting from the chitohexaose-bound YKL-40

structure deposited by Houston et al. (PDB ID 1HJW) [43]. The apo simulation simply
removed the chito-oligomer from the primary binding cleft. As crystal structures of YKL40 bound to other polysaccharides are not available, we used the structural similarity of
polysaccharides as the basis for modeling the remaining polysaccharides in this
investigation. In the case of cellohexaose, hyaluronan, heparan sulfate, heparin, and
chondroitin sulfate, we located the central ring atoms of the ligand backbone in the same
136

location as that of the original chitohexaose. Appropriate pyranose side chains and
glycosidic linkages (Figure 5.1) were added using CHARMM internal coordinate tables
to construct the remainder of the sugar residue [166]. All polysaccharides were described
using the CHARMM36 carbohydrate force field [193-195]. The missing force-field
parameters for N-

in heparin were developed using the

Force-field Toolkit (ffTK) plugin for VMD [170, 238]. More details of this force-field
parameterization are provided in Appendix 2.
Protonation states of all the titratable residues were determined according to the
corresponding pKa values calculated by the H++ web server [189]. The protein,
structural waters, and ligands were constructed in a vacuum using CHARMM [166]. The
system was minimized for 1000 steps in vacuum using the Steepest Descent (SD)
algorithm followed by another 1000 steps of minimization with the adopted basis
Newton-Raphson (ABNR) algorithm. This procedure reduces the number of bad contacts
prior to solvation of the solute. The polysaccharide systems were solvated in 100 Å × 100
Å × 100 Å cubic boxes. Sodium or chloride ions were added to the solution to ensure

the charge of YKL-40 titratable residues. The charged ligands, hyaluronan (-3), heparan
sulfate (-12), and chondroitin sulfate (sodium ions for charge neutrality, respectively. After solvation, the systems were
SD with the protein and ligand
restrained, 1000 steps of SD with only the protein restrained, and 2000 steps of SD and
2000 steps of ABNR with no harmonic restraints. Extensive minimization, up to 10000
steps of SD, was carried out for systems bound to highly sulfated polysaccharides and
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MD simulations. The systems were heated from 100 K to 300 K in 50-K increments over
NPT
ensemble at 300 K and 1 atm (101325 Pa) for 100 ps. The Nosé-Hoover thermostat and
barostat were used to control temperature and pressure in CHARMM [212, 213].
Production MD simulations of 250 ns were performed in the canonical ensemble
at 300 K using NAMD [169]. Temperature was controlled using Langevin thermostat
[214]. The SHAKE algorithm was used to fix the bond distances to all hydrogen atoms
[215]. Non-bonded interactions were truncated with a cutoff distance of 10 Å, a
switching distance of 9 Å, and a non-bonded pair list distance of 12 Å. Long range
electrostatics were described using the Particle Mesh Ewald method with a 6th order b[216]. The
velocity Verlet multiple time-stepping integration scheme was used to evaluate nonbonded interactions every 1 time step, electrostatics every 3 time steps, and 6 time steps
between atom reassignments. All simulations used a 2-fs time step. The CHARMM36
force field with the CMAP correction [166, 191, 192] was used to describe YKL-40. The
polysaccharides were described using the CHARMM36 carbohydrate force field [193195]. Water was modeled using the TIP3P force field [196, 197]. All simulations used
explicit solvent.
A complete list of simulations and calculations performed to meet the objectives
of this study is given in Table 5.1. The length of each MD simulation is also given, as not
all simulation lengths were the same; several of the hypothesized ligands dissociated
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from the binding cleft, and the simulation was halted to conserve computational
resources. The free energy calculations performed are also indicated. If a ligand did not
remain in the binding cleft throughout the entirety of the MD simulation, a free energy
calculation was not performed.
In addition to these protein-carbohydrate complexes, oligo-saccharides were
solvated in water separately, without YKL-40. These ligand-only simulations were
ations
beyond those originally proposed were also developed, as described below, in order to
study the effect of ligand position on conformational changes and to understand the
statistical significance of observed interactions with the putative heparin-binding subsite.
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Table 5.1 Simulations and calculations performed in the investigation of the binding of
polysaccharides ligands to YKL-40.

Case No.

a

System

MD
simulation

Free Energy
Calculation

1

Apo YKL-40

250 ns

--

2

YKL-40 + chitohexaose

250 ns

-REMD

3

YKL-40 + cellohexaose

250 ns

-REMD

4

YKL-40 + hyaluronan

250 ns

-REMD

5a

YKL-40 + heparin (fully sulfated)

50 ns

--

6

YKL-40 + heparan sulfate (unsulfated)

50 ns

--

7

YKL-40 + chondroitin sulfate

50 ns

--

Four YKL-40 + heparin systems were constructed: two with heparin initially in the

primary polysaccharide binding cleft and two with heparin initially located in bulk
solution.
5.3.2

-REMD
Free energy perturbation with Hamiltonian replica-exchange molecular dynamics

(FEP/ -REMD) was used to calculate the absolute free energy of binding the
polysaccharide ligands to YKL-40 [174, 175]. This protocol uses Hamiltonian replicaexchange as a means of improving the Boltzmann sampling of free energy perturbation
calculations. The parallel/parallel replica exchange MD algorithm in NAMD was
implemented as recently described [113, 169]. The free energy calculations performed
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using this approach were accomplished through two separate sets of free energy
calculations following the thermodynamic cycle illustrated in Figure 5.2. To obtain each
carbohydrate ligand was first decoupled from the
solvated protein-carbohydrate complex

1.

The second calculation

entailed decoupling the solvated oligosaccharide from solution into vacuum to obtain
2

2

–

1,

gives the absolute free energy

of binding the given ligand to YKL-40.

Figure 5.2

-REMD method.
-phase state.

In each free energy calculation, five separate terms contribute to the potential
energy of the system: the non-interacting ligand potential energy, repulsive and
dispersive contributions to the Lennard-Jones potential, electrostatic contributions, and
the restraining potential. In each calculation, the ligand was decoupled from the system
by thermodynamic coupling parameters controlling the non-bonded interaction of the
ligand with the environment. The parameters decoupled the ligand in a four-stage
process, wherein the coupling parameters defined replicas that were exchanged along the
length of the alchemical pathway. This decoupling, as reported shortly ahead, has been
described in detail previously [113]. A total of 128 FEP replicas were used (72
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dispersive, 24 repulsive, and 32 electrostatic), and a conventional Metropolis Monte
Carlo exchange criterion governed the swaps throughout the replica exchange process
[175]. The free energy of binding was determined from 20 consecutive, 0.1-ns
simulations of each corresponding system, where the first 1 ns of data was discarded as
. The oligosaccharide ligands were restrained in the ligand-binding pose
using a harmonic restraint on the distance between the center of mass of the protein and
the center of mass of the ligand. The harmonic restraint force constant was 10
kcal/mol/Å2. This restraint bias was removed from the free energy calculation according
to the approach outlined by Deng and Roux [173]. Multistate Bennett Acceptance Ratio
(MBAR) was used to determine electrostatic, repulsive, and dispersive contributions to
free energy [176]. Standard deviation of the final 1 ns free energy values serves as the
error estimate. All simulation parameters in the free energy calculations mimic those
described in the MD simulations section. The progress towards the convergence of free
energy calculations for cellohexaose, chitohexaose and hyaluronan systems are shown in
Figure 5.3.
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Figure 5.3
calculations using the

-ns free energy perturbation
-REMD method.
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5.4
5.4.1

Results and Discussion
Protein-polysaccharide binding in YKL-40
MD simulation suggests that of the six polysaccharide oligomers investigated,

only three bind in a stable fashion in the primary carbohydrate binding site of YKL-40.
The three potential polysaccharide physiological ligands at this site include chitohexaose,
cellohexaose, and hyaluronan. In the section that follows, we will describe the dynamics
of chitohexaose, cellohexaose, and hyaluronan binding to YKL-40. The remaining three
ligands – heparin, heparan sulfate, and chondroitin sulfate – were dislodged from the
binding site over the course of MD simulations.

-1,4 glycosidic linkages in heparin

-1,4, modifies the relative orientation of disaccharide
monomers from that of the chito-oligosaccharide. The NMR solution structure of heparin
(PDB ID 1HPN) shows that the relaxed conformation is semi-helical [239], which cannot
be feasibly accommodated in the conserved, narrow carbohydrate binding site of YKL40. Heparan sulfate suffers from similar steric constraints posed by the relaxation driving
force. The bulky sulfated side chains of heparin introduce further steric hindrance, and in
the case of heparin and chondroitin sulfate, unfavorably strong electrostatic interactions
resulting from negatively charged moieties inconveniently located along the cleft (i.e.,
without a co-located, oppositely charged protein residue) eject the ligands from the cleft.
In the cases of heparin, heparan sulfate, and chondroitin sulfate, the ligands
-shape” conformation as they are expelled from
the cleft by charge- and steric-based effects. Relaxation of the sugar from the initial
binding pose is sufficient to initiate loss of critical non-bonded interactions along with a
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chondroitin sulfate were expelled from the cleft into bulk solution. Each of the three
ligands capable of binding with the primary binding cleft maintained the -1 boat
conformation over the entire simulation. Chitohexaose and cellohexaose remained in the
binding cleft over the entire 250-ns MD simulation, while maintaining the initial wide
“V-shape.” Hyaluronan developed a sharp “V-shape” within a few nanoseconds and
maintained this conformation within the binding cleft for the remainder of the simulation
(Figure 5.5); this is primarily due to variation in glycosidic linkage, where hyaluronan
-1,3

-1,4 linkage of cello- and

chitohexaose.

- and hyaluronan-bound

structures disabuses one of the notion that similar binding mechanisms exist at alternate
binding sites, as only the -1 site pyranose appears to maintain similar sidechain
orientation.

Figure 5.4 Relaxation of the polysaccharide ligands in the primary binding cleft of YKL40. Each ligand is shown after a 100comparison, the chito-

n

lines behind each oligosaccharide. The YKL-40 protein has been aligned such that each
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oligosaccharide is oriented in the same manner; though, YKL-40 is not shown for visual
clarity. Heparan sulfate, heparin, and chondroitin sulfate relax significantly from the
initial distorted conformation.

Figure 5.5 Hyaluronan in YKL-40 binding site at 0 ns (left) and at 250 ns (right)
illustrating difference between V-shape conformations of hyaluronan.
The native distorted conformation is characteristic of glycoside hydrolase
pyranose binding behavior in the -1 site (Figure 5.4) [80]. In solution, polysaccharide
pyranose moieties adopt the energetically favorable chair conformation [240]; however
when bound to an enzyme, the active sites of catalytically-active glycoside hydrolases
distort the pyranose ring in the -1 binding subsite into a less energetically favorable
conformation, such as a boat or skew conformation [241-244], priming the substrate for
hydrolytic cleavage. Interestingly, the chitohexaose ligand bound in the primary binding
site of YKL-40 exhibits a boat conformation despite not being catalytically active [43].
This suggests that the sugar distortion in the -1 binding site contributes to ligand binding
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as well catalysis

overcome an activation

energy barrier in a catalytically-inactive lectins. A recent study of a homologous chitinase
suggested that -1 pyranose relaxation reduces binding affinity and affords the ligand more
flexibility and entropic freedom [245], which is consistent with our findings from the
250-ns MD here.
5.4.2

Putative heparin-binding site
Despite the fact that the heparin oligomer could not be accommodated by the

YKL-40 binding cleft, MD simulations do suggest that the oligomer interacts with the
surface of YKL-40 at a putative heparin-binding site (Figure 1.6B). After ejection from
the primary binding site, the oligomer spontaneously binds to the YKL-40 heparinbinding site (Movie 6.1). To address the significance of this unanticipated event, we
performed three additional independent MD simulations of the YKL-40/heparin system:
one with a new random number seed, though in the same configuration, and two
additional simulations with the ligand randomly placed in solution (Movie 6.2). In each
case, the heparin oligomers were capable of finding and binding to a group of charged
residues at the surface of YKL-40 (Figure 5.6); these were the basic residues of a putative
heparin-binding

-149. Interestingly, this domain follows
– XBBXBX, where B is a basic residue and X is any non-

basic amino acid – that is noted for its ability to recognize polyanions like heparin [246].
In all four cases, heparin recognized the binding site within 25 ns of MD simulation
(Figure 5.6), occasionally visiting other moderately basic surface locations before
motif. The strong electrostatic interaction arose from
the dynamic formation of salt-bridges between either the sulfate or the carboxyl groups of
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the heparin oligosaccharide and the side chains of the basic amino acids. Coupled with
experimental observation of heparin affinity, our MD simulations suggest a non-specific,
surface-mediated binding interaction between YKL-40 and the extensively sulfated
heparin oligomer [43, 44]. While the unsulfated variant, heparan sulfate, did not visit the
heparin-binding site, chondroitin sulfate also attached to the putative heparin-binding site

glycosaminoglycans, i.e., highly sulfated and negatively charged, we anticipate the
XBBXBX motif may also routinely appear in chondroitin-binding proteins.
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Figure 5.6 Snapshots from four independent MD simulations of heparin (white stick)
binding to a putative heparin-binding site (blue surface) of YKL-40 (gray surface). The
primary oligosaccharide binding site of YKL-40 is marked by an aromatic residue shown
in salmon surface representation. Transparent spheres illustrate the initial simulation
positions of heparin. In two cases, (a) and (b), the heparin ligand was initially bound in
the primary YKL-40 binding site. In both cases, the ligand was expelled from the primary
binding site into solution and located the heparin-binding site through electrostatic
interactions. Two additional simulations, (c) and (d), were initialized with the heparin
ligand free in solution.
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5.4.3

Polysaccharide ligand binding affinity
Each of the three polysaccharides maintaining contact with the primary binding

site of YKL-40, cellohexaose (or likely any glucose derivative), chitohexaose, and
hyaluronan, are feasible ligands. However, free energy calculations suggest that
hyaluronan may preferentially bind with YKL-40 when chitin is not indicated as a
foreign entity. The absolute free energies of binding cellohexaose, chitohexaose, and
hyaluronan to YKL-40 were 3.01

0.88,

, and

1.10 kcal/mol,

respectively. Repulsive, dispersive, and electrostatic components of the free energy
changes are tabulated in Table 5.2.
Table 5.2 Energetic components of the free energy of ligand binding to YKL-40. All
values are in kcal/mol.

System

repu

disp

elec

rstr

YKL-40 +
Cellohexaose

0.53

Cellohexaose

0.31

0.38

1.00

1.79

0.72

0.81

0.36

1.0

0.31

0.36

0

YKL-40 +
Chitohexaose
Chitohexaose a

78.81

1.08

0

YKL-40 +
Hyaluronan
Hyaluronan

a

0.67
79.65

0.33

Hamre, Jana [217]
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0

Tot

b

The free energy of solvation for chitohexaose was previously calculated by our
group as part of a study on family 18 chitinases [217]; this value has been used in our
calculation of chitohexaose binding affinity to YKL-40 for computational efficiency. The
methods used to calculate solvation free energy of chitohexaose were identical to those
described here. Furthermore, the binding free energy of chitohexaose to YKL-40 is in
good agreement with that of homologous family 18 chitinases, despite mutation of the
catalytic motif in the lectin.
Chitohexaose and cellohexaose are both neutral ligands but display a significant
difference in binding affinity to YKL-40. Electrostatic interactions appear to be one of
the more significant contributors to the enhanced affinity of chitohexaose over
cellohexaose (Table 5.2). For cellohexaose, the change in the electrostatic component of

for chitohexaose was energetically favorable (
hyaluronan, electrostatic interactions play an even greater role in enhancing affinity of
the ligand for YKL-40 (
contribution is reflective of increasing number of electronegative atoms in the sidechains
of carbohydrates as we go from cellopentaose to chitohexaose to hyaluronan. We observe
no significant differences in cellohexaose, chitohexaose, or hyaluronan binding to YKL40 arising from Weeks-Chandler-Anderson (WCA) dispersion and repulsion (Table 5.2).
This is largely a function of the molecular similarity of the pyranose rings comprising the
monomeric units of three oligosaccharides (Figure 5.1). The pyranose rings of
carbohydrates bound in the active sites of glycoside hydrolases, and by extension, the
binding clefts of lectins, form carbohydrate-
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aromatic residues along the clefts [247]. In YKL-40, these stacking interactions are
formed in the -3 and -1 binding sites with residues Trp31 and Trp352, respectively.
Naturally, any polysaccharide ligand capable of binding in the YKL-40 binding cleft will
likely exhibit a similarly favorable WCA binding free energy component. In the
following section, we expand upon the molecular-level interactions that contribute to
polysaccharide binding affinity in YKL-40.
Based on these results, it is unlikely that a cello-oligomer would bind in the cleft
of YKL-40 over a chito-oligomer, and thus, while there is potential for YKL-40 to bind a
cello-oligomer or glucose, it would not be inhibitory. Hyaluronan, on the other hand,
likely competes with chito-oligomers in binding, which is due in large part to the
-40 binding
cleft. Clinical data supports hyaluronan as a biomarker for cancer prognosis and
inflammation [236, 248], the same events in which YKL-40 appears at elevated serum
levels [42]. To our knowledge, there are no studies evaluating the coexistence of YKL-40
and hyaluronan. The cell receptor protein CD44 has been implicated in hyaluronan
binding interactions and is also involved in confounding scenarios, both aggravating and
improving inflammation [249].

nce alignment of YKL-40 with the hyaluronan-

binding domain of human CD44 [250], using BLASTP 2.3.0 [251], shows no homology,
further suggesting that this YKL-40-hyaluronan binding is different from previously
known hyaluronan-binding proteins [252].

152

5.4.4

Polysaccharide Binding Dynamics
YKL-40 is highly homologous with carbohydrate-active enzymes found in

glycoside hydrolase family 18 [74, 253]. Despite lacking catalytic ability, the primary
polysaccharide binding site of YKL-40 exhibits remarkable similarity to these family 18
chitinases. As such, one may reasonably expect that ligand binding within this family will
demonstrate similar trends, regardless of evolutionary origin. Indeed, we observe that
chitohexaose, cellohexaose, and hyaluronan binding in the primary binding site of YKL40 follow a general pattern common to carbohydrate-active enzymes. Namely, that ligand
binding interactions are mediated by carbohydrateresidues, and hydrogen bonding interactions are critical to overall ligand affinity and
stability. We investigate
simulation trajectories, including root-meanroot-mean-

) of both the protein and the ligands over the course

of the simulation, hydrogen bonding analysis, degree of solvation of the ligand, and
interaction energy of the ligand with the protein.
Cellohexaose, chitohexaose, and hyaluronan binding in the primary YKL-40
binding site did not adversely affect protein dynamics. In each case, binding the
polysaccharide ligand did not significantly disturb the protein backbone (i.e., protein
fold), and the ligand remained relatively unperturbed over the course of the simulation.
The RMSD of the protein (Figure 5.7a) is a measure of deviation over the course of the
simulation from the initial configuration, which was the first frame of the simulation
following NPT density

the protein

backbones suggests the simulations reached a local
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RMSD change over 250 ns is small given the significant chemical differences in the three
ligands examined, which indicates the primary YKL-40 binding site is forgiving of small
charged side chains such as the carboxylate of hyaluronan. The RMSF fluctuation of the
protein backbone similarly describes fluctuation of a given protein residue from the
average position over the course of the entire simulation. As with the RMSD calculation,
the RMSF of the protein backbone suggests the binding of chitohexaose and cellohexaose
does little to disturb the overall protein conformation (Figure 5.7b). In the case of
hyaluronan binding, we observe increased fluctuation in residues 178-189, 225-235, and
300-325 over that of cellohexaose and chitohexaose bound YKL-40. Both loops 225-235
and 300-325 are located away from the primary carbohydrate-binding site; the increase in
flexibility in these loops appears to be related to solvent exposed polar residues sampling
bulk solution and is likely unrelated to hyaluronan binding. Segment 178-189,
-

-helix just beneath the +1 and +2 binding sites,

becomes increasingly mobile as its interaction with hyaluronan is lost in the formation of
the sharp V-shape. Despite localized increases in backbone flexibility, the overall protein
structure largely remains in the same initial conformation, as evidenced by the similarity
in RMSD (Figure 5.7a).
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Figure 5.7 (a) Root-meanmean-

-ns MD simulations and (b) root-40 without a ligand (apo) and bound to chitohexaose,

cellohexaose, and hyaluronan. Binding of chitohexaose, cellohexaose, and hyaluronan do
not significantly alter the dynamics of YKL-40.
The RMSF of the ligand, averaged over 250 ns as a function of binding site,
provides a measure of relative ligand stability. Error was estimated by block averaging
over 2.5 ns blocks. Ligand stability over the course of the simulation suggests hyaluronan
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is as stable, if not more so, as chitohexaose in the primary binding site (Figure 5.8a).
Although, cellohexaose appears to be more stable relative to the two other ligands at the
ends of the binding cleft. This latter finding is a function of the length of the side chains
attached to the pyranose rings of each of the ligands. Of the three carbohydrates, the
cello-oligomer has the shortest side chains, and thus, the ligand fluctuates less, as it does
not need to rearrange as significantly to induce binding. As shown above, this does not
necessarily correspond to the most thermodynamically preferential ligand and lower
RMSF could also be interpreted hypothetically as loss of translational and conformational
freedom, resulting in unfavorable entropic contribution.
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Figure 5.8 (a) RMSF of the polysaccharide ligands on a per-binding-subsite basis. Error
bars were calculated using block averaging over 2.5 ns. (b) Average number of water
molecules within 3.5 Å of each ligand monomer. Error bars represent one standard
deviation.
The hydrogen-bonding partners of chitohexaose, cellohexaose, and hyaluronan
are

al change of hyaluronan (Table

5.3). Defining a hydrogen bond as a polar atom within 3.4 Å and 60° of a donor, we
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identified the formation of donor-acceptor pairs and percent occupancy of these hydrogen
bonds between the protein and each carbohydrate moiety over the course of the 250-ns
MD simulations (Table 5.3). As described above, hyaluronan formed a sharp “V-shape”
in the polysaccharide binding cleft, which minimized steric hindrance and in turn,
modified accessible hydrogen bonding partners relative to chito- and cellohexaose.
Hydrogen bonds at the +1 site, between glucuronic acid and Asp207, Arg263, and
Tyr141, stabilized the hyaluronan conformation (Table 5.3). In the -1 subsite,
chitohexaose primarily hydrogen bonds with the side chain of Tyr206 and the main chain
of Trp99. In the cases of both cellohexaose and hyaluronan, the interaction with Tyr206
was abolished, and instead, supplemented by Trp99 alone. In the -2 subsite, the oxygen of
the chitohexaose acetyl forms a long-lived hydrogen bond with the indole nitrogen of the
buried Trp352; neither hyaluronan nor cellohexaose interact with the -2 site through this
tryptophan. Rather, Trp31, which stacks with the pyranose in the -3 subsite, acts as a
hydrogen donor to the -2 subsite glucuronic acid side chain of hyaluronan. In the case of
cellohexaose, the main chain of a solvent-exposed asparagine, Asn100, almost
exclusively mediates hydrogen bonding in the -2 site. The +2, -3, and -4 binding subsites
the ligand and the protein, and there is
little consistency in bonding partners across ligands. Certainly, these variations will
manifest in enthalpic contributions to ligand binding, as even a single hydrogen bond
may account for 1 – 7 kcal/mol of binding free energy in biological systems [219, 220];
such is likely the case for cellohexaose and chitohexaose binding to YKL-40, where the
latter exhibits both greater hydrogen bonding capability and a more favorable binding
free

energy.
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Table 5.3 Hydrogen bonding pairs from polysaccharide-bound molecular dynamics simulations. A hydrogen bond was defined as a
polar atom having a donor-acceptor distance of 3.4 Å and a 60° cutoff angle. Occupancy refers to the percent of the simulation during
which the hydrogen bond was formed. Occupancies less than 10% have not been reported unless relevant in comparison.

Binding
Site

Cellohexaose
Donor
-SC

Acceptor
-SC

Chitohexaose
Occupancy
56.28%

Donor

Occupancy

Donor

-SC

9.32%

LYS289-SC

-MC

8.48%

-SC

69.52%

ASN100-SC

-MC

TRP352-SC
ASN100-MC

-SC

Acceptor

Hyaluronan
Acceptor

Occupancy

-SC

13.40%

TRP31-MC

12.55%

ASN100-SC

-SC

35.71%

67.68%

TRP69-SC

-SC

9.76%

-MC

93.24%

TRP31-SC

-SC

41.46%

-SC

66.00%

ASN100-MC

-SC

22.27%

-4
LYS289-SC
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-3

TRP69-SC

-SC

53.32%

-SC

-SC

34.76%

ASN100-SC

-SC

21.80%

ASN100-MC

-SC

87.40%

-SC

-SC

-2
-SC

-SC

30.32%

TRP99-MC

-SC

16.03%

-SC

ASN100-SC

13.44%

ASN100-SC

-SC

13.60%

TRP99-MC

-SC

76.20%

TYR206-SC

-MC

75.16%

TRP99-MC

-SC

39.56%

TYR206-SC

-SC

16.52%

TRP99-MC

-MC

86.76%

-SC

ASP207-SC

96.19%

-1

-SC

ASP207-SC

15.16%

-SC

TYR141-SC

32.32%

-MC

ASP207-SC

74.08%

-SC

ASP207-SC

18.08%

-SC

TYR141-SC

17.00%

-SC

-SC

76.88%

TYR141-SC

-SC

13.52%

TYR141-SC

-SC

62.75%

TRP99-SC

-SC

48.14%

+1
-SC

15.04%

-SC

-MC

14.28%

TYR141-SC

45.68%
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TYR141-SC

TYR141-SC

-SC

+2

SC – Side chain; MC –

52.04%

-MC
TYR141-SC

-SC

18.88%

TRP99-SC

-SC

10.28%

– -D-

– N-acetyl- -D-

– -D-glucuronic acid.

Key aromatic residues – Trp31, Trp99, and Trp352 – play a significant role in
binding all three oligosaccharides. Notably, these tryptophans are conserved in other
-40) and mammalian lectin Ym1 [131,
225]. According to previous structural studies, these aromatic residues form hydrophobic
stacking interactions with pyranose moieties at the -3, +1, and -1 binding subsites,
respectively [44]. As mentioned above, this carbohydrate-

was observed across

the three polysaccharide ligands as a result of the chemically similar carbohydrate
“backbone” of pyranose rings. However, at the +1 site of hyaluronan, the stacking
interaction with Trp99 was not maintained. Instead, prominent hydrogen bonding forces
the +1 pyranose ring in an orientation that is perpendicular to aromatic Trp99 (Figure
5.5). Nevertheless, the similarity in WCA contributions to binding free energy for all
three polysaccharides suggests this +1 site stacking interaction weakly contributes to the
overall binding free energy.
The degree to which the binding cleft of YKL-40 was accessible to water
molecules did not change significantly with the bound polysaccharide. The degree of
ligand solvation was determined by calculating the average number of water molecules
within 3.5 Å of a given pyranose ring over the course of the simulations (Figure 5.8b);
error is given as one standard deviation. Chitohexaose and cellohexaose display similar
degrees of solvation across the length of the cleft. Hyaluronan allows a moderate increase
in degree of solvation of the cleft by comparison to chitohexaose, across the -3 and +1
subsites, where its sharp V-shape again contributes to variation in behavior.
similarity in solvent accessibility within the binding cleft regardless of ligand, it is
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unlikely that entropic contributions from solvation play a role in the observed differences
in ligand binding free energy.
5.4.5

Conformational changes in the YKL-40 binding site
Crystal structures of YKL-40 bound with chito-oligosaccharides suggest that

YKL-40 undergoes a conformational change upon chitin ligand binding [43], contrary to
suggestions that lectin binding sites, in general, are “pre-formed” to accommodate their
natural substrates and undergo little change upon sugar binding [13]. Houston et al.
reported that the residues forming a loop (residues 209 to 213) near the primary YKL-40
binding cleft occupy an unusual conformation in apo YKL-40 when compared to the
ligand bound YKL-40 structure, where Trp 212 lines the +2 and +3 subsites [43].
However, a second structural investigation published concurrently did not observe a
similar conformation change in either of two crystal structures (1NWR and 1NWS),
where no ligand occupied either the +2 or +3 subsites [44]. Additionally, the positioning
of Trp99 at the +1 site in both apo structures of human YKL-40 (1HJX and 1NWR) and
-40 (1LJY) differs from that of holo-YKL-40 and homologous
mammalian lectin Ym1 (1E9L) [43, 44, 131, 225], with the tryptophan blocking the
binding cleft in the apo form. This conformational variation as a function of binding site
occupancy has been proposed as a tryptophan-mediated gating mechanism for ligand
binding in chitolectins [224].
Based on MD simulations we did not observe data suggesting binding cleft
rearrangement is important in polysaccharide binding to YKL-40. To investigate possible
loop rearrangement upon ligand unbinding, the apo YKL-40 simulation was prepared by
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undocking the bound chitin oligomer. One can reasonably expect that over the course of a
250-ns MD simulation, the 5-amino acid residue loop would, at a minimum, sample a
variety of conformations indicating flexibility in this region. However, in examining the
trajectory of this loop with respect to its initial position, we did not observe the peptide
loop returning to the unusual conformation even for a single frame (Figure 5.9). This
suggests that the crystallographic apo conformation may have resulted from serendipitous
crystal packing interactions and may not represent a typical conformational behavior.
Additionally, the phenomenon of tryptophan mediated gating, according to which one
would expect the Trp99 to return to the “pinched” conformation of the apo state, was not
observed. Though, we note the likelihood of observing that the latter behavior, i.e.,
returning to a “pinched” conformation, in an unbiased MD simulation is low and may
ugh enhanced sampling approaches.

Figure 5.9.
configuration in apo YKL-40 crystal structure during 250-ns MD simulation of apo YKL40 prepared by removing the bound ligand from holo crystal structure.
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5.5

Conclusions
We constructed polysaccharide-bound YKL-40 models understand the molecular-

level interactions of the protein with potential physiological ligands. MD simulations as
well as free energy calculations overwhelmingly suggest polysaccharide ligands, in
particular chito-oligomers and hyaluronan, are preferential physiological ligands of YKL40. The ability of YKL-40 to bind the polysaccharide ligands is related to the ability of
the carbohydrate ligands to adopt the primary binding cleft. These ligands are able to
form longer-lived hydrogen bonds deeper in the hydrophobic interior of the protein.
Additionally, electrostatic interactions play a key role in ligand recognition and affinity to
YKL-40. Improper alignment of side chains of heparan sulfate with the residues lining
the YKL-40 cleft, additional large and highly charged side chains of heparin and
chondroitin sulfate prohibit these ligands from binding in the primary binding cleft.
However, the smaller, negatively charged side chain of hyaluronan interacts favorably in
the primary binding cleft and contributes significantly to the affinity of this molecule.
Additionally, we confirmed the non-specific interaction of heparin with the putative
heparin-binding domain suggested from previous structural studies. The charged side
chains repeatedly and spontaneously interact with charged residues at this secondary
surface-binding site. Based on this study, we suggest that hyaluronan is a preferential
physiological ligand of YKL-40, which may explain the pervasive association of YKL-40
with the physical maladies in which hyaluronan has also been associated. These findings
not only identify physiological ligands of YKL-40, they enable future efforts to rationally
guide design of YKL-40 inhibitors, the design of which, is invaluable in the control of
inflammation-based disorders and possibly several types of cancer.
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Chapter 6 – Protein-protein interactions of YKL-40: Identification and
characterization of collagen binding sites
This chapter focuses on how these carbohydrate-binding proteins can also be
involved in surface interaction with other proteins as well. We worked on determining the
unknown binding site for collagen on YKL-40, analysis of protein-protein binding
abilities and calculation of relative binding affinities. This chapter has been adapted with
permission from Kognole and Payne [223], Copyright © 2017, American Society for
Biochemistry and Molecular Biology.
6.1

Introduction
Till now, the clinical use of YKL-40 as a biomarker in various mammalian

diseases and structural properties of this chitinase-3-like-1 lectin have been described in
the general introduction (Section 1.3.2). In the previous chapter we reported the
carbohydrate-binding abilities of YKL-40 with hyaluronan being thermodynamically
most preferred polysaccharide and heparin finding the surface binding site, however the
story of binding partners for YKL-40 does not stop there. As YKL-40 protein has been
observed to be up-regulated in various diseases that involve connective tissue
remodeling, and based on YKL-

for various types of collagen and

uncharted participation in collagen fibril formation [45], collagen has also been
considered as a potential physiological ligand. Hence, in this chapter we specifically
focus on identification and characterization of the collagen binding site of YKL-40 and
exploring different surface properties that facilitate this protein-protein interaction.
Collagen, unlike the other potential physiological ligands, is a macromolecular protein
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triple helix structure (Figure 6.1); there are at least 27 distinct types of human collagen,
forming a variety of biological networks, all of which are constructed of a basi
Xxx-Yyy

-

[254]

Xxx and Yyy, are proline (P) and hydroxyproline (O), respectively (Figure 6.1).

Figure 6.1 Triple helical structure of collagen from crystal structure (PDB ID –
-Pro-Hyp. Three strands

hydroxyproline (O) are also shown.
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Model collagen peptides have been observed in two different symmetries: the
original Rich and Crick model with 10/3 symmetry, 10 units in 3 turns, and the 7/2
symmetry of a more tightly symmetrical triple helix [255-257]. On the molecular scale,
collagen type will have relatively little impact on binding to YKL-40. However,
symmetry may have an impact on hydrogen bonding to the binding site, and thus overall
affini
collagen peptides of a true 10/3 symmetry have not been reported. Rather, the peptides
either have a 7/2 helical pitch or are somewhat “intermediate” in symmetry leading some
to believe that the 7/2 symmetry is representative of the true collagen helical structure
[258]. However, it is not known how universally true this hypothesis is, as the structures
of model peptides capture just a small subsection of the larger macromolecular structure
[259].
With a broad range of possible collagen architectures, we have selected four
representative model collagen peptides whose structures are both available from
crystallographic evidence and span the 10/3 and 7/2 symmetries to the greatest possible
extent. The first collagen peptide considered is that of the basic collagen peptide model,
[260]
substitution and 7/2 symmetry overall. Near the substitution site, the helix relaxes
somewhat from 7/2 symmetry, though not so much as to change overall symmetry. The

reverted the alanine substitution to its native glycine. Minimization of this structure
returns the helix to full 7/2 symmetry

.

The third model represents a segment from type III homotrimer collagen with
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approximate 10/3 symmetry in the middle part of the helix (PDB ID 1BKV) [255]. This
middle part of the 1BKV model peptide, also referred as the T3-785 peptide, has an
imino acidcollagen-

Our fourth model, 1Q7D, is a triple helical
including a

-Phe-Hyp-

-

-Arg

) motif in the middle [261]; this motif is not sufficiently long to exhibit 10/3
symmetry, exhibiting, rather, an intermediate degree of 7/2 helical symmetry. This 1Q7D
model

-I domain protein [262], and the
.

6.2
6.2.1

Methods
Docking of collagen triple helix on YKL-40
As stated in Chapter 6, all MD simulations were constructed based on the

chitohexaose-bound YKL-40 crystal structure deposited by Houston et al. (PDB ID
1HJW) [43]. However, construction of the collagen-bound YKLdocking calculations to appropriately position the ligand. The collagen peptides are
significantly larger than any of the carbohydrate ligands; thus, it is unlikely that a
collagen molecule occupies the primary YKL-40 binding site in the same manner as
chito-oligomer. Standard affinity-based docking calculations, such as the ones performed
in AutoDock, are not feasible for determination of an initial collagen-binding domain
given the size and flexibility of the triple helix structures. Rather, the collagen peptides
were docked on the basis of molecular shape complementarity using the online web
server PatchDock Beta v.1.3 [154, 156]. In the case of each of the four collagen-like
model peptides, PatchDock predicted two potential occupancies along the surface of
YKL-40, site A and site B. Binding site A corresponds to the primary carbohydrate-
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binding domain of YKL-40, though the collagen ligand was not as deeply entrenched in
the cleft as chitohexaose. Binding site B is located on the opposite side of YKL-40 from
the primary binding cleft. Thus for each collagen-like peptide, two MD simulations were
constructed representing the two potential binding sites. Figure 6.2 illustrates results of
the docking with predicted collagen binding sites A and B for the 1Q7D collagen-like
model peptide.

Figure 6.2 Molecular shape complementarity docking calculations predict collagen-like
peptides will bind to YKL-40 in two possible orientations. (a) the front view of YKL-40
(gray surface) with collagen docked in site A (green stick), (b) the back view where
collagen is docked in site B (cyan stick), and (c) top view of YKL-40 illustrating relative
positions of binding sites. The putative heparin-binding subsite is shown in blue surface
to aid in visualization of relative orientation of the protein-protein complexes. This
particular figure shows the integrin-binding collagen peptide, 1Q7D [261], in the
predicted binding sites along the surface of YKL-40; similar docking was carried out for
other collagen models.
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6.2.2

Molecular Dynamics Simulation
Most of the simulation setup procedure and parameters were exactly the same as

described in earlier chapter for YKL-40 with carbohydrate ligands. The only difference
was that the simulation box size was larger in this case with collagen being a larger
binding partner. The YKL-40 complex with collagen-like peptides was solvated in 120
Å × 120 Å × 120 Å cubic boxes. The CHARMM36 force field with the CMAP correction
[166, 191, 192] was used to describe YKL-40 and the collagen ligands. The parameters
for hydroxyproline were determined using ParamChem, which determines force field

version 0.9.7 beta [263]. The CMAP corrections for hydroxyproline were adopted simply
based on the analogy between proline and hydroxyproline residues. Water was modeled
using the TIP3P force field [196, 197]. All simulations used explicit solvent.
A list of simulations and calculations performed to meet the objective of this
study is given in Table 6.1. As described earlier, docking calculations of collagen-like
peptides on YKL-40 indicated two potential binding surfaces; for these cases, the
description in Table 6.1 lists both site and ligand. The free energy calculations performed
are also indicated. Free energy calculations being highly expensive in terms of
computational resources, only selective systems were included in this calculation. In
addition to these protein-protein complexes, collagen-like peptide models were solvated
in water separately, without YKL-40. However they were not used in any calculation or
analysis as their only purpose was to preliminarily confirm weather the triple helical
collagen-like peptides are eligible for dynamic studies and we have proper set of
parameters to represent their chemical properties.
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Table 6.1 Simulations and calculations performed in the investigation of the binding of
collagen ligands to YKL-40.

Case
No.

System

MD
Free Energy
simulation Calculation

8&9

YKL-40 + c

250 ns

--

10 & 11 YKL-40 + c

250 ns

Umbrella
Sampling

12 & 13 YKL-40 + collagen (1BKV) at site A & B

250 ns

--

14 & 15 YKL-40 + collagen (1Q7D) at site A & B

250 ns

Umbrella
Sampling

The constructed protein-ligand systems were minimized in vacuum and
[166], the solvated
systems were extensively minimized and heated to 300 K for 20 ps, which was followed
by MD simulation for 100 ps in the NPT ensemble. The coordinates following density
used as a starting point for 250 ns of MD simulation in the NVT
ensemble at 300 K using NAMD [169]. Explicit procedural details were similar to the
Chapter 6.
6.2.3

Free Energy Calculations: Umbrella Sampling
Convergence challenges make

-REMD inappropriate for determining the

binding free energy of the much larger and more flexible collagen-like model peptides.
Thus, umbrella sampling was used to determine th

detach the collagen

ligands from the shallow clefts of YKL-40. Over the entire reaction coordinate, this value
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, enabling relative comparison of collagen peptide affinity. The
MD umbrella sampling simulations used a native-contacts based reaction coordinate
analogous to that defined by Sheinerman and Brooks and as implemented in recent
cellulose decrystallization studies [209, 210, 264]. Here, a native contact was defined as
YKL-40 protein residue within 12 Å of a collagen peptide residue; distance was defined
by center of geometry of a given residue. The cutoff distance was selected to be larger
than the non-bonded cutoff distance, ensuring that the collagen ligand was no longer
interacting with YKL-40. Additionally, the water boxes of the collagen-YKL-40 systems
were made bigger to accommodate the
The change in free energy was determined as a function of the reaction
ulated as the weighted sum of the states of the native contacts. The
initial coordinates of the bound systems were selected from 250snapshots. The initial number of native contacts and their weights were calculated from
these snapshots. An initial reaction coordinate of 0 (normalized) corresponds to this
initial condition, and a final reaction coordinate of 1 corresponds to all of the native
contacts being outside the 12-Å cutoff (i.e., the ligand is decoupled and freely sampling
the bulk). The reaction coordinate was divided into 20 windows evenly spaced along the
reaction coordinate, and each window was sampled for 5 ns, where the reaction
coordinate was maintained at the specified value using a harmonic biasing force with the
force constant of 10000 kcal/mol. The potential of mean force profiles were calculated
using the weighted histogram analysis method (WHAM), and error analysis was
performed using bootstrapping [181].
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6.3
6.3.1

Results and Discussion
Protein-protein binding in YKL-40
Based on biochemical characterization, it is clear that YKL-40 functionally

interacts with collagen. For example, Bigg et al. uncovered the ability of YKL-40 to
specifically bind types I, II, and III collagen fibers [45], and Iwata et al. recently
discovered that YKL-40 secreted by adipose tissue inhibits degradation of type I collagen
by matrix metalloproteinase-1 and further stimulates the rate of type I collagen formation
[265]. However, a lack of structural evidence has precluded development of an
understanding of the molecular nature of these interactions. Using molecular docking,
MD simulation, and free energy calculations, we describe interactions of four collagenlike peptides with two putative protein-binding sites along the surface of YKL-40. The
selection of model peptides, as well as multiple binding sites, encompasses as many
potential binding modes as feasible to describe protein-protein binding dynamics and
relative affinity of YKL-40 for collagen.
6.3.2

Ligand Binding Dynamics and Comparison of Model Collagen-like Peptides.
Dynamics of the collagen-like peptide ligands varies with both binding site and

the pitch of the triple helix. Root-mean-

ility of

each collagen peptide in each of the two binding sites, A and B (Figure 6.3). Although
the molecular docking results in very close contacts between collagen and YKL-40
(Figure 6.2), such that collagen appears to be almost buried in the primary carbohydratebinding site of YKL-40, minimization and MD simulation results in slight rise and shift
in the position of collagen for every model at binding site A. Each of the four ligands
maintains association with the binding site A over the course of 250 ns, though with
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slightly different protein-protein contacts with YKL-40 (Figure 6.4). N
1BKV, and 1Q7D attained relative stability in a position not significantly different from
disrupted helical
content resulting from t
before associating with YKL-40. This relative change in position is shown in the RMSD
of the peptides during first 50 to 100 ns before stabilization (Figure 6.3a). Binding site B
accommodates helical pitches of 7/2 collagen
associated with YKL-40 with very little change in orientation relative to the initial
docked positions. T

was expelled from binding site B as was the

somewhat imperfect 10/3 pitched-1BKV peptide. This suggests YKL-40 may avoid
physiological interactions with certain collagen fibril domains, especially those having
imperfect helical pitches. The integrin-binding collagen-like peptide 1Q7D demonstrated
the greatest stability among collagen peptides in both binding sites (Figure 6.3) and
formed more native contacts with YKL-40 than the other three collagen peptides at
binding site A (Figure 6.4

stantial role

in mediating the interaction of this collagen peptide with YKL-40.
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Figure 6.3 Root-mean-

-like peptides over the course of 250-

ns MD simulations at (a) collagen binding site A and (b) collagen binding site B. Each of
the four collagen model peptides are shown.
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Figure 6.4 Native contact analysis of each collagen-like peptide model binding to YKL40 at site A and at site B. The
fractional percentage of frames in which the contact was formed) of the respective YKL40 residue as a native contact. A native contact was defined as anytime a collagen residue
was within 12 Å of a YKL-40 residue where distance was defined by center of geometry
of a given residue. Only frames from the last 100 ns simulation, following the period of
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Examining the number of native contacts between each collagen peptide and
binding site A of YKL-40 reveals several common interaction sites mediate collagen
binding and helps narrow down key regions of interest (Figure 6.4). YKL-40 residues 69
to 71, 98 to 108, 205 to 215, and 230 to 235 interact with all four collagen peptides, and
likely contribute to binding affinity, as we will discuss below. The region of YKL-40

position from docked conformation to stabilize the interactions. The 1Q7D model formed
the greatest number of interactions with YKL-40 residues relative to the other three
models. Similar native contact analysis for binding site B shows that even N-terminal and
C-terminal residues of YKL-40 are involved in collagen binding at binding site B (Figure
6.4). It shows that, unlike binding site A, there is little difference in number of

YKL-40.
To better understand the interactions collagen makes with YKL-40, identified
through the native contact analysis, we calculated electrostatic and van der Waals
interaction energies of each YKL-40 residue with each collagen peptide over the 250-ns
MD simulations (Table 6.2). Visual inspection of the simulations reveals aromatic
residues in the binding sites, such as Trp212 and Trp99 in binding site A and Phe49 in
binding site B, were involved in aromatic-proline stacking interactions with the collagen
triple helices. Such interactions are favorable, occurring due to both hydrophobic effects
-H bonds [266]. This is
illustrated in the van der Waals component of the interaction energy, where at binding
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site A, Trp69, Trp71, Trp99, Trp212 and Phe234 show substantial favorable interaction
with collagen peptides, though the contribution varies with each collagen peptide (Table
6.2). Additionally, acidic and basic residues of the integrin-

from

collagen-like peptide 1Q7D form ionic interactions with the counter-ionic amino acids of
YKL-40, also known as salt bridges. Specifically, 1Q7D forms three salt bridges at
binding site A and one salt bridge at binding site B (Figure 6.5). At site A, Arg105,
Asp207, and Arg263 of YKLrespectively, where the a, b, and c in the parenthesis corresponds to one of the three
strands of the
-binding motif. At site B, Lys23 of YKL-40 forms a salt bridge with
anticipated,

ed a substantial role in the

interaction of this collagen peptide with YKL-40, but its role was different from that of
the integrin binding mechanism, which further involves coordination of a metal ion [262].
Nevertheless, salt-bridges and hydrophobic contacts are very important in both cases,
significantly contributing to the electrostatic component of the binding affinity of this
collagen peptide relative to collagen peptides lacking acidic or basic amino acids (e.g.,

YKL-40 residues
(favorable electrostatic interaction energies, Table 6.2), though as a result of hydrogen
bonding rather than salt-bridge formation. We note that the interaction energies of YKL40 residues with residues of each collagen model peptide are not conserved as a result of

different imino-triplets.
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Table 6.2 Interaction energies of YKL-40 residues with collagen peptides. The values are reported in terms
of average interaction energy between major YKL-40 residues and collagen as a whole. van der Waals and
electrostatic contributions are also provided separately. Residues with total average interaction energy
greater than -4.18 kJ/mol have not been reported unless relevant to discussion. All the energies are in
kJ/mol.

VdW-Avg

Elec-Avg

Total Avg

Residue #

VdW-Avg

Elec-Avg

Total Avg

0.079

-5.635

-5.557

ASP232

0.000

-6.651

-6.651

THR184

-0.270

-3.917

-4.188

TRP99

-3.250

-1.806

-5.056

LYS182

-0.173

-3.992

-4.165

TRP212

-3.746

0.084

-3.662

TRP212

-3.268

-0.468

-3.736

VAL183

-2.367

-0.387

-2.754

ASP207

-0.175

-3.432

-3.607

PHE234

-2.445

-0.020

-2.465

TYR141

-1.061

-2.314

-3.376

ASN100

-1.265

-0.606

-1.871

0.010

-3.197

-3.187

-0.166

-1.182

-1.348

-0.809

-1.939

-2.748

-0.678

-0.588

-1.266

0.033

-2.461

-2.428

-0.525

-0.544

-1.068

TYR34

-1.861

-0.195

-2.056

TYR141

-0.909

-0.092

-1.001

ASN100

-1.631

-0.393

-2.024

ASP207

-0.158

-0.770

-0.928

TRP99

-1.365

-0.552

-1.917

PRO142

-0.091

-1.330

-1.421

VAL183

-1.500

0.143

-1.357

-0.347

-0.937

-1.283

VdW-Avg

Elec-Avg

Total Avg

Residue #

VdW-Avg

Elec-Avg

Total Avg

-0.211

-5.383

-5.594

ASP207

-0.970

-14.302

-15.272

-3.128

-0.966

-4.094

PHE208

-1.266

-3.398

-4.663

-0.576

-2.309

-2.884

ALA180

-0.468

-4.172

-4.640

ASN100

-1.971

-0.605

-2.576

TYR141

-1.302

-3.032

-4.334

TRP69

-1.520

-0.763

-2.283

TRP99

-3.116

-1.091

-4.207

TRP71

-2.146

-0.106

-2.252

HIS209

-1.763

-1.774

-3.537

Residue #

TRP99
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THR184

1BKV_A

1Q7D_A

Residue #

-1.386

-0.670

-2.056

TRP212

-1.972

-0.960

-2.931

TRP212

-1.583

-0.300

-1.882

LYS182

-0.377

-2.365

-2.742

ASP207

-0.074

-1.337

-1.411

SER179

-0.419

-2.309

-2.728

TYR34

-1.309

0.178

-1.131

-1.192

-1.388

-2.580

TRP31

-0.803

-0.121

-0.924

-0.433

-2.107

-2.540

-0.247

-2.058

-2.305

-0.652

-1.647

-2.299

ALA211

-0.195

-1.887

-2.082

TYR34

-1.660

-0.298

-1.958

-0.443

-1.035

-1.478

VAL183

-1.421

0.035

-1.386

ASN100

-0.947

-0.348

-1.296

TRP31

-1.096

-0.089

-1.184

1Q7D_B

1BKV_A

ALA211

TYR206

Residue #

VdW-Avg

Elec-Avg

Total Avg

Residue #

VdW-Avg

Elec-Avg

Total Avg

LYS23

-0.190

-20.619

-20.809

ASN89

-2.861

-6.322

-9.182

TYR22

-1.145

-11.156

-12.301

LYS377

-1.703

-6.249

-7.952

LYS91

0.011

-9.232

-9.221

ASP378

-1.224

-3.781

-5.004

PHE49

-3.618

-0.449

-4.066

ALA381

-2.240

-0.846

-3.086

ASP367

-0.062

-3.849

-3.912

-1.533

-1.004

-2.536

LYS377

-1.282

-2.186

-3.469

-1.952

-0.552

-2.504

THR52

-0.760

-2.420

-3.179

-1.526

-0.721

-2.247

ASP47

-0.227

-1.987

-2.215

PHE49

-1.761

-0.218

-1.980

LYS253

-0.280

-1.631

-1.911

TYR22

-1.055

-0.631

-1.686

ASN89

-1.654

-0.172

-1.825

LYS91

-0.891

-0.689

-1.581

ASP378

-0.225

-1.367

-1.592

LEU50

-0.677

-0.685

-1.362

ALA381

-1.250

0.077

-1.174

HIS53

-0.669

-0.541

-1.210

ASP199

-0.130

-0.880

-1.010
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THR52

Figure 6.5. Collagen binding with YKL-40. (a) Salt bridges formed between the 1Q7D
collagen peptide (green cartoon) and binding site A (gray surface) (b) Salt bridge
interactions of the 1Q7D collagen peptide (cyan cartoon) with binding site B (gray
surface).
From MD simulation, we observe substantial hydrogen bonding between the
collagen peptides and YKL-40 across the length of each binding site, which contributes
to overall stability and binding affinity. The hydrogen bonding analysis for the collagenYKL-40 systems was performed as described above for the polysaccharide ligands; pairs
exhibiting greater than 10% occupancy over the simulation are reported individually in
Table 6.3. The YKL-40 residues responsible for hydrogen bonding are not consistent
across each collagen model (Table 6.3). In ge
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Arg145, Ser179, Lys182, Thr184, Asp207, Arg213, Phe218, Asp232, Arg263 in binding
site A form hydrogen bonds with the peptides. Similarly at site B, Tyr22, Lys23, Asn87,
Asn89, Lys91, Lys377, Asp378 are typically involved in hydrogen bonding. The
variation in hydrogen bonding pairs between YKL-40 and the collagen peptides is a
natural extension of the

-Xxx-

;

there are many different potential donor and acceptor pairs in each case. Hydroxyproline
residues play a crucial role both as donor and acceptor in most pairs, benefitting from the
extra hydroxyl group relative to proline. Although all the collagen peptides maintain
association with collagen-binding site A, the hydrogen-bonding characteristics are
slightly different for each, which will in turn lead to affinity differences. The relaxed
effectively disrupts hydrogen bonding, and affinity for
the ligand is lost at binding site B. The 1BKV peptide model with 10/3 symmetry was
also unable to remain associated with binding site B, suggesting that binding site B may
be more sensitive to helical pitch and prefers 7/2 symmetrical helices.
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Table 6.3 Hydrogen bonding pairs between YKL-40 and collagen model peptides at binding site A,
including percentage occupancy, over 250-ns MD simulations. A hydrogen bond was considered to be a
polar atom having a donor-acceptor distance of 3.4 Å and a 60° cutoff angle. Occupancies above 100%
mean that the same pair was involved in more than one type of hydrogen bond.

1Q7D_A
Donor

Acceptor

Occupancy

Donor

Acceptor

Occupancy

HYP8-SC

79.68%

ASP232-SC

76.56%

-SC

-SC

164.84%

-SC

ASP207-SC

126.36%

-SC

THR184-SC

51.96%

-MC

HYP14-SC

19.60%

-SC

ALA291-MC

26.76%

SER103-MC

HYP14-SC

16.24%

HYP9-SC

-SC

25.56%

-SC

HYP2-SC

13.44%

HYP6-SC

-SC

18.80%

ASN100-SC

10.32%

TYR141-SC

-SC

17.28%

ASN100-SC

HYP9-SC

14.56%

SER179-SC

13.44%

TYR34-MC

13.24%

ASP207-MC

12.04%

-SC
HYP6-SC
-SC

other pairs

100.20%

Total

585.04%

-SC
HYP8-SC

HYP17-SC

other pairs

123.68%

Total

339.52%

1BKV_A
Donor

Acceptor

Occupancy

Donor

Acceptor

Occupancy

TRP99-SC

ALA17-MC

64.92%

HYP20-SC

-SC

75.72%

ASN100-SC

HYP17-MC

35.84%

-MC

PHE218-MC

56.88%

-MC

HYP5-MC

29.24%

-SC

SER179-SC

54.08%

-SC

HYP5-SC

26.20%

LYS182-SC

THR8-SC

45.60%

ALA291-MC

17.80%

-SC

TYR141-SC

42.56%

11.00%

-SC

ALA180-MC

40.04%

HYP14-SC
-MC

-MC
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other pairs

112.08%

Total

-MC

THR184-SC

33.00%

-SC

ASP207-MC

28.64%

-SC

ASP207-SC

21.56%

-SC

THR11-MC

20.24%

-SC

-MC

15.92%

-SC

TYR206-MC

13.72%

TYR141-SC

-MC

13.04%

TRP212-SC

-MC

12.76%

-SC

ALA211-MC

11.04%

other pairs

80.28%

Total

554.28%

307.88%

1Q7D_B
Donor

Acceptor

Occupancy

Donor

Acceptor

Occupancy

LYS23-SC

-SC

120.84%

ASN89-SC

-MC

94.68%

ASN87-SC

HYP6-SC

61.20%

HYP17-SC

ASN89-MC

84.72%

ASN89-SC

HYP6-MC

55.32%

LYS377-SC

HYP20-MC

59.92%

LYS91-SC

HYP9-SC

23.80%

ASN89-SC

HYP17-MC

47.84%

LYS377-SC

HYP3-SC

21.12%

HYP23-SC

ASP378-SC

32.80%

LYS91-SC

-SC

18.68%

LYS377-SC

-MC

30.20%

LYS377-SC

-MC

16.52%

-SC

HYP8-MC

18.40%

TYR22-MC

-SC

15.48%

HYP20-SC

ALA381-MC

16.92%

-SC

HYP15-SC

11.76%

ASN87-SC

HYP20-SC

15.68%

-SC

HYP18-SC

11.16%

HYP11-SC

LYS169-MC

15.28%

THR52-SC

-SC

10.00%

-SC

HYP11-MC

15.04%

HYP17-SC

12.80%

other pairs

Total

129.24%

LYS91-SC

495.12%
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other pairs

98.36%

Total

542.64%

6.3.3

Collagen-like peptide binding affinity
The relative binding affinity of collagen-like peptides to YKL-40 was determined

from umbrella sampling MD simulations. Here, we report the binding affinity of the
1Q7D collagen-like peptide, which is the integrin binding peptide with an overall 7/2
helical pitch [261, 262], at both sites A and B. We have also calculated binding affinity of

collagen

peptides

having

different residue substitutions

and helical pitches.

Unfortunately, in case of umbrella sampling for the native

at site B, we

were unable to obtain statistically reliable results, and thus, we will not discuss findings
relative to affinity of this model.
The umbrella sampling MD simulations of the 1Q7D collagen peptide at both
sites A and B show that YKL-40 has similar affinity for 1Q7D at both sites; whereas, the

site A (Figure 6.6). We note that the last umbrella sampling window in case 1Q7D at
binding site A shows a sudden, sharp increase in the PMF, which is an artifact of the use
of native contacts as an umbrella sampling reaction coordinate. As the standard Cterminals of three strands of collagen helix are negatively charged, they are attracted to
the nearby, highly positively charged surface of heparin-binding site. As a result, the final
window of the PMF overestimates the work to remove the 1Q7D peptide from binding
site A exclusively (Figure 6.6). Removing this latter window from the calculation, the
free energy of binding 1Q7D is

in site A and 10.26

in site B

kJ/mol
kJ/mol. The

relatively low statistical uncertainty at each window along the potential of mean force
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suggests sampling of the system was sufficient, providing a meaningful estimate of
binding affinity.

Figure 6.6. Binding free energy obtained from umbrella sampling MD simulations of the
YKL-40-collagen peptide systems, interpreted as negative of potential of mean force

reaction coordinate, where the reaction coordinate is fraction of native contacts.
The potential of mean force determined from umbrella sampling MD simulations

As free energy is a state function, the difference between the beginning and end state is
the binding affinity, regardless of path taken, as reported above. The path can provide
information as to barriers to unbinding; however, the collagen peptides are readily
removed from the binding sites along a relatively smooth path. This suggests there is
186

-40 in the release of the collagen
ligand.
reflected in the total hydrogen bonding occupancy in those two cases (Table 6.3).
Notably, the binding free energies of collagen to YKL-40 are approximately half that of
the tighter binding polysaccharide ligands. This suggests that YKL-40 will bind both
hyaluronan and chito-oligomers over collagen in the presence of all three. This does not
rule out collagen as a physiological ligand, but strongly supports hyaluronan as a
preferred physiological ligand of YKL-40.
6.4

Conclusions
The docking of triple helical collagen-like peptide models on YKL-40 surface

based on molecular shape complementarity at two surface binding sites again proves that

Analysis of protein-protein binding dynamics, compared over various collagen models,
provides detailed characteristics of surface binding residues at both the proposed binding
sites. Binding site A showed more adaptability towards different helical symmetries and
mutant disruptions. Binding site B only accommodated collagen peptides with 7/2
symmetry. Native contact analysis was very helpful in pointing out the most important
residues/loops that were involved in protein-protein interaction. 1Q7D collagen-like
-motif, appears to be the most favorable and stable
binding partner at both the sites among the four cases studied. The affinity of surface
binding of collagen was much less than the affinities for chitohexaose and hyaluronan in
the primary binding cleft. The demonstrated ability of YKL-40 to bind collagen
molecules with two surface binding sites adds another dimension to its functionality in
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extracellular matrix, as it has already been experimentally shown to affect collagen fibril
formation. However, further investigation of significance of this protein-protein
interaction is needed and combined with experimental evaluation of hyaluronan binding,
we could ultimately use this knowledge in order to utilize the mammalian glycoprotein in
many roles than just biomarker.
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Chapter 7 – Conclusions and future work
This dissertation has covered a crucial aspect of non-catalytic proteins having the

sugar codes, sometimes with the aid of surface-binding sites. As the underlying
mechanisms of such substrate recognition abilities are important to various applications,
we set out to develop a molecular-level understanding of interesting protein-carbohydrate
binding sites, their adaptability for ligand orientations, dynamical differences in binding
to various morphologies, and thermodynamic preferences to certain protein-carbohydrate
pairs; such an investigation provides critical insights that are beneficial towards the
development of biotechnological applications, for example better use of CBM diversity in
developing enzyme cocktails for efficient enzymatic hydrolysis. In this chapter, we
discuss how our work can impact the future directions of this research area.
Through our CBM studies, we reached two main conclusions about Type B
CBMs, based on MD simulations and free energy calculations. In the first part of the
study, Chapter 3, we not only confirmed the original Johnson, et al. [61] hypothesis that
C. fimi CBM4s are capable of binding cello-oligomers with the reducing end of the
pyranose at either end of the binding cleft, but also showed that this bi-directional
binding phenomenon also holds true for four other Type B CBMs. From this, we
hypothesize that all cellulose-specific CBMs with a -sandwich fold may exhibit this
ability. This bi-directional binding ability of cellulose-specific CBMs suggests that multimodular enzymes are evolved to recognize the free glycan chains with higher efficiency.
It is another indication nature has evolutionarily selected for proteins with mechanisms
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like bi-directional substrate recognition in response to the structural features of cellulose,
with the approximate symmetry of sidechains, as a means to break it down in faster ways
to maintain the balance of the carbon cycle. Nonetheless, we have more to learn from
nature to capitalize on it for industrial and developmental purposes. Accordingly, CBMs
with their basic attributes being independently folding proteins, abundant and
inexpensive matrix attachment regions, and compliant binding specificities have already
been employed in many applications, for example high-capacity purification tags for
protein isolation [35]. The bi-directional binding ability of Type B CBMs could be
harnessed for applications in which a directional preference is not critical, for example
targeting of functional molecules to materials containing cellulose. CBMs are already
being used to probe for polysaccharides in plant cell walls [94], and knowing that the
CBMs can bind bi-directionally necessitates considering additional factor in designing
probes for differentiation of the substrate morphologies. The molecular-level knowledge
of these Type B CBM binding clefts can be utilized to engineer proteins with more
flexibility towards binding orientations where ligands can offer symmetric interactions.
In Chapter 4, the architectural features of CBM binding sites in three families
from the same type of CBMs were studied, extensively illustrating various characteristic
differences that facilitate the tighter oligomeric binding within twisted platforms. The
investigation further leads to the fact that this difference in binding site, within same
family, is evolved to target distinct regions of non-crystalline cellulose and not only
single glycan chains. The study highlights an overlooked element in structural
characterizations of proteins that, although the active site or ligand-binding site is of
prime importance towards proteins functionality, the rest of the protein surface and,
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specifically, the neighboring loops of the binding site may play a critical role in defining
the larger aspect of protein functionality. We anticipate our work will motivate more inat extend beyond the immediate proteincarbohydrate interface. Undoubtedly, MD simulations facilitate such investigations once
structural data from either X-ray crystallography or NMR spectroscopy is available, but
homology modeling is proving to be an increasingly reliable tool for structural biologists.
We envision extension of this research would involve mutations in the exterior loops
around the twisted binding platforms of family 17 and 28 CBMs, which would be tested
across range of non-crystalline substrates; from this, we would be able to identify the true
contributions to specificities. This information would also benefit development of refined
CBM probes for probing plant cell wall architecture by enabling biotechnology with
differential arrays of CBMs capable of recognizing specific morphologies on noncrystalline substrates. Exact identification the composition of pretreated biomass in terms
of crystalline, non-crystalline, and soluble substrate, with better resolution of noncrystalline morphologies, allows design of complementary enzyme cocktails for efficient
and faster hydrolysis. The different hydrogen bonding patterns across the two platforms
pose a great example that even the small differences in binding site have evolved to
provide the functional specificity.
As stated earlier, Section 1.3.1.5, there is more to the story of Type B CBMs,
pertaining to the fact that, in nature, four out of six CBMs studied here are found in
tandem. The tandem Type B CBM construction further confounds fundamental
understanding, as the two tandem CBM systems, CfCBM4-1/CfCBM4-2 and
BspCBM17/BspCBM28, differ in their binding abilities. There are two basic

191

dissimilarities in these tandems. First, both have either sandwich or twisted binding
platforms in their individual CBMs, and second, there is significant difference in linker
length. The BspCBM17/BspCBM28 tandem, having twisted platform CBMs and a longer
peptide linker length, exhibits cooperative binding effects, with up to 100-fold higher rate
of association over that of the individual CBMs [106]. The tandem CfCBMs have a very
short linker in combination with sandwich platforms of both individuals, and show only
additive affinity improvement relative to separate domains [98]. Using these tandems
CfCBM4-1/CfCBM4-2 and BspCBM17/BspCBM28 as representative models, we plan

binding. The relative orientation of two partners in the wild-type tandems, length of the
linker region between the two, and relative presence of the bound glycan chains are
parameters that may contribute to cooperativity. We have obtained preliminary results
examining the wild-type tandems, where the individual CBMs were connected by
modeling the linker peptide between them based on t

[105, 267].
-ns

trajectories that we have analyzed through residue-residue cross-correlations (Figure 7.1)
and principal component analysis (PCA) (Figure 7.2). In the case of tandem CfCBM4s
with a short linker, a large amount of strong negative correlations were observed between
the residues from the two different CBMs; while in tandem BspCBMs, correlation across
the CBMs was relatively very low. Additionally, we observed a large network of strong,
positive correlations in tandem BspCBMs between residues of the same CBM, and these
two CBMs only interact through the linker. In contrast, the tandem CfCBMs show strong
positive correlations that extend across the linker to connect residues of one CBM to that
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of the partner CBM. This is a promising indication that short linkers induce highly
interdependent motions of the CBMs, which may restrict co-cooperativity. The PCA
analysis provides the essential dynamic information that allows us to describe the protein
motions that contribute the most to conformational variation. Figure 7.2 shows that the
tandem BspCBMs have highly scattered conformations in a trajectory along largest
principal components (PC), while tandem CfCBMs have closely related groups of
conformers.
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Figure 7.1 Visualization of residue-residue cross-correlation of tandem CBMs calculated
based on RMSD of the protein backbone ( -carbon only). The linker length in BspCBMs
is longer than that in CfCBMs. The blue lines represent strong negative correlation
between a pair of residues, while the red lines represent strong positive correlation.
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Figure 7.2 PCA analysis of preliminary MD simulation data. Left panels illustrate the
clustering of conformers on a principle components 1 and 2 (PC1-PC2) space. A
c
the trajectory. The r
displacement (or variance) of atomic fluctuations captured in each dimension
characterized by their corresponding eigenvalue.
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Through long-timescale MD simulations and post-process analysis, such as these
above, future studies will address protein-protein networking in these tandem CBMs,
comparing individual CBM dynamics and binding mechanisms. With variations in linker
lengths, through swapping of the linkers between tandems, adding cello-oligomeric
ligands in the binding sites of CBMs to consider possible allosteric effects, and further
introduction of the catalytic module in the modeling, I expect to characterize the overall
behavioral attributes of these multi-modular enzymes.
For the other non-catalytic protein, YKL-40, studied in this dissertation apart
from CBMs we also arrive at remarkable conclusions. We have covered most of the ECM
components having the potential to be a physiological ligand of this multi-functional
protein. In Chapter 5, we modeled and analyzed the binding mechanism of YKL-40 for
its known binding partner, chitohexaose, along with 5 different oligosaccharides, where
chitohexaose, hyaluronan and cellohexaose could remain in the primary binding site;
heparin was able to bind to a surface binding site. Moreover, in Chapter 5, the same
mammalian glycoprotein was able to bind four different model collagen peptides through
two different surface binding sites. The absolute thermodynamic favorability of YKL-40
for hyaluronan over not only chitohexaose but also collagen model peptides calls for
prompt experimental confirmation of this prediction. In vitro binding studies of YKL-40
with hyaluronan and structural characterization of their interactions would provide further
resolution of this novel interaction, which along with in vivo studies for expression levels
of both the partners in various malignant tissues, will reveal a clear picture about the
physiological significance of this strong biomolecular binding. Nonetheless, the details of
these non-catalytic protein-carbohydrate interactions discussed in this dissertation can be
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adapted to develop new inhibitory molecules/pathways for this lectin. The affinity of the
YKLneeds further attention, as this surface-binding site may play a role in cell-cell and cellmatrix interactions. Heparin-Sepharose chromatography is used to purify YKL-40 [45]; a
similar purification approach could also be developed for other proteins by modifying a
surface patch with high positive charge density in the heparin-binding motif,

YKLof many types and symmetries of collagen triple helices. The significance of having two
binding sites needs to be further analyzed, as it may play a crucial role in bringing the
two helices together in fibril formation; however, the experimental evidence of YKLinvolvement with collagen fibril formation is ambiguous and reports both inhibitory and
stimulatory effects based on different forms of protein [45]. Study of this protein-protein
relationship will clarify the higher expression levels of YKL-40 in inflammatory joint
diseases like osteoarthritis.
In summary, this dissertation applies state-of-art computational approaches to
gain molecular-level understanding of inconspicuous mechanisms and unidentified
interactions in two studies of carbohydrate recognition by non-catalytic proteins namely,
Type B CBMs, recognizing oligomeric and non-crystalline cellulose, and YKL-40,
-protein interactions, such as tandem CBMs or collagen
binding of YKL-40, inevitably come into the picture, as many biological events are
highly interdependent and often must be studied simultaneously for effective analysis of
results.
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Appendix
A1 Supporting information related to CBMs
As the title suggests, Appendix A1 reports the additional details of simulation
procedures. Also, some additional results about data analysis and free energy calculation
methods that are not exactly related to actual theme of the dissertation are reported here.
Information in this appendix has been adapted with permission from Kognole and Payne
[184], Copyright © 2015, Oxford University Press.
A1.1 Additional methods for Chapter 3
The CBM-ligand complex systems illustrated in Figure 3.1 were constructed
using CHARMM as described in the manuscript [166]. Protonation states of the titratable
residues were determined by H++ and manual inspection [187-190].
ASP120 from CfCBM4-1 were protonated whereas no residues were protonated in
CfCBM4-2.
A1.1.1 Molecular Dynamics (MD) Simulation
The CBM-cellopentaose systems were minimized in vacuum in a stepwise fashion
using the method of steepest descent. For 1000 steps, the ligand side-chains were
minimized, holding all other atoms fixed. The entire ligand was minimized for an
additional 1000 steps, with the protein held fixed. Finally, the protein and ligand were
minimized for another 1000 steps with no constraints. An additional 1000 steps of
minimization using Adopted Basis Newton-Raphson algorithm completed the vacuum
minimization procedure. The minimized systems were then solvated; CfCBM4-1 systems
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-box (~27,300 atoms), and CfCBM4-2 systems were
-box (~22,000 atoms). Sodium atoms, 13 for CfCBM4-1 and 13
for CfCBM4-2, were added to neutraliz
Particle Mesh Ewald electrostatic approximations. The solvated systems were reminimized in a stepwise fashion. Holding the protein and the ligand fixed, the water
molecules were minimized for 1000 steps of steepest descent. The restraints on the ligand
side chains were then removed, and the water and ligand side chains were minimized for
1000 steps of steepest descent. The entire ligand and water molecules were then
minimized for 1000 steps of steepest descent, and then, the entire solvated complex was
minimized for 2000 steps of steepest descent and 2000 steps with adopted basis NewtonRaphson method.

NPT ensemble for 100 ps. The Nosé-Hoover thermostat was used to control temperature
in CHARMM [212, 213]. Shake was used to fix the distances to hydrogen atoms [215].
Non-bonded interactions were truncated with a 10-Å cutoff. The Particle Mesh Ewald
method with a 6th order b-spline [216],
mesh size of 90 × 90 × 90 was used to describe the electrostatics. All simulations used a
2-fs time step. The CHARMM36 force field with the CMAP correction was used to
describe the protein [166, 191, 192], and the CHARMM36 carbohydrate force-field was
used for the ligand [193-195]. Water was modeled using the modified TIP3P force field
[196, 197]. Production MD simulations were performed using NAMD in the NVT
ensemble at 300 K for 250 ns using a 2 fs time step [169]. Temperature was controlled
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using Langevin thermostat in NAMD [214]. All other simulation parameters were the

A1.1.2 Free Energy Simulation
To determine the absolute binding free energy of the CfCBM4-1-RE and
CfCBM4-1-NRE systems to cellopentaose per the defined thermodynamic pathway
(Figure 3.3), the solvation free energy of the cellopentaose ligand must be determined.
Accordingly, a solvated ligand system was constructed in a fashion similar to the proteinligand systems. The cellopentaose ligand was solvated in a 65-Å

-box (~9,000

minimized, heated, and
energy simulations were started from the 0.1effective diffusion of the highly mobile water molecules.
One hundred twenty-eight Free Energy Perturbatio

-windows, treated as

replicas, were run concurrently, obtaining an acceptance ratio of > 80% along the
alchemical path. These 128 replicas were distributed into 72 repulsive, 24 dispersive, and
32 electrostatic replicas. The MD simulations were performed using periodic boundary
conditions in the NVT ensemble at 300K with a 1-fs time step. The systems were
propagated with the multiple time step integration scheme and Langevin dynamics. Forty

1/100 steps. The force field parameters were the same as described above for the MD
simulations. Initial structures of the enzyme-ligand complexes were taken from the final
. Translational and rotational
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restraining potentials were applied in the enzyme-ligand free energy calculations. The
distance from the initial center of mass of the ligand to the initial center of mass of the
protein was maintained through an applied 10 kcal/mol/Å2 harmonic restraint.
Energies collected from the MD simulations were used to determine repulsive,
electrostatic, and dispersive contributions to the free energy of binding. The Multistate
Bennett Acceptance Ratio (MBAR) was applied to determine free energy and statistical
uncertainty associated with each 0.1 ns interval [176].

-

REMD calculations (40 × 100 ps), the last 30 (3 ns) were used to obtain the average free
energy of binding. The contribution of this restraint to the free energy was determined via
rule as described by Deng and Roux [173]. The
error associated with the binding free energy was obtained from determining the standard
deviation over the last 3 ns for each of the two sets of calculations and combining
standard deviation using error propagation rules.
A1.2 Additional results
A1.2.1 The effect of replicaThe time progression of the 40 consecutive 0.1 ns FEP calculations is illustrated
in Figure A.1a. The free energies reported in Chapter 3 (Table 3.1) were obtained from
the final 3 ns. Statistical uncertainty of each point has been determined using MBAR. The

also considered. One g
improve the statistical sampling, perhaps leading to faster convergence. The reported free
energy
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as described in
steps and 1/10 steps. All other parameters were identical. The binding free energies for
kJ mol-1

CfCBM4-1-

kJ mol-1, respectively (Figure A.1b). We found a moderate

toward convergence did not appear to be affected (Figure A.
increase in computational expens
CfCBM4-1-NRE free energy calculation was not warranted.
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Figure A1.1

-ns calculations using

-REMD. (a) The difference between the average value for either CfCBM4-1-RE or
CfCBM4-1-NRE and the cellopentaose solvation free energy represents the binding free
energy. (b) The free energy calculation for CfCBM4-1-RE system using different replica

steps.
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A2 Supporting information related to YKL-40
Appendix A2 reports the details of forceMD simulation. Information in this appendix has been adapted with permission from
Kognole and Payne [223], Copyright © 2017, American Society for Biochemistry and
Molecular Biology.
A2.1 Force-field parameterization for modeling heparin
Modeling of h

ment of new force-field

parameters for a sugar, where the acetyl group in N-acetyl glucosamine was replaced by
SO3-1 (Figure A2.1). ParamChem was used to obtain an initial set of parameters based on
analogy with available data [263, 268]. As the sulfamate anions were not explicitly
supported, parameters obtained for –NHSO3 group by analogy

optimization.

The Force Field Toolkit (ffTK) Plugin Version 1.0 in VMD [238] was used to optimize
the partial charges, bonds, angles, and dihedrals as described in the reference publication
and provided examples. Parameters obtained using this approach are given in Table S2.
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Figure A2.1 Atom labels of N-sulfo- -D-glucosamine structure used for optimization of
missing force-field parameters. The only missing parameters were the ones around N-S1
bond as documented in Table S2.

205

Table A2.1 CHARMM-additive

optimized using the ffTK v.1.0

plugin in VMD. The atom labels are as illustrated in Figure A2.1.
Bonds

Kb

b0

C2 – N

271.158

1.464

N – S1

332.175

1.823

N – HN

440.214

1.029

S1 – O2

540.346

1.452

Angles

Ktheta

Theta0

C1/C3 – C2 –N

91.721

112.507

N – C2 –H2

114.884

111.824

C2 – N – S1

124.591

117.44

C2 – N – HN

79.624

107.895

S1 – N – HN

74.629

129.979

N – S1 – O2

152.857

109.282

O2 – S1 – O7

103.66

105.957

Dihedrals

Kchi

n

Delta

N – C2 – C1 – O5

0.2

3

0

N – C2 – C3 – O3

0.2

3

0

N – C2 – C1 – O1

0.2

3

0

C4 – C3 – C2 – N

0.2

3

0

N – C2 – C3 – H3

0.2

3

0

N – C2 – C1 – H1

0.2

3

0

C1/C3 – C2 – N – S1

1.12

3

180

H2 – C2 – N – HN

0.527

3

180

H2 – C2 – N – S1

2.994

3

0

C2 – N – S1 – O2

1.048

3

180

NH – N – S1 – O2

0.831

3

0

C1/C3 – C2 – N – HN

1.575

1

0

O4* – C1 – C2 – N

0.2

3

0

*this O4 is from the glycosidic linkage this residue will be involved in.
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